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Preface
The first clinical use of a cardiac valvular prosthesis took place more than 50 years
ago, when Dr. Charles Hufnagel implanted the first artificial caged ball valve in the
descending aorta of a patient to treat aortic insufficiency. Since then, it has become
clear that quality of life can be improved if a diseased heart valve is replaced by a
prosthetic device. Studies on the medical complications in currently used substitutes
involve many expensive and time-consuming experiments. Too often, the develop-
ment of improved prostheses or new concepts is based on empirical knowledge and
understanding.
Existing artificial (biological or mechanical) heart valves are studied in animal and
clinical studies and in experimental in vitro studies. Experimental models use mock
loops or pulse duplicator systems to mimick the physiological environment of the
left or right heart in a controllable manner. Heart valves can be tested under stan-
dardized hydrodynamic conditions and thus they can be compared more accurately
and subject independent. Important design criteria of heart valves are related to the
behavior of the valve in the flow field. In particular, pressure gradients should be as
low as possible. Stagnation, recirculation zones and shear stresses are to be mini-
mized in order to prevent platelet activation and initiation of coagulation.
In vitro testing implies that prototypes of the valves are already available at the
time of testing. In the course of the design process, valves are computer designed
and virtual valve prototypes are available in an early stage of the design process.
The challenge remains, however, to test the haemodynamic performance of these
virtual prototypes. To do so, advanced computational algorithms, which take into
account the continuous and full interaction between the flow and the valve leaflets
(Fluid-Structure Interaction), are required. They may specifically be helpful in ob-
taining insight in system responses, which are difficult to capture experimentally.
In this dissertation it will be demonstrated that computational fluid dynamics or
CFD simulations can be used to study the complex valve hydrodynamics in detail.
The developed algorithms will be applied on two cases. First, it will be shown that
the CFD code allows to simulate the behavior of existing numerical valves, such as
bileaflet valves, in a 3D flow field. As such, CFD can be a tool for valve design prior
1
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to manufacturing prototypes for detailed testing. In future, numerical models will be
a major research tool to unravel the haemodynamics associated with thrombolytic
and hemolytic events of new and existing mechanical heart valves. Computer meth-
ods may help estimating blood damage in different heart valve designs. As such,
they can help in the development of a heart valve that doesn’t require any antico-
agulation therapy. It’s a long way before computers, if ever, will replace animal
testing. Nevertheless, together with better experimental testing, numerical model-
ing integrated into the clinical research may help in significantly reducing animal
experiments.
Secondly, there are new developments in tissue engineering (TE), where big effort
is done to produce viable and durable tissue engineered valves. A critical point in
the production process is the maturation and conditioning of TE valves in a biore-
actor. It is important to know and to control the forces exerted on the leaflet and
cells throughout the growing process. Here also, CFD can play a major role. From
CFD perspective, the challenging task is to model the dynamic interaction of the
flexible valve leaflet with the surrounding blood and to calculate the local defor-
mations and stresses in the structure. However, the large differences in material
properties of the fluid and structure and the finite motion of the leaflets complicate
blood-valve interaction modeling. Until now, this has impeded numerical analysis
of valves operating under physiological conditions. With the presented computer
methods, the shear stress on the cells of a tissue engineered heart valve construct
can be calculated. This could play a key role in the successful development of a
tissue engineered heart valve.
The dissertation is structured as follows. Part A contains all the introductory chap-
ters. In the first chapter heart valve anatomy, physiology and histology are ex-
plained. In the second chapter heart valve diseases, diagnosis, treatment and tissue
engineering are described. The third chapter gives an engineering perspective on
the testing and performance of heart valve constructs.
Subsequently, part B concentrates on experimental in vitro testing and modeling of
heart valves. Two more chapters focus on a mitral bileaflet heart valve (On-X) and
on an aortic monoleaflet heart valve (Omnicarbon), respectively. The third chapter
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of part B investigates a newly developed bioreactor environment for the creation of
a viable tissue engineered heart valve.
The main goal of these chapters is to familiarize the reader with fluid dynamic valve
testing and to provide some background on (i) performance estimation as used in
this field of research, and (ii) the requirements of bioreactor systems as used in tis-
sue engineering.
The major achievements of this work are within the domain of numerical model-
ing, both of mechanical and biological heart valves. These novel contributions are
assembled in part C, which is the core of this PhD. A first study presents the al-
gorithm, followed by a 2D validation study. The model is then applied on a 3D
realistic mechanical heart valve (ATS) in the next two chapters. The final chapter
gives a detailed explanation of a 2D flexible heart valve numerical model.
The developed methods are discussed with attention for improvement of some crit-
ical points. It is our believe that the experimental and numerical models presented
in this dissertation will be useful as an analysis tool to improve existing valve pros-
theses and to develop new prosthetic valve concepts leading to more advanced heart
patient care and cure.
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Part A.
Introduction
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Chapter I
Anatomy and physiology of heart
valves
Scientific knowledge of the heart dates back almost as far as the beginnings of
recorded history. Among the first people to investigate and write about the anatomy
of the heart was the Greek physician, Erasistratus, around 250 BC. Erasistratus de-
scribed the appearance of the heart and the four valves inside it. Although he cor-
rectly deduced that the valves prevent blood from flowing backward in the heart,
he did not take into account that the heart was a pump. Claudius Galenus (129-201
AD), a Greek-born Roman physician, recognized that the heart was made of muscle,
but he believed that the liver was responsible for the movement of blood through the
body. Leonardo da Vinci (1452-1519 AD) made a number of advances in the un-
derstanding of blood flow. He deduced that eddy currents help heart valves to close,
but he was not aware of a closed blood circulatory system. An important milestone
was William Harveys discovery (17th century) of the pumping function of the heart
and the circulation.
Nevertheless, now nearly 400 years later, an accurate quantitative description of car-
diac function is still a challenge. In this chapter, the anatomy and physiology of the
normal heart, heart valves and the blood are introduced.
I.1. The human heart and circulation
The human heart acts like a pump which provides the circulation of blood in the
human body. To achieve an efficient circulatory system that allows sufficient gas
exchange through the lungs and supplies the organs with heat and oxygen, the hu-
man circulatory system consists of two circuits connected in series (figure I.1(a)).
The largest loop is the systemic circulation that is maintained by the left side of the
heart and provides oxygen rich blood to the muscles, tissue and the organs. After the
7
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(a) The sequence of blood flow in the circula-
tion.1
(b) Anatomy of the heart and governing pres-
sures.2
Figure I.1.: The heart and circulation.
blood has passed the organs, it flows into the right side of the heart. The right heart
subsequently pumps the blood through the pulmonary circulation. The main func-
tion of this circulation is to pass blood through the lungs where it is oxygenated.3
Looking at the heart in somewhat more detail, it is divided into four cavities or
‘chambers’ - two atria (left and right) and two ventricles (left and right) - each
closed off by a one-way valve (figure I.1(a)). The left and right side of the heart are
separated by the septum. The upper and lower caval veins (venae cavae) collect the
blood into the right atrium (RA) from where it passes through the tricuspid valve
into the right ventricle (RV). Contraction of the right ventricle squeezes the blood
through the pulmonary (pulmonic) valve towards the lungs where the oxygenation
takes place. Via the pulmonary veins, the blood reaches the left atrium (LA), passes
through the mitral valve and fills the left ventricle (LV). With the following contrac-
tion, the blood is squeezed through the aortic valve into the aorta and the rest of the
systemic circulation (figure I.1).5
In the course of a day, the heart contracts and expands on average 100,000 times,
pumping approximately 8,000 liters of blood.6 By opening and closing in a synchro-
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Figure I.2.: Left ventricular heart cycle with from top to bottom: ECG, pressure, flow velocity,
volume.4
nized manner, the four valves ensure the one-way flow of the blood in the human
circulation.
I.2. The cardiac cycle
While pumping blood through the circulatory system, the heart goes through alter-
nating phases of filling and ejection. Both atria and ventricles work synchronously,
but the atria and ventricles go through different phases. Hereafter the phases for the
left heart will be discussed. In the right heart, the exact same phases occur but at
lower pressures (figure I.1(b)).
The cardiac cycle can be divided into a systolic (ventricular contraction) and dias-
tolic (ventricular relaxation) time interval (figure I.2).
During the isovolumic systolic contraction of the left ventricle (LV), pressure rises
from 10 to around 80 mmHg. During this phase both the aortic and mitral valve are
closed. When the ventricular pressure rises above aortic pressure, the valve opens
and blood is ejected from the LV into the aorta. The aortic velocity profile shows
a maximum velocity of about 1 to 1.4 m/s. The ventricular and aortic pressures
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further rise to 120 mmHg.
The diastolic portion of the heart cycle can be subdivided into four phases: (1) iso-
volumetric relaxation, (2) rapid or early filling (E-wave), (3) diastasis (L-wave) and
(4) atrial contraction (A-wave). In the first phase, between the time of aortic valve
closure and mitral valve opening, LV pressure drops exponentially from the aortic
pressure level to a pressure of a few mmHg existing in the left atrium (LA). The
next phase, i.e. early filling (E-wave), begins when pressure in the left ventricle
(LV) falls below that in the LA, opening the mitral valve and the LV to start fill-
ing. The third phase is diastasis (L-wave), with little extra filling of the atrium. The
fourth phase or atrial contraction of the left atrium (A-wave), contributes for an ex-
tra 15 to 25 % of the LV filling.5 The mitral velocity profile has a first peak of 0.7
m/s (E-wave) in early diastole and a second increase of velocity 0.5 m/s following
the atrial contraction (A-wave).
I.3. How valves function
The upper chambers of the heart, the atria, are anatomically separated from the
lower chambers or ventricles by a fibrous ring. The four cardiac valves are embed-
ded within this ring. All valves have thin flaps, called leaflets or cusps, that open to
let the blood through and close to prevent it from flowing backward (figure I.1).
I.3.1. Atrioventricular valves
The atrioventricular valves, i.e. the mitral and tricuspid valve, are situated between
the atrial and ventricular chambers. The mitral (figure I.3(a)) and tricuspid valve
leaflets are connected by chords (chordae tendineae) to muscle bundles or papillary
muscles in the chamber walls. Contraction of these muscle bundles during the ejec-
tion phase pulls the chords to open the valve and also prevents the valve leaflets
from flipping upward into the atria.
I.3.2. Semilunar valves
The semilunar valves, i.e. aortic and pulmonary valves, are flaps of connective tissue
reinforced by fibers. They are shaped like half a moon, hence the name semilunar.
The aortic (figure I.3(b)) and pulmonary valves have no chords but consist of flaps
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(a) Mitral valve. (b) Aortic valve.
(c) In normal individuals, the mitral valve opens
to allow blood to flow into the left ventricle.
(d) In the normal individual, the left ventricle
contracts and fully opens the aortic valve.
Figure I.3.: Left ventricular heart valves.1,7
of tissue or cusps at the exit from the chamber, which are pushed open by the flow
of blood and fall back together to close off the ventricle once the blood has been
ejected. Because of their structural design, they are less likely to experience any
form of prolapse. Each cusp has a margin that is attached to the wall of the aorta
or pulmonary artery and another free margin. The cusps are positioned so that a
portion of their free margin overlaps the adjacent cusp, i.e. the lunulea (coapta-
tion).7 This mechanism is of great importance in maintaining valve competence
and preventing backwards leak of blood into the ventricle. The point where two
adjacent cusps meet at the wall of the artery is called a commissure. Since there are
three cusps, a semilunar valve normally has three commissures. The aortic cusps
11
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are named according to the coronary artery which arises above it. There is a right
coronary cusp, a left coronary cusp, and a non-coronary cusp which is unrelated to a
coronary artery. The aortic heart valve furthermore consists of three sinus cavaties,
i.e. the sinuses of Valsalva (figure I.3(b)). These sinuses are a widening of the aortic
wall. The pulmonary valve also has three cusps, named according to their position
- anterior, left and right posterior cusps. The aortic valve has been thought of as
a passive structure where all of its mobile components move only as a results of
blood pressure and flow. It has been shown, that the commissures move outward
in a passive response to pressure resulting in an increase of the aortic valve radius.
This outward movement of the commissures initiates valve opening.8, 9
I.4. Histology of heart valves
It is widely believed that all heart valves are simple structures contributing to the
unidirectional flow of blood and responding to pressure gradients across the valve.10
It is now becoming apparent, however, that heart valves have a complex structure
optimized for an active performance in the microenvironment in which they are
placed.11
It is thus important to consider the histology of natural heart valves. The princi-
pal cell types in the native heart valve are the valvular interstitial cells (VICs) and
valvular endothelial cells (VEC).10, 12, 13 They are embedded into the heart valve
extracellular matrix.
I.4.1. Valvular interstitial cells
VICs mediate ongoing extracellular matrix (ECM)14 repair and remodeling. This re-
generative process appears to be vital to normal valve function.15, 16 Moreover, the
integrity of collagen and other ECM components (i.e., elastin and proteoglycans) is
the principal determinant of the durability of heart valves. Structural deterioration
of native and biological substitute valves is ultimately mediated by chemical (enzy-
matic) and mechanical damage to collagen. The quality of valvular ECM depends
on the condition of VICs and their ability to adapt to environmental need. The VICs
of nearly all current bioprosthetic valve substitutes become nonviable during pro-
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cessing. Thus, in a tissue valve without any viable cells, ECM damage that occurs
during substitute valve function after implantation cannot be repaired.17
I.4.2. Valvular endothelial cells
VECs form a monolayer on the leaflet surface that constitutes the primary inter-
face between the bloodstream and inner valve tissue. Whilst there is significant
data on the various functions of vascular endothelium,18 the specific role of valve
endocardium remains unclear and has not been widely studied. However, it seems
reasonable that the VECs minimally act to maintain a nonthrombogenic valve sur-
face, similar to the vascular endothelium.19
I.4.3. Heart valve extracellular matrix
The principal components of the valve extracellular matrix (ECM) are the fibrous
macromolecules (i) collagen and (ii) elastin, (iii) proteoglycans and (iv) glycopro-
teins, each component conferring unique physical and mechanical properties.20
Each of the three major structural valve components (collagen, elastin and proteo-
Figure I.4.: Aortic valve histology.21
glycans) constitutes a significant proportion of each of the three morphologically
distinct and functionally significant layers of the valve leaflet matrix.22 These lay-
ers are termed the fibrosa, spongiosa, and ventricularis.23 Finally the valve leaflet is
covered by an endothelial cell layer.
13
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• Fibrosa. The fibrosa layer forms the load-bearing fibrous backbone of the
valve leaflet, consisting of sheets of collagen bundles.20 They are mainly
arranged parallel to the cuspal free edge24 as shown in figure figure I.4.21 The
collagen fibers are highly folded in radial direction and when stretched they
are simply unfurling their coils. Furthermore, the collagen on its own is not
highly deformable (extensible).21
• Spongiosa. The central located spongiosa is composed of loosely arranged
collagen and glycosaminoglycans (GAGs). The spongiosa appears to lubri-
cate relative movement between the fibrosa and the ventricularis and dissipate
energy by acting as a shock absorber during closure.20
• Ventricularis. The ventricularis layer is much thinner than the other two lay-
ers, and is abundant in radially aligned elastic20 fibres as shown in figure I.4.21
Elastic fibres, i.e. elastin, allow tissues to withstand repeated deformation.25
Elastin is believed to be responsible for maintaining the aortic valve collagen
fibre architecture (mainly in the fibrosa) in its neutral corrugated state.26
Structural components of the ECM, such as collagen and Glycosaminoglycans (GAGs),
have major roles in valvular degeneration and calcification of bioprosthetic heart
valves. In particular the GAGs located in the spongiosa layer of the heart valves are
extremely important for mechanical properties.20 Their rigidity provides structural
integrity to cells and provides channels between cells that permit cell migration.
The elastin fibers permit distension of the aortic wall and leaflets while the colla-
gen bundles provide tensile strength, limit distension and prevent disruption. This
organization controls the distribution and magnitude of tensile stress.27
I.5. Mechanical properties of the aortic valve leaflets
Recent morphologic observations of elastin structures in aortic valves suggest that
elastin is mechanically coupled to collagen. Since the mechanical stiffness of elastin
is considerably lower than that of collagen, and aortic valves contain relatively little
elastin, the mechanical importance of elastin in heart valve function is not clear.21
Examining the tension/strain curves,21 it can be seen that in the radial direction (fig-
ure III.9), the ventricularis appears to dominate the elastic response of the elastin
fibers in the low-strain region. At these low strains, the fibrosa does not contribute
14
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any tension since its collagen fibers are highly folded in radial direction and is sim-
ply unfurling its coils. In the circumferential direction (figure III.9), a similar pro-
Figure I.5.: Mechanical properties of the aortic valve layers.21
cess occurs, but to a lesser extent. Below strains of 0.15, the fibrosa has little effect;
between 0.15 and 0.25, the fibrosa and the ventricularis contribute almost equally,
and above strains of 0.25 and loads of 2.0 N/m, the fibrosa begins to dominate, be-
cause the collagen fibers are fully unfolded.
Elastin tends to dominate the distensibility curves of the radial ventricularis, but
participates very little in the fibrosa. The low but significant tension produced by
the elastin structures of the aortic valve, together with previously observed elastin
morphology as well as the measurable preload of elastin, suggest that the purpose of
elastin in the aortic valve leaflet is to maintain a specific collagen fiber configuration
and to return the fibers to this state, once external forces have been released.21, 26
Furthermore Lee and Vesely et al.27 showed that damage to elastin in vivo will
enable the collagen network to elongate, reducing valve cusp extensibility and in-
creasing stiffness. Damage to elastin may therefore contribute to the degeneration
and failure of prosthetic valves.27, 28
The modulus of Young E for normal aortic valve leaflets found in literature is be-
tween 1 · 106 N/m2 and 2 · 106 N/m2.29, 30, 31, 32 The thickness of the leaflet varies
between 0.2 and 1.4 mm,29, 33 but most researchers use about 0.6 mm as a standard
leaflet thickness for aortic valve.31, 32, 34
I.6. Rheology of blood
So far, the properties of the fluidum at hand have not been addressed. For experi-
mental and numerical studies it is important to consider the properties of the fluid
as they influence the behavior of the heart and valves.
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Blood is a concentrated suspension of blood cells in plasma. The properties of blood
are governed by the concentration of red blood cells (hematocrit or Ht). The viscos-
ity of blood increases with the concentration of red blood cells.35 The discussion
on the properties of blood in this section is limited to physiological values of Ht
(30-50%). Furthermore Fahraeus and Lindqvist36 observed a decrease in the blood
viscosity in tubes with small diameters (<500µm). Since heart valves have bigger
diameters, the so-called Fahraeus-Lindqvist effect is not further discussed.
Figure I.6 demonstrates the shear-thinning behavior of blood. At low shear rates (γ˙
< 10s-1), the red blood cells tend to aggregate. This aggregation of red blood cells
increases the viscosity. If shear rate is increased, the aggregates break up and the
Figure I.6.: Viscosity in steady shear of normal blood, blood with hardened red blood cells
(no deformation) and blood in Ringer solution (no aggregation).37,38,39
red blood cells align with the flow. The higher shear rates are deforming the red
blood cells and eventually decreasing the viscosity.37
In the literature on blood flow in large arteries and heart valves, blood is generally
modeled as a Newtonian fluid (fluid with a constant viscosity value) with the high
shear rate limit viscosity of blood (µ=µ∞).29, 40, 41, 42, 43 When studying low levels
of shear such as pertain to recirculation regions and vortices populating a heart valve
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wake, the blood non-Newtonian characteristics overwhelm its Newtonian high shear
characteristics. In these cases it is valuable modeling the blood as a non-Newtonian
fluid.44, 45 The Cross and Carreau model is commonly used for the modeling of the
shear rate dependent viscosity of blood.45, 46, 47, 48, 49, 50, 51
µ = µ∞ + (µo − µ∞) · [1 +K · γ˙a]
n-1
a (I.1)
where µo=0.1072 10-3 mPa·s, µ∞=3.5 mPa·s, n=0.3568, K=2.6502, a=2 and γ˙ the
shear rate in 1/s.52 The Casson and the power-law model are other models which
can be used for the modeling of the non-Newtonian behavior of blood in the low
shear rate region.53
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Chapter II
Heart valve disease and treatment
Surgical replacement of diseased human heart valves by mechanical and tissue valve
substitutes is now commonplace, with approximately 93,000 valve replacements
done each year in the US54 and 275,000 worldwide.17 Although survival and quality
of life are enhanced for many patients, prosthesis-associated complications55 and
failure are still frequent and have a great impact on patient outcome.17 In an attempt
to further reduce the incidence of complications, new valve designs continue to be
developed. Yet to understand the future of valve replacement therapy it is important
to understand the nature of natural heart valve diseases and the history of artificial
heart valve development.55
II.1. Causes of heart valve disease
Some diseases of the valves take 20 to 30 years to develop, and by the time a patient
becomes aware of the symptoms, the condition has often progressed to an advanced
and sometimes irreversible stage. Many damaged valves, however, may not cause
any trouble at all, and people with one or more abnormal valves can go through
a normal life6 without ever being diagnosed for valve dysfunction. The causes of
heart valve damage vary depending on the type of disease present, and may include
the following:
• Rheumatic Fever . In the past, heart valve disease was usually caused by
rheumatic fever, an inflammatory condition that often starts with a strep throat
(a streptococcal bacterial infection). Damage is caused not by the bacteria
themselves, but by an autoimmune response - a process in which the body,
mistakenly begins to damage its own tissues.6
• Infective Endocarditis. Infective endocarditis is an infection of the endo-
cardium, the lining that covers the inner wall of the heart chambers and heart
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valves caused by bacteria, viruses, fungi, or other infectious agents. The in-
fection can cause vegetations on the heart valves.6
• Myxomatous Degeneration. In the elderly, one of the most common causes
of heart valve disease is a process called myxomatous degeneration, which
usually affects the mitral valve. This dysfunction stems from a series of
metabolic changes. The valve’s tissue loses its elasticity, becomes weak, and
becomes covered by deposits. The chords that control the opening and closing
of the valve may break off6 (not only in myxomatous disease).
• Calcific Degeneration. Another common cause of heart valve disease in the
elderly is calcific degeneration, a process in which calcium deposits build up
on the valve. This type of tissue degeneration usually causes aortic stenosis,
a narrowing of the aortic valve.6
• Congenital Anomalies. Heart valve disease may also result from congen-
ital abnormalities, problems that are present from birth. The most common
congenital defect is a misshapen aortic valve, which has two leaflets instead
of three and is therefore referred to as bicuspid.6
• Other Causes. Finally, heart valve disease may be a result of other heart
disease, particularly coronary artery disease or a heart attack. These condi-
tions can cause injury to one of the papillary muscles that support the valves,
or annulus dilatation so that it doesn’t close properly.
II.2. Diagnosis
Cardiac auscultation remains the most widely used method of screening of heart
disease. While almost no sound is heard when blood flows through a normal valve,
its passage through a diseased valve creates a whooshing noise, referred to as a mur-
mur.56, 57 The production of murmurs is due to 3 main factors: (1) high blood flow
rate through normal or abnormal orifices; (2) forward flow through a narrowed or
irregular orifice into a dilated vessel or chamber; or (3) backward or regurgitant flow
through an incompetent valve.
To further define the type of valve disease and extent of the valve damage, physi-
cians may use any of the following diagnostic procedures:
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• Electrocardiogram (ECG). The absence of ventricular hypertrophy, atrial
abnormality, arrhythmias, atrio-ventricular conduction abnormalities, prior
myocardial infarction, and evidence of active ischemia on the ECG provides
useful negative information at a relatively low cost.
• Chest X-ray. Chest X-ray often yields qualitative information on cardiac
chamber size, pulmonary blood flow, pulmonary venous pressures, pulmonary
vascular redistribution, and cardiac calcification in patients with cardiac mur-
murs.57
• Transthoracic Echocardiography. A major diagnostic tool in assessing
valve disorders is echocardiography, a non-invasive and painless procedure.
Standard echocardiography may indicate abnormal valve motion and mor-
phology. With Doppler echocardiography, the detected velocity reflects the
severity of stenotis and regurgitation of the valves.56, 57
Figure II.1 shows normal Doppler echocardiographic flow profiles for the aor-
tic (figure II.1(a)) and the mitral (figure II.1(b)) valve.
(a) Normal aortic Doppler pro-
file.
(b) Normal mitral Doppler pro-
file.
Figure II.1.: Aortic and mitral Doppler profiles.58,59
• Cardiac Catheterization. A thin (hollow) catheter is inserted into one of
the patient’s arteries (arterial catheterization) and guided to the heart. When
the catheter is in place, a chemical dye is injected through the tube. The
dye shows up on the X-ray, allowing physicians to visualize the inside of the
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left heart, to see whether all the blood is flowing in the proper direction or if
there is any backflow, and to assess the performance of natural or prosthetic
valves.6
In the venous system, a catheter is seen coming from a vein in the neck and
enters the right-sided heart chambers. In the arterial system, a catheter is
seen coming from an artery in the leg and enters the left-sided heart cham-
bers.60
(a) Typical catheters used for pressure
measurements and angiography.
(b) Cardiac catheterization in
clinical practice.
Figure II.2.: Invasive Catheterization.60
II.3. Types of heart valve disease
The mitral (figure I.3(a)) and aortic (figure I.3(b)) valves are the most common sites
of heart valve disease, because of their location on the left side of the heart. The
left chambers have a greater workload, because they pump blood to the entire body,
whereas the right chambers push blood only to the lungs, which is an organ with low
resistance and flow. Any abnormality in the mitral and aortic valve is more likely to
produce symptoms and be quickly noticed by both patients and physicians.
Two major problems may arise in the functioning of the valves: they may fail ei-
ther to open fully or to close completely. The narrowing of a valve, called stenosis,
occurs when the leaflets become rigid, thickened, or fused together, reducing the
opening through which the blood passes from one chamber to another. As flow is
obstructed, the blood accumulates in the chamber, forcing the heart to work harder
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in order to pump the blood. When the valve fails to close properly - a condition
referred to as insufficiency or regurgitation - a portion of the ejected blood flows
backward. For example, if the aortic valve is unable to close properly, some of the
blood that is pumped forward from the left ventricle into the aorta leaks back into
the ventricle during ventricular diastole. In severe cases, as much as 90 percent of
the entire pumped volume may flow back.6
In some cases, stenosis and insufficiency may occur together. This happens when
the leaflets have become shrunken and stiff with the valve fixed in a halfopen posi-
tion.
Valvular stenosis and insufficiency can gradually wear out the heart. At first, the
heart muscle dilates and thickens. This enables it to compensate for the extra work-
load and allows the heart to supply an adequate amount of blood to the body. Even-
tually, however, the enlarged heart may grow weaker and become unable to pump
blood as efficiently as before.6
The major complication resulting from heart valve disease is congestive heart fail-
ure, a condition that occurs when the heart is unable to pump out an adequate volume
of blood. The heart’s weak pumping action leads to a buildup of fluid (congestion)
in the lungs and other tissues such as the legs, feet, ankles and the abdomen. The
‘water’ in the lungs makes breathing difficult and in the legs, for instance, it causes
obvious swelling (edema).
II.3.1. Mitral valve prolapse
This condition is also known as click-murmur syndrome, floppy-valve syndrome
and balloon mitral valve. Mitral valve prolapse means that one or both of the valve
cusps may be enlarged, and sometimes the supporting chords and muscles are too
long. Instead of closing evenly, one or both of the cusps prolapse or bulge out into
the left atrium.61 Depending on the degree of the deformity, the prolapse can lead to
mitral regurgitation. Mitral valve prolapse is the most common type of mitral valve
disorder, and perhaps the best known to the general public.
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(a) In the patient with mitral re-
gurgitation, the valve does not
close completely.61
(b) In patients with mitral valve
stenosis, the valve has a re-
stricted opening.61
(c) Doppler recording of typi-
cal mitral regurgitation from the
apex (Scale marks = 2 m/s).62
(d) Typical diastolic pattern of
mitral stenosis using Doppler.
Note early diastolic velocity
rises to 2 m/s (Scale marks = 1
m/s).63
(e) Mitral insufficiency: during
ventricular contraction (systole),
the left ventricle eject into the
left atrium as well as into the
aorta, thereby increasing LAP.
(f) Mitral stenosis: during
ventricular filling (diastole),
LAP exceeds LVP (gray area:
pressure gradient generated by
stenosis).
Figure II.3.: Mitral regurgitation and mitral stenosis.
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II.3.2. Mitral regurgitation
Mitral regurgitation (figure II.3(a)) is most often caused by annulus dilatation or by
a dysfunction of the papillary muscles that control the closing of the valve, or by a
rupture of the chordae tendineae. A heart attack may result in mitral insufficiency
if a portion of the heart that supports the position of the valve is disrupted. Prolapse
of the mitral valve (figure II.3(a)) may also be associated with insufficiency. In rare
cases, insufficiency is a result of a congenital defect or disorder.61
If a great deal of leakage occurs between the atrium and ventricle and when this
persists over long periods, pressure will build up in time in the lungs and shortness
of breath will occur.
The full spectral profile of mitral regurgitation obtained by Doppler echocardiogra-
phy commonly reaches peak velocities of between 3 and 6 m/s, depending on the
systolic pressure gradient between the two chambers. The profile is usually quite
symmetric, as seen in figure II.3(c). The opening and closing motions of the mitral
valve will sometimes result in sharp spikes on the spectral velocity recording be-
cause the rapidly moving valves will also render a Doppler signal.62
In mitral regurgitation (figure II.3(e)), blood flows back into the left atrial chamber
during systole. There is also a large increase of the atrial pressure at the end of the
systole (figure I.2 and II.3(e)). The regurgitant flow reduces the net stroke volume of
the ventricle into the aorta and causes an enlargement of the proximal atrial cham-
ber and an increase in atrial pressure. The atrium will compensate by increasing
its force of contraction through the Frank-Starling mechanism in order to enhance
ventricular filling. However, the increased atrial pressure can lead to pulmonary
congestion and edema.
II.3.3. Mitral stenosis
Mitral stenosis (figure II.3(b)) is a narrowing or blockage of the mitral valve.61
The narrowed valve causes blood to backup in the left atrium instead of flowing
into the left ventricle and results in an increase in the pressure in the left atrium.
This pressure is transmitted back through the pulmonary veins, causing congestion
of the lungs. Mitral stenosis can be aggravated by atrial fibrillation, a condition
in which the atrium weakens and contracts with irregular movements instead of a
coordinated pumping action and loses its transport function. Mitral stenosis may
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also be associated with aging and a buildup of calcium on the ring around the valve
where the leaflet and heart muscle meet.
The normal mitral valve area is 4-6 cm2, and severe mitral stenosis is present with
valve areas smaller than 1.5 cm2.
The typical echocardiographic spectral recording of mitral stenosis demonstrates
spectral broadening in diastole, with peak flow in early diastole and a progressive
but slowed diastolic descent (figure II.3(d)).63
Mitral valve stenosis results in the left atrial (LA) pressure being much greater than
left ventricular (LV) pressure during diastolic filling (shaded gray in figure II.3(f)).
The high resistance across the stenotic mitral valve causes blood to back up into the
left atrium and reduces filling (end-diastolic volume) of the left ventricle despite the
elevated LA pressure. The reduced ventricular filling (decreased preload) can result
in reduced ventricular stroke volume by the Frank-Starling mechanism. If the stroke
volume drops significantly, the reduced cardiac output may result in a reduction in
aortic pressure. The increase in LA pressure can result in pulmonary congestion and
edema because of increased pulmonary capillary hydrostatic pressure.
II.3.4. Aortic regurgitation
In its acute form, aortic regurgitation (figure II.4(a)) usually occurs as a result of
an infection that destroys the valve’s leaflets. The chronic form, which is more
common, is usually a consequence of widening of the aorta in the region where it
connects to the valve. Sometimes the ascending aorta may be widened due to a ge-
netic disorder, such as Marfan syndrome, a congenital connective tissue disease.64
Aortic regurgitation, unlike other valve abnormalities, often produces no symptoms
for many years. Shortness of breath, sometimes accompanied by chest pain and
ankle swelling, may be noticed after many years if the condition is not severe. The
constant regurgitation of blood results in a dilation or enlargement of the left ventri-
cle.
The Doppler evaluation of aortic insufficiency appears as a high frequency turbu-
lent jet with spectral broadening and flow toward the transducer as noted in figure
II.4(c).62
In the case of aortic regurgitation, blood flows back into the left ventricle chamber
after ejection is complete. This leads to an increase in diastolic volume and pres-
sure, which causes the ventricle to contract more forcefully (Frank-Starling mecha-
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(a) In this patient with aortic re-
gurgitation, the abnormal aortic
valve does not close fully.64
(b) In this patient with aortic
stenosis, there is an abnormal
calcified aortic valve that cannot
open fully.64
(c) Aortic insufficiency is
recorded as diastolic flow
toward the transducer with a
peak velocity of 3 m/s (Scale
marks = 1 m/s).62
(d) Typical aortic systolic veloc-
ity recording in a patient with
aortic stenosis. Note that the
peak velocity is almost 5 m/s
(Scale marks = 1 m/s).63
(e) Aortic insufficiency: during ven-
tricular relaxation (diastole), blood
flows backwards from the aorta into
the ventricle. Aortic pulse pressure
and LAP increase.
(f) Aortic stenosis: during ventric-
ular ejection (systole), LVP exceeds
AP (gray area: pressure gradient
generated by stenosis).
Figure II.4.: Aortic regurgitation and aortic stenosis.
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nism) thereby increasing the stroke volume to help compensate for the regurgitation.
If there is significant regurgitation across the valve, the rate of decline in pressure
(pulse pressure PP) within the aorta will be greater as illustrated in the figure II.4(e).
This results in a characteristic widening of the aortic pulse pressure.
II.3.5. Aortic stenosis
There are three major causes of aortic stenosis: calcific degeneration or deposits of
calcium on the valve (in elderly), congenital abnormality (uncommon), and rheumatic
fever. The disorder is recognized by a characteristic murmur; which can become
quite loud and is usually easily recognized with a stethoscope.
Stenosis of the aortic valve (figure II.4(b)) obstructs the flow of blood from the left
ventricle, causing it to thicken (hypertrophy) and/or enlarge (dilation) and eventu-
ally weaken over time. At rest, the ventricle can compensate for the presence of the
stenosis by pumping harder, but during physical exertion it may not be able to main-
tain a sufficient output of blood to the organs and the brain. Fainting may result.64
The normal aortic valve area is 2.6-3.5 cm2 in adults. Valve areas of 1.0 cm2 or
smaller are considered as severe aortic stenosis.
A Doppler velocity pattern of a patient with severe aortic stenosis is shown in fig-
ure II.4(d). In this condition, there is marked spectral broadening, delayed systolic
peaking, and a marked increase in velocity. In this patient, the peak systolic velocity
is almost 5 m/s.63
Aortic valve stenosis (figure II.4(f)) is characterized by the left ventricular pres-
sure being much greater than aortic pressure during left ventricular ejection (shaded
gray in figure). The pressure gradient across the stenotic lesion results from both in-
creased resistance (related to narrowing of the valve opening) and turbulence distal
to the valve. The magnitude of the pressure changes is determined by the severity
of the stenosis and the flow rate across the valve.
II.3.6. Tricuspid and pulmonary stenosis and regurgitation
These disorders account for less than 5 percent of valve disease. Abnormalities of
the tricuspid valve are generally caused by rheumatic fever or metabolic abnormali-
ties affecting the heart (a secondary cause to longstanding and severe mitral disease).
Among the major symptoms they produce are edema and fatigue. Pulmonary steno-
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sis - are also rare and are primarily due to congenital defects. Children born with
a severely narrowed pulmonary valve may require immediate surgical intervention
for survival.
II.4. Treatment
II.4.1. Drugs
No drugs can cure severe valve diseases. The major function of drugs administered
in valve disorder are to reduce the severity of symptoms, possibly reduce the work-
load of the heart, and/or prevent complications.6, 57 Without being exclusive, the
following categories represent the most commonly applied types of drugs.
• Vasodilators: dilate venes and peripheral arterioles, reduce the vascular re-
sistance against which the heart must pump, and decrease the workload of
the heart. They are used to treat congestive heart failure associated with heart
valve disease (usually valve insufficiency).
• Diuretics: lower the salt and fluid levels in the body and reduce intra- and
extra-vascular volumes. Diuretics also reduce swelling and ease the heart’s
workload by decreasing the volume of blood that needs to be pumped.
• Anticoagulants: prevent formation of blood clots. These include medica-
tions such as warfarin and heparin.
• Antiarrhythmics: maintain a regular heartbeat and slow down rapid heart
rhythms.
II.4.2. Balloon valvuloplasty
This relatively new technique is increasingly used as an alternative to surgical repair
of valve stenosis. Balloon valvuloplasty is a procedure in which a balloon catheter
with a small deflated balloon at the tip is inserted through the skin into a blood
vessel, and then is threaded up to the opening of the narrowed heart valve. The bal-
loon is inflated, which stretches the valve open. This procedure relieves some valve
obstructions. While somewhat less effective than surgery, it is a less invasive pro-
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cedure. Balloon valvuloplasty may relieve many of the symptoms of valve disease,
but it will not cure valve disease.6
II.4.3. Surgical repair
The surgeon will always try to repair a damaged valve, however this requires normal
valve tissue.
For mitral and tricuspid valve disease, the surgeon is able to open fused leaflets,
remove calcium deposits, repair floppy leaflets so they close normally, tighten the
chords and support an enlarged annulus by attaching a ring or band (annuloplasty).
Bicuspid aortic valve disease (two leaflets instead of three) is a common type of
aortic valve disease. When there is a leak, the surgeon may be able to reshape the
aortic valve leaflets, allowing the valve to open and close more easily.
In the majority of cases, however, a severely stenotic calcific valve (with no normal
tissue) has to be replaced.6
(a) Traditional open
heart surgery.
(b) Minimal invasive
heart surgery.
(c) Heart valve replacement.
Figure II.5.: Heart valve surgery and heart valve replacement.
II.4.4. Valve replacement surgery
This type of surgery is usually recommended when the valve is severely damaged
and potentially life-threatening.6
Valve replacement requires open heart surgery (figure II.5). During traditional heart
valve surgery, a surgeon will medically open the entire sternum (breastbone) to
get direct access to the heart. The surgeon then repairs or replaces the abnormal
heart valve or valves. Minimally invasive heart surgery is an alternative approach
performed through a smaller incision. The incision is only a few centimeters instead
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of the 15 to 25 centimeters required for traditional heart surgery.
Artificial valves are carefully sutured or sewn into the valve annulus after removal
of the diseased valve, completely replacing the natural valve. There are two types of
prosthetic valves that can be used to replace the original valves: mechanical (figure
II.6) and biological (bioprosthetic) (figure II.8) valves.
(a) Caged ball
valve.
(b) Tilting disc (monoleaflet)
valve (Omnicarbon).
(c) Bileaflet valve (ATS
Open Pivot).
Figure II.6.: Mechanical valve types.
II.4.4.1. Mechanical valves
Charles Hufnagel successfully implanted a human patient in 195265 with a caged-
ball valve (figure II.6(a)); the valve was placed in the descending aorta. Starr-
Edwards66, 67 was the first to replace a patient’s mitral valve with a caged-ball valve
(figure II.6(a)) in 1960. The cage-ball valve consists of a metal ring covered in
Dacron and a thin metal cage. Inside the cage is a ball, which exactly fits the di-
mension of the ring. Blood flowing in the correct direction pushes the ball away
from the ring towards the cage and flows by uninterrupted. When the blood flows
in the opposite direction, it pushes the ball back into the ring, creating a tight seal
that prevents leaking. The tilting disc valves work somewhat along the principle of
a hinged door that is opened. Mechanical valves make a clicking noise with each
heartbeat.
The mechanical valves, currently most in use, are bileaflet valves and single tilting
disc valves (figure II.6).68
The following mechanical heart valves are studied in further detail in this work:
• Omnicarbon Monoleaflet Valve. The Omnicarbon cardiac valve is a mono-
leaflet prosthesis (figure II.6(b)) that basically consists of a ring and a curved
freely-rotatable disc, which is retained by two shields extending from the ring.
The Omnicarbon valve is particularly appropriate for ultrasound visualization
31
II. Heart valve disease and treatment
(a) Opening angle and travel an-
gle of the leaflet in a mechanical
bileaflet valve.
(b) On-X shaped orifice with
flared inlet.
(c) Bileaflet hinge design.
Figure II.7.: Design of bileaflet mechanical heart valves.
because of its simple geometric shape and the absence of inner structures. Its
hingeless design produces central flow of blood. The disc opens to a max-
imum angle of 80° at maximum cardiac output rate. An adequate opening
angle of approximately 60°-70° is expected at normal cardiac output at rest.
Leakage flow is relatively low because of the presence of a disc seat on the
housing ring where the disc closes at 12° angle. The seat eliminates the open
gap which exists in other valve designs. Further motion of the disc beyond
its 12° position is wasted energy and does not benefit the flow process. The
travel angle thus varies between 48°-68°.
• On-X Bileaflet Valve. Bileaflet valves have two semicircular leaflets that
pivot in hinges integrated into the flange. Typical design characteristics of the
On-X valve are a shaped orifice with flared inlet design (figure II.7(b)) to re-
duce inlet turbulence, an elongated body to reduce exit losses, thinner leaflets
and a supra-annular sewing ring for small aortic valves.69, 70, 71 The main ef-
fect of its design is an enlarged valve area available for flow, as compared to
other equally sized prosthetic valves. The travel angle of these valves is 50°.
32
II.4. Treatment
Table II.1.: Opening and travel angles.
Maximum and Observed Opening and Travel Angles73
Mechanical
Valve
Type
Maximum
Opening Angle
[degrees]
Observed
Opening Angle
[degrees]
Maximum
Travel Angle
[degrees]
Observed
Travel Angle
[degrees]
Pivot
Type
SJM HP 85 85 60 60 Cavity Pivot
CM 78 78 53 53 Cavity Pivot
On-X 90 81.6 47 38.6 Cavity Pivot
ATS 85 74.8 60 49.8 Open Pivot
SJM HP: St. Jude Medical Haemodynamic Plus Series, Inc., St. Paul, MN, USA
CM: CarboMedics, Inc., Austin, TX, USA
On-X: Medical Carbon Research Institute, Austin, TX, USA
ATS: Advancing the Standard, ATS Medical, Inc., Minneapolis, MN, USA
• ATS Open Pivot Bileaflet Valve. The ATS valve (ATS Medical, Minneapo-
lis, MN, USA) is a pyrolytic carbon, open pivot, low-profile cardiac prosthe-
sis (figure II.6(c)). The theoretical opening angle of the ATS valve is 85°with
60° angle of travel. Specific to this valve is its open pivot design, in which the
convex pivot and stops are located on the inner circumference and extended
in the flow field.72
Table II.1 gives a summary of the opening and travel angles of four types of bileaflet
valves. Note that, for some valves, the theoretical opening angle is not reached while
operating in vivo. Data in table II.1 are from an in vitro study done by Feng et al.73
Besides the difference in opening and travel angles, there is also a difference in the
design of the hinge region. Figure II.7(c) explains the difference between an “Open
Pivot” hinge and a “Cavity Pivot” hinge. In the “Open Pivot” hinge, the valve leaflet
rotates over a circular ‘bulb’ made on the housing, while the leaflet rotates in a ‘hole’
made in the housing of valve with a “Cavity Pivot” hinge. The ATS valve is the
only valve based on the Open Pivot Hinge mechanism.
The mechanical valves have the advantage of durability: they may often last a life-
time.55 On the rare occasions that a mechanical valve does fail, it may do suddenly
and cause the heart to fail. The most important disadvantage is that the patient will
have to follow a lifetime regimen of anticoagulants such as warfarin to prevent blood
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clots causing valve thrombosis.68 Taking anticoagulants also places some restric-
tions on the patient’s activity; contact sports or other activities that could result in
bruising or internal bleeding usually have to be avoided.
II.4.4.2. Biological or bioprosthetic valves
Bioprosthetic valves (figure II.8), also known as tissue valves, can be categorized as
heterografts, homografts, or autografts. Heterograft valves (also called xenografts)
are either whole porcine aortic valves or hand-fabricated valves made from bovine
pericardial tissue. Homograft valves are human aortic valves harvested from cadav-
ers and cryogenically preserved. Autografts are used solely in the Ross procedure,
where the native pulmonary valve is used to replace the aortic valve and in which
the pulmonary valve is replaced with a homograft.74
Biological valves do not ordinarily require the patient to take anticoagulant med-
ication for more than six to eight weeks following surgery. The disadvantage of
these replacement valves is that they do wear out and may have to be replaced after
about ten to fifteen years.75 Mostly, they wear out gradually, so there is little risk
of a sudden episode of heart failure. Bioprosthetic valves degenerate more slowly
in elderly patients than in the young. In contrast the risk of anticoagulation related
complications may be higher in the very elderly.
In so called stented bioprostheses, porcine or bovine pericardial leaflets are mounted
onto a fixed plastic or metallic frame or stent (figure II.8(a)). Nonstented or stentless
aortic bioprostheses (figure II.8(b)), where this metal frame is absent, have been the
focus of numerous studies in the last decade.
(a) Stented valve. (b) Stentless valve.
Figure II.8.: Stented versus stentless valve.
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Stentless heart valves Compared with stented valves, stentless valves are
thought to offer superior haemodynamics, with a higher effective orifice area76 (fig-
ure II.9(a)), possibly yielding to survival advantage.77 Nonstented bioprostheses
have been associated with lower pressure gradients, at rest and exercise, than stented
bioprostheses or mechanical valves.76 Their durability is as yet undetermined,78 al-
though their design may overcome some of the disadvantages stemming from the
presence of a rigid stent and the resulting forces on the valve leaflets79, 80 (figure
II.9(b)). Furthermore the leaflet opening behavior changes in presence of stent (fig-
ure II.9(c)), resulting in different stress distribution in the valve leaflet.81, 8
(a) Effective annulus diameter for stented and
stentless valves.82
(b) Reduced stress distribution in valve leaflets.
(c) Leaflet profiles during opening for expansile (I) and nonexpansile (II) leaflet
attachments.8
Figure II.9.: Why stentless heart valves?
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II.5. Recent developments: progress towards a
tissue engineered heart valve
An underlying problem with all current methods of heart valve replacement is that
the non-living material lacks an intrinsic repair system that can recondition the valve
after structural injury.22 Optimal valve replacement tissue should be biocompatible
whilst exhibiting growth and reparative capabilities.83 The relatively new field of
Tissue Engineering (TE) may offer a solution to heart valve replacement.84 Cur-
rent strategies in this field of tissue engineering are: (i) transplantation of constructs
containing specific cell types to the site of injury following an in vitro conditioning
period (in vitro colonization approach), or (ii) constructs which will recruit endoge-
nous progenitor or differentiated cells from the surrounding tissue (in vivo coloniza-
tion approach).22 Either of these constructs, theoretically, could functionally inte-
grate with the host tissue and encourage tissue regeneration. A thorough knowledge
of normal heart valve development and functional tissue composition is an essential
prerequisite to establish the desired structural makeup of a tissue-engineered alter-
native.17
II.5.1. Tissue engineering approach to heart valve replacement
In the following the most important parameters which need to be considered for the
creation of a tissue engineered heart valve (TEHV) are described.
Cells To create a functional and durable TEHV, the establishment of cultured
cells is a priority. To avoid rejection, cells are ideally autologous.85 However, in
diseased states or with geriatric patients, autogeneic cells may not be an appropri-
ate transplantation source.86 At present, autologous cells are unavailable ‘off-the-
shelf’.87 Another cell source may be stem cells, but currently ethical issues make
it impractical to use these cells for research purposes. However, the stem-cell ap-
proach shows great potential for future TE-applications.88
Scaffolds The traditional concept of tissue engineering involves the use of three-
dimensional scaffolds as cell transplant devices to replace the extracellular matrix.
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The cells can be seeded on a biodegradable polymeric scaffold89, 90, 91 or on an acel-
lularized bio-matrix.92
Signals Successful tissue regeneration is not achieved ‘simply’ by combining
cells and scaffolds.22 A key challenge in tissue engineering is to understand quan-
titatively how cells respond to molecular and biomechanical signals and integrate
multiple inputs to generate a given response, and to control nonspecific interactions
between cells and a biomaterial, so that cell responses specifically follow desired
receptor-ligand interactions.17
In vitro methods of mechanical stimulation or physical signaling have been shown
to improve cell and tissue growth. This has led to the design and development of
bioreactor systems mimicking the environment on the transplant site.22, 93
II.5.2. Bioreactor technologies
A bioreactor aims to mimic the complex in vivo environment, including all natural
stimuli that have impact on cell growth and differentiation. In a classic general cell
culture bioreactor system,94 these stimuli can be divided into 4 different basic as-
pects: (i) the matrix or scaffold in or on which cells grow, (ii) the biochemical and
physiological composition of the medium, (iii) the composition of the gas phase
and (iv) the incubation temperature. All of these stimuli are of great importance
for cell differentiation and proliferation. A more modern approach is to create an in
vitro environment that not only embodies the 4 above-mentioned aspects but also in-
cludes a mechanical stimulus. The involved cell cultures have a controlled delivery
of a mechanical input like hydrostatic pressure, fluid shear stress or substrate strain.
This mechanic signal is translated by the cell membrane and membrane proteins to
the cytoskeleton.95 Many studies have shown that cell and tissue growth is enhanced
in response to mechanical stresses under fluid flow as compared to that under static
incubation conditions. These studies define a bioreactor as ”a system that simulates
physiological environments for the creation, physical conditioning, and testing of
cells, tissues, precursors, support structures, and organs in vitro”.93, 95, 96, 97, 98 The
bioreactor system allows for a tissue construct to be s(t)imulated in a controlled en-
vironment. Fluid flow, to provide biochemical and mechanical stimulation, is con-
trolled in terms of composition, flow rate, pressure, and temperature. A mechanical
force can be applied and controlled to provide direct mechanical stimulation. Pul-
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Figure II.10.: Rotating-wall vessels provide a dynamic culture environment to the constructs,
with low shear stresses and high mass-transfer rates.101
satile forces, pressure, flow rate, shear stress, frequency and stroke volume are ex-
tremely important design considerations. The biochemical environment is equally
important in the design of a bioreactor. The transfer of nutrients to the cells and
removal of waste products is necessary for the healthy development of tissue.93
Today there are a number of different types of bioreactors available including static,
dynamic, and biomimetic systems. The evolution of the bioreactor is described in
the following, originating with static culture flasks, the biomimetic bioreactors of
today and the future devices of tomorrow.93
Static systems The static flask system is the simplest type of bioreactor and
consists of a flask with tissue constructs fixed in place in a culture medium.99 In
these systems tissue constructs may be grown in a static environment or a mixed
environment by employing the use of a magnetic stirrer. The use of static systems
can lead to structurally inadequate nonuniform tissue constructs.94, 100
Dynamic systems Since physical stimuli have been shown to modulate tissue
development, the design of bioreactors has been motivated to expose growing tis-
sues to mechanical forces. One such system that employs the benefit of a low shear
stress environment is a rotating wall vessel (figure II.10) wherein cells are grown
in a microgravity environment.102, 103, 104, 105, 106 It has been shown that engineered
cardiac tissues grown in rotating vessels are structurally and functionally superior
to constructs grown in static or mixed flasks.94, 100, 101, 107, 108
Biomimetic systems Based on the fact that physical stimuli improve cell and
tissue growth, Niklason et al. developed a bioreactor to closely mimic in vivo con-
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Figure II.11.: Photograph and schematic diagram of pulsatile bioreactor developed by Hoer-
strup et al.;97 (V) tissue engineered heart valve, (F) flexible membrane, (A) air chamber and
circuit, (M) culture medium circuit.
ditions.95 This perfusion system provides intraluminal pressure and pulsatile flow
to four bioreactors, each of which contains one tissue-engineered vessel. Gas ex-
change is provided via a reservoir bag, and the pressure is monitored constantly.
The development of an optimal system for tissue engineering heart valves (figure
II.11) and small diameter vascular grafts under pulsatile flow conditions is currently
an innovative research topic.17, 96, 97, 109
II.5.3. Current progress towards a Tissue Engineered Heart
Valve
Figure II.12.: Experimental design for preparing and evaluating a tissue engineered heart
valve.110
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Design of tissue-engineered heart valves is difficult due to the complex nature of the
dynamic mechanical environment in which they must perform.93 The heart valve
must open and close at a frequency of approximately 1 Hz. In addition, they are also
exposed to bending stresses and high shear stresses associated with blood flow.111
Sodian et al.112 created a trileaflet heart valve from a porous biodegradable scaffold.
Results indicated that the cultured cells appeared to be viable and that extracellular
matrix formation was induced after pulsatile flow exposure.112
The TE valves were grown in an in vitro pulse duplicator97 system under gradually
increasing flow and pressure conditions, thereby providing physical signals to the
developing tissues comparable to those encountered in vivo. After 14 days of in vitro
culture, the valves grown in the bioreactor showed significantly higher formation of
matrix proteins, a more organized histological structure, and more favorable me-
chanical properties than did constructs grown under static culture conditions. Six of
these valve constructs were then implanted into the pulmonary position of sheep for
in vivo evaluation. Echocardiography showed functioning valves up to 20 weeks.
Hoerstrup fabricated trileaflet heart valves using polyglycolic-acid (PGA) scaffolds
coated with poly-4-hydroxybutyrate (P4HB).110 In all of the tissue engineered heart
valves grown in the bioreactor,97 synchronous opening and closing of the leaflets
was observed. All leaflets were intact, mobile, pliable, and competent during valve
closure compared to those grown in static culture, which were fragile and began to
lose structural integrity after 14 days. Histology of the TE leaflets revealed cellular
tissue organized in a layered fashion with a dense outer layer and lesser cellularity in
the deeper portions after 14 days in the pulse duplicator. Formation of extracellular
matrix was demonstrated as predominantly GAGs and some collagen.110 Smooth
muscle cells were detectable throughout the tissue. The static controls showed less
tissue formation and organization at all time points. Additionally, the tissue grown
in the bioreactor had a confluent smooth surface with cell orientation in the direction
of flow, while a rough surface was observed for the static grown tissues. There was
mild to moderate valve regurgitation present at 16 and 20 weeks that was due to cen-
tral noncoaptation. This may result from shrinkage of the cuspal tissue during the
process of scaffold bioabsorption and/or the observed increase of the inner diameter
of the valve constructs in accordance with the sheep pulmonary artery growth (4
mm over the 5-month time period).110
Ideally, when tissue engineering techniques will be introduced in future clinical rou-
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tine, the schedule for a patient diagnosed for valve disease may be (1) cell harvest
by a bone marrow puncture under local anesthesia; (2) differentiation and expansion
of the cells; (3) tissue engineering of a heart valve prosthesis in vitro; and (4) fol-
lowing yet to be defined quality criteria (biochemical, histological, bio-safety, etc.)
implantation of a living autologous prosthesis into the patient.113
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Chapter III
Haemodynamic assessment of
prosthetic heart valves
III.1. Parameters derived from flow and pressure data
III.1.1. Cardiac output
The performance of a valve depends on the flow passing through it. When evaluating
a valve, an important parameter is thus the total flow rate through the valve. During
each cardiac cycle, a volume of blood, i.e. the stroke volume (SV), is ejected. The
amount of cardiac cycles or beats per minute (bpm) is defined as the heart rate
(HR). The volume of blood ejected by the ventricles per minute is called the cardiac
output (CO). Cardiac output in humans varies between 4-6 l/min at rest to 20-35
l/min during exercise, with heart rate variations from 40-70 bpm at rest to 170-
200 bmp during exercise and SV from 60-125 ml during rest to 100-200 ml during
exercise. A well trained person develops a larger CO with a lower HR, and thus his
heart delivers a larger SV.5 The stroke volume (SV [ml]), times the number of beats
per minute (heart rate, HR), equals the cardiac output (CO [l/min]; equation III.1).
CO = SV · HR (III.1)
Changes in either stroke volume or heart rate will alter cardiac output. The SV can
be calculated from velocity measurements over the valve (equation III.2) as
SV = VTI · A (III.2)
with VTI, the velocity time integral (VTI [cm]) and A the valve area in [cm2]. The
VTI =
∫
v·dt is obtained from the Doppler velocity-time curve as the area under the
velocity curve.
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III.1.2. Pressure gradient
The resistance of the valve against the flow can be quantified by pressure/energy
losses over the valve.
Pressure gradient from catheterization A dynamic systolic gradient be-
tween left ventricular and aortic pressures is evident. Assuming proper alignment of
the pressure tracings, a series of instantaneous pressure differences can be measured,
and the mean systolic gradient ∆Pmean can be calculated. The gradient ∆Ppeak be-
tween the peak systolic left ventricular pressure and the systolic aortic pressure can
also be determined, even though these two peaks are non-simultaneous. Note that
the maximum instantaneous gradient ∆Pmax is always larger than the peak-to-peak
gradient. Similar gradients can be determined for the mitral valve during ventricular
filling (diastole).114
(a) Pressure gradient from
catheterization; LVP: left
ventricular pressure, AP aortic
pressure.114
(b) Flow through a stenosis. The pressure drop between
points 1 and 2 is calculated from velocity measurements
at point 2 (assuming that it is much greater than the ve-
locity at point 1) using the simplified Bernoulli equa-
tion.115
Figure III.1.: Pressure gradients in heart valves.
Pressure gradient from Doppler measurements The simplified Bernoulli
equation is derived from the Bernoulli equation based on the assumptions that the
flow through the stenosis is laminar and inviscid (viscous forces negligible). Bernoulli’s
hydraulic formula states the conservation of mechanical energy between two points
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along a streamline (figure III.1(b)):115
P1 − P2 = 12 · ρ(v
2
2 − v21) + ρg(z2 − z1) + ρ
∫ 2
1
dv
dt ds (III.3)
where P1 [Pa], v1 [m/s], z1 [m] are the pressure, velocity, and height from a reference
level at the upstream location, and P2 [Pa], v2 [m/s], z2 [m] are the pressure, velocity,
and height at the downstream location. The integral term accounts for the flow
acceleration or deceleration between the two locations. If the equation is applied at
peak systolic velocity, this term becomes zero, because the derivative becomes zero.
When further applied on two points along a stream line located at the same height,
one finds that:115
P1 − P2 = 12 · ρ(v
2
2 − v21) (III.4)
When the downstream velocity is much higher than the upstream velocity (v2>>v1),
v21 can be neglected. Filling in the value of ρ of blood at 37°C (1060 kg/m3) and
converting pressure from Pa to mmHg (133 Pa = 1 mmHg) results in a factor of
about 4, in the so-called simplified Bernoulli equation:115
∆PDoppler [mmHg] = 4 · v22 and v2 in [m/s]
where ∆P is in [mmHg] and v2 is in [m/s].115 This equation has found wide applica-
tion clinically in determining pressure drops across severe stenosis from noninvasive
velocity measurements with Doppler ultrasound.
The Bernoulli equation is not valid in cases in which viscous forces are significant,
such as in long constrictions with a small diameter, or in flow with separation re-
gions. In addition, it does not account for turbulent energy losses in cases of severe
stenosis. Such losses should be taken into account, because they reduce the energy
content of the fluid.115
In normal individuals, there is a very slight (1-2 mmHg) pressure difference be-
tween the left ventricle and aorta during ejection that helps drive the blood across
the aortic valve. In contrast, very high pressure gradients are observed in patients
with a stenotic valve. We refer to figures II.4(d) and II.3(d) where a pressure gradi-
ent ∆P of 4·(5 m/s)2 = 100 mmHg occure in the case of a severe aortic stenosis and
4·(2 m/s)2 = 16 mmHg in the case of a mitral stenosis.
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III.1.3. Effective orifice area and performance index
When blood is flowing through an orifice with cross section area A [m2], conver-
gence of streamlines make that only part of the cross section is effectively used
for flow passage. This is particularly important in valve dynamics where the ef-
fective valve area should be maximized to avoid high velocities, turbulence, shear,
and associated high pressure drops. The effective orifice area (EOA) is the standard
parameter for the clinical assessment of the severity of the valve stenosis. It is also
a parameter that can be used to compare performance of different mechanical and
biological valve prostheses. As demonstrated in figure III.2, the flow through the
valve is narrowing, using only the EOA, i.e. a fraction of the total geometric ori-
fice area (GOA). The effective orifice area (EOA [cm2]) is calculated - based on the
continuity equation - as the ratio of forward stroke volume and VTI:
Figure III.2.: Geometric and effective orifice area (GOA and EOA).
EOAContinuity =
SV
VTI
(III.5)
Besides the continuity equation, the Gorlin equation provides an alternative way to
calculate the effective orifice area (EOAGorlin). With Q the flow rate [m3/s] and v
the maximal velocity [m/s] in the vena contracta, the EOA is given by
EOA = QC1v (III.6)
where C1 is a coefficient to adjust for the velocity profile in the vena contracta.
Through the orifice, there is a conversion of potential energy to kinetic energy, and
this conversion is described by:115
v = C2 ·
√
2 · g ·∆h (III.7)
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with the pressure head across the orifice ∆h=∆z+∆Pρg and where C2 is a coefficient
to adjust for loss in the conversion of energy from potential to kinetic energy. With
∆z=0 and assumption of C1·C2=1, the formula can be written as:
EOA = Q
v
=
Q√
2∆Pρ
=
Q√
2ρHg·g·∆hHgρ
(III.8)
The commonly used SI units [m2], [m3/s], [Pa] are converted into clinical used units
[cm2], [ml/s], [mmHg] for the area, the flow and pressure respectively.
EOA [cm2] = 104 · EOA [m2]
Q [ml/s] = 106 · Q [m3/s]
∆P [mmHg] = 103 ·∆hHg [mHg] (III.9)
ρHg = 13600 [kg/m3]
g = 9.81 [m/s2] (III.10)
Combining equations III.8 and III.9 results in:
EOA · 10-4 = Q · 10
-6√
2ρHg·g·10
-3·∆P
ρ
(III.11)
And thus finally the Gorlin equation can be written as:
EOAGorlin =
Q
51.6
√
∆P
(III.12)
with EOA in [cm2], ∆P in [mmHg] and the mean forward flow Qfwd,mean in [ml/s],
calculated as the ratio of the “positive” area under the flow curve (forward stroke
volume SV) divided by the duration of forward flow.
EOAGorlin is a fraction θ of the available geometric orifice area GOA, with θ known
as the orifice constant, so that EOAGorlin = θ·GOA.
The performance index (PI [-]) of the valve is calculated as the ratio of the effective
orifice area and the geometric orifice area (GOA):
PI =
EOA
GOA = θ (III.13)
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III.1.4. Regurgitation
Figure III.3.: Flow cycle divided into forward flow, closing volume, and leakage volume.55
Regurgitation is reversed flow through the ‘one way’ valve. The percentage of re-
gurgitation (% reg) in relation to the total SV is calculated as
% reg =
Vreg
(Vreg+ SV)
. (III.14)
Vreg [ml] is the total volume of regurgitation and can be split into Vclose and Vleak.
Vclose is the volume of regurgitation due to the closing of the valve. Vleak is the
volume of regurgitation due to leakage of the closed valve.
III.1.5. Flow patterns and shear stresses
Laminar and turbulent flow The Reynolds number (Re; equation III.15) is a
quantity that engineers use to assess whether a fluid flow is laminar or turbulent.
This is important, because increased mixing and shearing occur in turbulent flow.
This results in increased energy losses which affects the efficiency of heart valves. A
good example of laminar and turbulent flow is the rising smoke from a cigarette. The
smoke initially travels in smooth, straight lines (laminar flow) then starts to ”wave”
back and forth (transition flow) and finally seems to randomly mix (turbulent flow).
The dimensionless Reynolds number Re [-] is defined as:
Re = ρ
U D
µ
(III.15)
with ρ the density of the fluid (kg/m3), U the velocity of the flow (m/s), D the diam-
eter of the vessel (m) and µ the dynamic viscosity of the fluid (mPa·s). Figure III.4
demonstrates the different flow regimes in function of Re for the flow in a straight
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tube. Generally, a fluid flow is laminar in a stiff tube from Re = 0 to some critical
value (Re < 2000) at which transition flow begins. Transition flow is fluctuating
Figure III.4.: Diagram of flow regimes in pipe flow.
between laminar and turbulent flow (2000 < Re < 4000). The fluid flow becomes
unstable for higher Reynolds numbers (Re > 4000). In turbulent flow, there is in-
creased mixing that results in viscous losses which are generally much higher than
those in laminar flow.116 The Reynolds number can reach up to 4500 at peak flow
in the normal aortic valve.
The Strouhal number gives an indication of a steady or transient regime of the flow.
The Strouhal number is defined as
Sr = D
Tp · U (III.16)
with Tp the period of time of the observed flow phenomena. A very small Strouhal
number (Sr<<1) is considered quasi-steady. For Strouhal number close to one the
flow is considered transient.
Shear stresses As blood flows through a vessel or valve, it exerts a physical
force on the vessel wall or the valve leaflet. This force can be resolved into two
principal vectors. Shear stress, being tangential to the wall, represents the frictional
Figure III.5.: Shear stress represents the frictional force exerted by the flowing blood on the
endothelial surface of the wall.
force exerted by the flowing blood at the endothelial surface of the wall. The shear
stress on the vessel wall or on the valve leaflet is normally called wall shear stress
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or WSS. Normal stress, or pressure, is perpendicular to the wall. In case of laminar
flow shear stress is calculated with equation III.17.
−→τ laminar = µ ·
∂U−→
∂y
= µ · γ˙ [Pa] or [N/m2] (III.17)
with µ the dynamic viscosity of the fluid, U−→the velocity vector and γ˙ the shear
rate. Turbulence in the blood system increases resistance to flow, resulting in higher
pressure gradients. Turbulent shear stresses are calculated in a slightly different
manner, as shown in equation III.18:44
−→τ turbulent = µ ·
∂U−→
∂y
− ρu′v′ (III.18)
with u’ and v’ the turbulent fluctuations of the velocities u and v respectively.
The vascular and valvular endothelial cells are subjected at all times to shear forces
that act on the vessel surface as a result of the flow of viscous blood. Fluid shear
stress regulates endothelial phenotype by altering its gene expression profile, in-
cluding growth factors.117, 118 Fluid shear stress transforms polygonal, cobblestone-
shaped endothelial cells of random orientation into fusiform endothelial cells aligned
in the direction of flow (figure III.6(b)). High shear stress (>40 N/m2) can cause
direct endothelial injury.117 Low and oscillating shear stress regions (< 0.4 N/m2)
can lead to atherosclerotic lesions (plaque), mainly in arterial bifurcations and in
coronary arteries.117
High shear stresses in the blood may create platelet activation119, 120 leading to
thrombosis,121 and the subsequent risk of embolism. Blood platelet damage starts
(a) Low arterial haemo-
dynamic shear stress
(τ ∼ 0-0.4 N/m2).117
(b) Physiologic ar-
terial haemodynamic
shear stress (τ > 1.5
N/m2).117
Figure III.6.: Transformation of endothelial cell morphology by fluid shear stress: aortic en-
dothelial cells exposed to physiologic shear stress (1.5 N/m2, right panel) for 24 hours align
in the direction of blood flow while those exposed to low shear stress.117,118
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to occur at shear stress values of 10 N/m2.122 Furthermore, the magnitude, expo-
sure time, and spatial distribution of the shear stresses coincide with damage to red
blood cells. Shear stresses above 200 N/m2 will cause hemolysis.123, 124, 125 Hemol-
ysis can also occur at lower shear stress values if there is a long exposure time.44, 126
Therefore recirculation zones in prostethic heart valves are to be avoided, unless
they are washed out every next heart beat,127 so that the residence time of parti-
cles remains limited. In vitro studies of aortic prosthetic heart valve designs have
distinctly revealed shear stress values sufficiently high to cause lethal or sublethal
damage to blood cells.128, 129
Shear stress can not be measured directly in vitro nor in vivo on a moving heart
valve leaflet. For that reason the technique of computational fluid dynamics can be
used, to estimate the shear stress.
III.2. In vitro measurements
Heart valve studies are often performed based on clinical or animal studies. An in
vitro setup provides a way to test heart valves in a controlled environment. Further-
more animal studies are minimized due to these models.
A pulse duplicator system PDS73, 130, 131 is a hydraulic model of the human left
heart, connected to a windkessel model of the human systemic circulation.132 Fig-
ure III.7(a) shows an example of PDS of the Hydraulics Laboratory (UGent). As a
test fluid, a mixture of 40% glycerine - 60% water is commonly used to simulate the
dynamic viscosity of 3.0 mPa.s of the blood. The fluid enters the model from a con-
trollable preload reservoir representing the lungs(9) via 2 rigid pulmonary veins(8).
The fluid reaches the left ventricle (LV)(2) through the mitral valve(5). The left ven-
tricle ejects through the aortic valve(15) into the afterload system that consists of an
air chamber(16) or ’windkessel’ and a hydraulic resistor(13). This air chamber repre-
sents the elastic function or compliance of the large arteries. The resistor mimicks
the hydraulic function of the arterioles and capillaries. A venous reservoir(12) guar-
antees a constant venous pressure of 5 mmHg. Both the preload lung (9) and the
venous reservoir have an overflow system, with the overflows ending in a central
buffer reservoir (11) out of which the test fluid is pumped (10) continuously into the
lung reservoir.
The left ventricle is represented by an anatomically shaped silicone sac, mounted in
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(a) Hydraulics Laboratory Pulse Duplicator System.130, 133
(b) Vivitro Pulse Suplicator System.131
Figure III.7.: Pulse duplicator heart models.
a Perspex housing. It is surrounded by water and connected to an external circuit,
consisting of Perspex cylindrical reservoirs (3). Pressurized air is delivered to this
external circuit and controls the contraction and relaxation of the cardiac chamber.
The PDS is computer controlled: a target left ventricular pressure curve is sent to
the computer system and a feed-back system controls the amount of pressurized air
delivered to the system such that the target curve is respected as closely as possi-
ble.130, 133 Physiological parameters such as the heart rate, the stroke volume and
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the pressure levels can be varied with these PDS systems. A picture of a comparable
commercially available system is shown in figure III.7(b).131 These artificial heart
models can be used to test different types and sizes of artificial heart valves. Pres-
sure, flow and even Doppler measurements130, 133 made with these systems make
it possible to estimate the hydrodynamic performance of artificial heart valves in a
controllable in vitro environment.134, 135
III.3. Results from clinical and experimental heart
valve studies
The following section gives a short overview of some clinical and experimental
studies. It is not the intention to give a detailed literature study, but to give the reader
an idea of heart valves examinations and how these heart valves will perform.
III.3.1. Pressure gradient in experimental and clinical studies
Results73 from in vitro experiments done by Feng et al73 are displayed in figure
III.8(a). The SJM HP (St. Jude Medical Hemodynamic Plus) and On-X valves pro-
duced the lowest mean positive pressure drop, and the CM (CarboMedics) valve
produced the highest under every condition. The differences in these pressure drops
were related to the geometric orifice diameter and the degree of valve opening. That
the On-X valve produces the smallest pressure drop is mainly due to its larger inter-
nal orifice diameter and the parallel opening of its leaflets. The SJM HP valve also
benefits from a larger internal orifice diameter and a large opening angle. The ATS
valve has a lower mean positive pressure drop than the CM valve in pulsatile flow
despite the findings that its maximal opening angle is less than that of the CM valve.
Furthermore, it can be observed from figure III.8(a), that the pressure drop over the
valves increases with the cardiac output.
In the clinical setting, this maximum pressure gradient cannot be measured inva-
sively because it is not possible to position a catheter across or between mechanical
prosthetic valve leaflets in patients.136 Doppler gradients across the central orifices
are significantly higher than the transvalvular and net catheter pressure gradients
measured across the valve (figure III.8(b)). These differences are due to downstream
pressure recovery (figure III.8(c)).136, 137 This pressure recovery is demonstrated in
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(a) Example of pressure gradient measurements.73
(b) Correlation between catheter transvalvular
pressure gradients and Doppler-derived pressure
gradients without and with incorporating a pres-
sure loss coefficient K=0.64 in the simplified
Bernoulli equation.136
(c) Schematic representation of a centerline
pressure profile showing the locations where
pressures were read out for comparison; this also
illustrates the calculations of maximum, net, and
transvalvular pressure gradients as well as the
two phases of downstream pressure recovery.136
Figure III.8.: Pressure gradient.
figure III.8(c), which gives the pressure at a certain time along the axis of the valve.
The pressure shows a drop, but recovers at a certain distance downstream the valve,
due to conversion of kinetic energy into potential energy upon deceleration of the
flow through the valve.
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III.3.2. Effective orifice area
Many clinical and experimental studies are done in order to estimate the EOA. From
the EOA one can calculate the performance index PI and this provides clinicians and
engineers of a way to compare different types of heart valves. The higher the PI, the
better the hydrodynamic performance is of the studied heart valve. This means the
contraction of the flow through the valve is minimized and the flow utilizes a high
percentage of the available geometric orifice area. Bech-Hanssen et al. showed
similar effective orifice areas in vitro for St Jude Medical and Omnicarbon valves
(figure III.9).138
Figure III.9.: Effective orifice area of two different mechanical valve types.138 Results are
shown for the in vivo (black o) and in vitro (open o) studies. Bars indicate mean ± SD. Boxes
show the geometric orifice area.
III.3.3. Regurgitation
Figure III.10 gives an example of data on regurgitation of different types of bileaflet
valves.73 As reported by Wu et al.,139 the closing volume - expressed as a percent-
age of the forward flow volume - increased with decreasing cardiac output. The
closing volumes shown in figure III.10 of the valves are within the acceptable range
(<8%).73 The SJM HP valve under the low cardiac output condition at 100 bpm
showed a somewhat higher closing volume of 11.4%.
Closing volume is believed to be proportional to opening angle of the mechanical
heart valve (figures II.7(a) and III.10).73 We refer to table II.1 which summarizes
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Figure III.10.: Closing volumes of different bileaflet heart valves (ATS: Advancing The Stan-
dard, CM: Carbomedics, SJM HP: St. Jude Medical Hemodynamic Plus, On-X) studied in
mitral position in an experimental setup at 70 beats/min and at 100 beats/min.73
the maximum and observed opening and travel angles of mechanical bileaflet valves
used in their study. Figure II.7(a) defines the opening and travel angle of a bileaflet
valve. One can see that the SJM HP valve presents the maximum opening angle as
well as, consistently, the largest closing volume, under each drive condition. Corre-
spondingly, the smaller opening angles for the CM and ATS valves gave rise to the
smallest closing volumes. Although the On-X valve has a parallel-opening leaflet
design (opening angle of 90°), the closing volume remained low because the actual
non-fully open and the original small travel angle design minimizes the volume that
is swept during closure. As a result, the On-X valve generally presents as small a
closing volume as does the CM valve.73
III.3.4. Flow patterns and shear stresses
The caged ball valve Natural heart valves allow blood to flow straight through
the center of the valve. This property, known as central flow, keeps the amount
of work done by the heart to a minimum. With non-central flow, the heart works
harder to compensate for momentum lost to change the direction of the fluid. Caged-
ball valves completely block central flow (figure III.11(a)); blood therefore requires
more energy to flow around the occluder. In addition, collisions with the occluder
ball caused damage to blood cells. Caged-ball valves are also notorious for stimu-
lating thrombosis, requiring patients to take lifelong prescriptions of anticoagulants.
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(a) Caged ball valve. (b) Tilting disc valve. (c) Bileaflet valve. (d) Bioprosthesis.
Figure III.11.: Velocity profiles in cm/s based on in vitro measurements on 27 mm aortic valve
designs. Measurements were done downstream the valve on a centerline at peak systole, at
a cardiac output of 6 l/min and a heart rate of 70 beats/min.55
High turbulent shear are observed at the edges of the jet (figure III.12(a)). The in-
tensity of turbulence during peak systole does not decay very rapidly downstream
of the valve. Elevated shear stresses occurred during most of systole.55 This type of
valve is no longer used in patients nowadays.
(a) Caged ball valve. (b) Tilting disc valve. (c) Bileaflet valve. (d) Bioprosthesis.
Figure III.12.: Turbulent shear stress profiles in 0.1·N/m2 based on in vitro measurements on
27 mm aortic valve designs. Measurements were done downstream the valve on a centerline
at peak systole, at a cardiac output of 6 l/min and a heart rate of 70 beats/min.55
The monoleaflet tilting disc valve This valve design allows more central flow
while still preventing backflow. However, flow is not completely central (figure
III.11(b)), because the blood has to make a significant directional change to flow
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around the occluder disc. Newer models of monoleaflet valve improves this short-
coming.
In the major orifice region (figure III.12(b)), high turbulent shear stresses are con-
fined to narrow regions at the edges of the major orifice jet. During the acceleration
and deceleration phases the turbulent shear stresses are relatively low.55 High tur-
bulent shear stresses are more dispersed in the minor orifice than those in the major
orifice regions as shown in figure III.12(b).
The bileaflet valve These valves provide the closest approximation to central
flow yet achieved in a mechanical heart valve (figure III.11(c)). The two leaflets
block flow to some extent, leading to a three-part flow pattern. High turbulent
shear stresses occure at locations immediately distal to the valve leaflets55 (figure
III.12(c)).
Biological valves Biological valves, optimally mimick native heart valves and
provide nice central flow (figure III.11(d)).Turbulent shear stress measurements dur-
ing deceleration phase showed low shear stresses spread out over a wide region.55
During peak systole, the high turbulent shear stresses were confined in a narrow
region (figure III.12(d)).
III.4. Computational fluid dynamics and
fluid-structure interaction of heart valves
With the advent of high speed computers and the development of computational
fluid dynamic (CFD) analysis algorithms, fluid dynamic simulation of the valve
function provides a viable alternative for the detailed analysis of the haemodynam-
ics of prosthetic heart valves. Recently, realistic simulations have become possible,
modeling the leaflet motion including the fluid-structure interaction (FSI)140, 141, 142
during the opening and closing phases. These new fluid-structure interaction (FSI)
algorithms will be a major engineering tool available to unravel the haemodynam-
ics associated with thrombolitic and hemolytic events of existing and new prosthetic
heart valves. Within the context of clinical application, stenotic and/or incompetent
valve performance can be studied with respect to the associated medical complica-
tions using computational models.29, 30, 81, 143 In general, these models can be used
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to study and resolve problems associated with failure and medical complications of
diseased valves and currently used prosthetic devices.29, 30, 81, 143
III.4.1. Computational fluid dynamics
Computational Fluid Dynamics is the analysis of systems involving fluid flow, heat
transfer and associated phenomena such as chemical reactions by means of computer-
based simulation. The technique is very powerful and spans a wide range of indus-
trial and non-industrial application areas. Increasingly CFD is becoming a vital
component in the design of industrial products and processes.144
The equations governing the fluid flow problem are the continuity (conservation of
mass) and the Navier-Stokes (conservation of momentum). These equations form a
system of coupled non-linear partial differential equations (PDEs). Because of the
non-linear terms in these PDEs, analytical methods can yield very few solutions.
CFD is the art of replacing the differential equation governing the fluid flow, with a
set of algebraic equations (the process is called discretization), which in turn can be
solved with the aid of a digital computer to get an approximate solution. The well
known discretization methods used in CFD are Finite Difference Method (FDM),
Finite Volume Method (FVM) and Finite Element Method (FEM). A thorough ex-
planation of these techniques falls beyond the scope of this work.
III.4.2. Fluid-structure interaction methods
Fluid-structure interaction or FSI involves the dynamic interaction between an elas-
tic deformable structure and a fluid. This computational technique can be used for
studying biofluid dynamics problems, e.g. the coupled motion of the blood filling
the ventricles of the heart, the muscles of the heart wall, and the leaflets of the car-
diac valves.29, 145, 142
There are different ways to tackle a coupled interaction problem. One possibility
is to develop new software and solution methods for each of these coupled applica-
tions. This is referred to as a monolithical approach,146 or sometimes as the direct
method.147 On the other hand, one may assume that the methods and software
systems which have been developed for either fluid or structural applications will
continue to be used separately. Therefore we consider partitioned methods148 - also
known as iterative methods147 for fluid-structure interaction, i.e. separate solvers
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are used for the fluid and the structure.149
Furthermore, different numerical methods have been developed to tackle the com-
plex FSI problems: the Immersed Boundary Method, the Fictitious Domain Method
and Arbitrary Lagragian Eulerian or ALE based FSI Method.
III.4.2.1. Immersed boundary method
In designing the original immersed boundary method, Peskin145 realized the advan-
tages of describing the fluid variables and the immersed objects in different ways.
The fluid variables are described in what is known as an Eulerian manner. One fo-
cuses on each point in space and asks how the fluid variables change with time at
that point in space. On the other hand, the objects are described in what is called
a Lagrangian manner. The location of each material point is tracked as time ad-
vances and the system evolves. The state of the system at any time is given by
the fluid velocity and pressure fields, and by the locations of the Lagrangian points
which constitute the immersed objects. The essence of how the Immersed Boundary
method computes the change in the system over a short time interval (or timestep)
is as follows: from the Lagrangian description of each immersed object, it is deter-
mined how much the object has been deformed at the beginning of the timestep, and
from this elastic forces generated within the object are calculated. Since the object
is in direct contact with the fluid, these forces affect the fluid motion. To calculate
the effect of these forces on the fluid, they are transmitted from the elastic objects
to the fluid, and their contribution is added in the fluid dynamics equations which
drives the fluid motion.
III.4.2.2. Fictitious domain method
The fictitious domain (FD) method is based on the imposition of velocity constraints
associated with rigid internal boundaries by means of Lagrange multipliers.150, 151
It has similarities with the so-called immersed boundary technique of Peskin and
McQueen,145 in which at a number of control points (at the intersection of fluid and
solid), tension forces are imposed pointwise and distributed to neighboring nodes.
It gained popularity to solve the fluid-structure interaction of the flexible aortic heart
valve over the last years. De Hart et al.29, 30, 81 studied a 3D model of the aortic valve
with this method. However, the accuracy of the pressure and wall shear stress in the
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vicinity of the solid is poor. Therefore, a mesh adaptation algorithm is applied,
which locally adapts the fluid mesh to the position of the solid mesh every time
step.152
(a) Traditional fictitious domain mesh: alignment of in-
terface with the structure, which is positioned arbitrarily
in the fluid mesh.29
(b) Adaptation of the fluid mesh by shifting nodes.152
Figure III.13.: The fictitious domain method.
III.4.2.3. Remeshing methods combined with arbitrary Lagrangian
Eulerian method
In an Eulerian setting, the fluid is described using a fixed mesh. The Lagrangian
formulation is what we normally associate with FEM for structural mechanics. It is
a formulation where the numerical grid follows the motion of the material. Each el-
ement represents the same piece of material through out the whole simulation. This
method is suitable for solid structures undergoing limited deformations. Severely
distorted elements can lead to bad or non-useful results. The applicability of the La-
grangian formulation is somewhat limited in general applications involving gases
and liquids. However, the Eulerian and Lagrangian formulations are, at first sight
incompatible.
The arbitrary Lagrangian-Eulerian (ALE) formulation,153, 154 effectively combines
these two formulations and is often applied for fluid-structure interaction simula-
tions. In the arbitrary Lagrangian-Eulerian (ALE) method, the computational mesh
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is allowed to move in space in an arbitrary way conform to the body motion.155 Fig-
Figure III.14.: Computational mesh for closure dynamic simulation: Mesh for fully open posi-
tion and with the leaflet at 27.21°.141
ure III.14 demonstrates that it requires a continuous adaptation of the mesh without
modification of the mesh topology.
III.4.3. Numerical modeling of heart valves
III.4.3.1. Mechanical heart valve modeling
Several studies have been reported on the computation of recirculation regions127, 156
and wall shear stresses in the clearance region157 with the leaflets of the mechan-
ical valve in a fixed position (figure III.15).158, 159, 160 These studies neglected the
interplay between the flow field and the leaflet motion. In other studies, however,
the fluid flow has been coupled to the leaflet motion from the fully open to closed
position using prescribed valve motion in a simplified flow domain.155 Such a spec-
ification avoids the complex problem of the leaflet-fluid interaction during the valve
closure.
One of the important requirements of an accurate simulation of valve function is the
development of a validated fluid-structure interaction (FSI) algorithm for the predic-
tion of the leaflet motion resulting from the fluid stresses acting on that same leaflet.
Several attempts on the development of a FSI algorithm for mechanical heart valve
function have been reported recently. These studies have been restricted to two-
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Figure III.15.: Geometry and coordinate definitions of the modeled bileaflet mechanical heart
valve: the symmetric aorta with the inset showing the two leaflets. Calculations are carried
out for the full three-dimensional valve geometry under steady inflow conditions.158
dimensional analysis (figure III.14)51, 141 with the leaflets in the closed position and
a complete three-dimensional FSI algorithm for valve functional simulation is yet
to be developed.
These simulations can be used to analyze the details of the fluid dynamic stresses
in the regions of interest with the mechanical valve prostheses where detailed ex-
perimental measurements are impractical. Leaflet behavior and variations of shear
stresses with time and space can also be obtained. Also the regurgitation flows can
be calculated. The maximum shear stress, an important issue for valve haemody-
namic analysis, has been found in the vicinity of the contact point where a leaflet
contacts with housing in the final stage of the closing phase.51, 141 Such regions in-
clude the peripheral clearance region between the leaflet edge and the valve housing
as well as the hinge area where the leaflets and the housing interact.
III.4.3.2. Bioprosthesic heart valve modeling
Many numerical structural models have been developed that describe the behavior of
the aortic valve ignoring its interaction with the blood.161, 162, 163, 164, 165 The open-
ing and closing behavior of this valve during systole involves, however, a strong
interaction between blood and the surrounding tissue. Several attempts have been
made to analyze the valve kinematics using numerical fluid-structure interaction
models. Horsten et al.167 modeled the interaction of a two-dimensional leaflet with
a rigid channel flow. Peskin and McQueen et al.145 developed a three-dimensional
model including the surrounding vessel walls (figure III.16(a)). However, these
models used simplified descriptions for the structures and were only applicable for
relatively low, non-physiological Reynolds numbers. Fluid-structure simulation of
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(a) Section through the model
left ventricle showing stream-
lines of ventricular filling. The
closed aortic valve is at the top
left side, and the open mitral
valve is at the top right.145
(b) Three-dimensional coupled fluid-structure
simulation of pericardial bioprosthetic aortic
valve function.166
(c) A three-dimensional analysis of a fiber-reinforced
aortic valve prosthesis.30, 81, 143
Figure III.16.: Fluid-structure interaction modeling of bioprosthesic heart valves.
a bioprosthetic aortic valve functioning is performed by Makhijani et al. (figure
III.16(b)),166 where the leaflet structure has a much higher resistance to bending
compared to the natural leaflets. A physiological more realistic fluid-structure inter-
action model of the natural valve (figure III.16(c)), accounting for the phenomena
occurring during systolic phase, has been developed by De Hart et al.30, 81, 143
In case of bioprosthetic valves, these simulations can be used to compute the magni-
tude and the location of regions of high stress and shear concentrations where struc-
tural disintegration of the leaflets is suspected. Design parameters, such as commis-
sural height, free edge length, leaflet/root fixation, leaflet fiber-reinforcement, sinus
depth and height, and aortic root compliance, can computationally be optimized
depending on the patients characteristics.7
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Conclusion
With this introductory part, we have tried to provide sufficient background that
should allow the reader to situate the following chapters, containing new contri-
butions to the field of heart valve research.
In this thesis different types of mechanical heart valves have been studied using ex-
perimental and numerical models. The On-X bileaflet mitral valve and the Omnicar-
bon monoleaflet aortic valve were tested with the pulse duplicator of the Hydraulics
Laboratory (UGent). Furthermore a prototype of a bioreactor pulse duplicator sys-
tem has been developed for the testing and creation of a tissue engineered heart
valve.
A numerical model for the simulation of mechanical heart valves was developed and
validated for a 2D aortic valve model. The model is based on the commercial Fluent
software, which uses the finite volume method. The software uses a dynamic mesh
model based on the ALE and local remeshing to adapt the mesh in FSI problems.
Therefore we developed a partitioned method or iterative methods for fluid-structure
interaction. The model has been used for the 3D modeling of the ATS Open Pivot
heart valve.
Finally, a 2D FSI model of flexible heart valve has been developed. We believe that
this model has great potential for helping to set up a protocol for the growing of a
Tissue Engineered heart valve construct.
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Part B.
In vitro studies of heart valves
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Chapter IV
Mock loop testing of
On-X® prosthetic mitral valve with
Doppler echocardiography
The contents of this chapter is published in Artif Organs 2002;26(10), 872-878.
Mock loop testing of On-X® prosthetic mitral valve with Doppler echocardiography
Verdonck P, Dumont K, Segers P, Vandenberghe S, Van Nooten G
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Abstract
Previous in vitro testing mainly in aortic position and clinical experience often based
on Doppler echocardiographic observations demonstrated an excellent haemody-
namic behavior of the On-X valve. However, integrative studies including simul-
taneous haemodynamic pressure and flow measurements and Doppler echocardiog-
raphy are lacking. Using our computer controlled mock loop system, two samples
of the Mitral 27/29 and one sample of the Conform-X Mitral 25/33 are tested in
mitral position. Data include transvalvular pressure gradient and flow as well as
transthoracic Doppler echocardiography. The valves were tested in 3 pressure con-
ditions (ventricular systolic pressure of 100, 130, and 160 mmHg) at three different
heart rates (60, 100, and 140 beats/min). In addition, ventricular pressure conditions
simulating fibrillation were imposed. Both valve types show similar hydrodynamic
characteristics and have an effective orifice area of 2.1 cm2 and a performance index
of 0.56 for a cardiac output of 3.5 l/min. Regurgitant volumes remain below 6 ml.
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IV.1. Introduction
Previous in vitro testing69, 70, 71, 168, 169 of the On-X prosthetic heart valve (figure
IV.1), mainly in aortic position and Doppler echocardiography based observations in
clinical practice demonstrated excellent hydrodynamic characteristics of the valve.
Typical design characteristics of the On-X valve are a shaped orifice with flared inlet
design to reduce inlet turbulence, an elongated body to reduce exit losses, thinner
leaflets, and a supra-annular sewing ring for small aortic valves.69, 70, 71 The main
effect of its design is an enlarged valve area available for flow, as compared to other
equally sized prosthetic valves.
Integrative studies on the On-X mitral valve, linking transvalvular Doppler echo-
cardiographic flow velocity measurements to transvalvular volume flow and pres-
sure gradients are lacking. Therefore, the aim of this study was to perform hydro-
dynamic tests of the On-X valve in mitral position in a mock loop in mitral position
using both standard hydrodynamic measurements (pressure and flow) as well as
Doppler echocardiography.130, 133
IV.2. Materials and methods
IV.2.1. Valves tested
Three valves were provided by the manufacturer (Medical Carbon Research Insti-
tute MCRITM, LLC, Address: 8200 Cameron Road, A-196, Austin, TX 78754,
H
V
Figure IV.1.: Top view of an On-X prosthetic heart valve with indication of the scan-planes of
the Doppler probe (V: vertical, H: horizontal).
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USA) for in vitro testing: two On-X Mitral 27/29 (valve A and C) and one On-X
Conform-X Mitral 25/33 (valve B). The Conform-X type is a newer valve type with
a modified sewing ring. It is a “one size fits all” valve, suitable for orifice areas of 25
to 33 mm. The other valves are standard On-X valves for orifices of 27 to 29 mm.
The geometric orifice area of these 3 valves is the same, as well as the travel angle
of 50°.169 Dimensions of the valves are given in table IV.1.
Table IV.1.: On-X valve specifications.
On-X cardiac valve specifications [mm]
Valve
Size
Descriptor
Tissue
annulus
Diameter
Internal
annulus
Geometric orifice
diameter:
ODmean
Disc height
at hinge:
hleaflet
Disc
thickness:
∆leaflet
27/29 25 23.40 21.80 20.60 0.86
Conform
25/33 27 23.40 21.80 20.60 0.86
On-X cardiac valve areas [cm2]
Valve size descriptor Geometric orifice area (OA) Orifice area without disc
27/29 3.74 4.10
Conform 25/33 3.74 4.10
IV.2.2. Pulse Duplicator System: measuring haemodynamic
data and transthoracic visualization of transmitral
flow.130,133,170
The valves were mounted in our pulse duplicator system (PDS) in mitral position
(figure IV.2; note that the numbers between brackets (. . .) refer to the numbers in
the figure). The PDS is a hydraulic model of the human left heart,130, 133 connected
to a windkessel model of the human systemic circulation.132 The test fluid (40%
glycerine - 60% water mixture with a dynamic viscosity of 3.0 mPa.s) enters the
model from a controllable preload reservoir representing the lungs (9) via 2 rigid
pulmonary veins (8). The fluid reaches the left ventricle (LV) (2) through the mitral
valve (5). The left ventricle ejects through the aortic valve (15) (bioprosthesis) into
the afterload system that consists of an air chamber (16) or ‘windkessel’ and a hy-
draulic resistor (13). A venous reservoir (12) guarantees a constant venous pressure
of 5 mmHg. Both the preload lung (9) and the venous reservoir have an overflow
74
IV.2. Materials and methods
Figure IV.2.: Pulse Duplicator System: measuring haemodynamic data and transthoracic
Doppler echocardiographic data.
system, with the overflows ending in a central buffer reservoir (11) out of which the
test fluid is pumped (10) continuously into the lung reservoir.
The left ventricle is an anatomically shaped silicone sac, mounted in a Perspex
housing. It is surrounded by water and connected to an external circuit, consisting
of Perspex cylindrical reservoirs (3). Pressurized air is delivered to this external cir-
cuit and controls the contraction and relaxation of the cardiac chamber. The PDS is
computer controlled: a target left ventricular pressure curve is sent to the system and
the feed-back system controls the amount of pressurized air delivered to the system
such that the target curve is respected as closely as possible.130, 133
Left ventricular pressure was measured with a 6 French pigtail catheter inserted in
the LV via an access port (4), 3 cm distal to the valve. Left atrial (LA) pressure
was measured 3 cm proximal to the valve via a short cannula (6). Both were then
connected to a piezo-electric pressure transducer (Ohmeda, Ghent, Belgium). In
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this setting, transmitral flow velocities could be visualized with a 3.25 MHz ultra-
sound probe mounted in position (1) (figure IV.1). This viewpoint corresponds to
the in vivo transthoracic apical window. Volume flow was measured with an ultra-
sonic flow meter (7) (H16C flow probe, Transonic Systems Inc., Ithaca, NY, USA)
mounted on the rigid tube (figure IV.2).
Valves were tested at 60, 100, and 140 beats/min and for 3 levels of LV systolic
pressure (100 mmHg, 130 mmHg, and 160 mmHg). We further applied an irregular
LV target pressure to study valve dynamics in simulated conditions of ventricular
fibrillation.
IV.2.3. Haemodynamic data and transthoracic flow visualization
IV.2.3.1. Parameters derived from the haemodynamic data
Data were measured with the PDS and consist of pressures upstream (atrial) and
downstream (ventricular) of the valve, and transvalvular flow with the Transonic
flow probe mounted on the rigid atrial inflow. Data were sampled using Lab-
view Software and a multifunction National Instruments data acquisition card (PCI
6024E, National Instruments, Texas, USA) also used for controlling the pulse du-
plicator system. For all heart rates, 1024 samples were taken at 200 Hz. After
calibration of pressure and flow, one averaged cycle was calculated, further used
for subsequent analysis. Figure IV.3(a) shows an example of averaged LA and LV
pressure and according flow cycle. The data shown in figure IV.3(a) are signals fil-
tered by use of a low-pass filter. This has no effect on calculated indices, as they
were derived from mean pressure values which are not affected by the filter. All
data have been analyzed and parameters derived using customized software, written
in Matlab (Matlab 5.3, The Mathworks, Inc., Natick, MA, USA). LV systolic pres-
sure (PLVsys [mmHg]) is the maximum value of LV pressure. Cardiac output (CO
[l/min]) was calculated as the average of the flow wave. Systolic and diastolic peri-
ods were determined from the flow curve as the periods of backward (regurgitation)
and forward flow, respectively. Mean forward flow (Qfwd,mean [ml/s]) was calcu-
lated as the ratio of the “positive” area under the flow curve (forward stroke volume
SVfwd) divided by the duration of forward flow. Regurgitant volume (Vreg [ml]) is
the “negative” area under the flow curve. Vreg is further split into the closing volume
(Vclose) and the leak volume (Vleak), based on visual identification of the inflection
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Figure IV.3.: (a) Example of an averaged pressure and flow cycle for a bileaflet valve, mea-
sured at 60 beats/min, (b) velocity contour and maximum velocity (Vmax) drawn manually on
Continuous Wave Doppler Data.
point in the flow signal (figure IV.3). The pressure difference (∆P [mmHg]) is the
instantaneous difference of LA and LV pressure. The mean (∆Pfwd,mean) value
during systole has been derived.
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IV.2.3.2. Parameters derived from the transthoracic flow velocity
measurements
The valve and transmitral flow were visualized using the 2D ultrasound echo (2D),
Continuous Wave Doppler (CW), Colour M-mode (CMM) and 2D colour flow (2D
colour) modalities on the Vingmed CFM 800 machine with the 3.25 MHz cardiac
probe in the transthoracic window and a vertical scan plane (indicated as “V” in
figure IV.1). Velocities (CW) were measured with the scan line through the center
of the valve. All data were stored on videotape and a colour M-mode and continu-
ous wave Doppler image were digitally stored on optical disc for off-line analysis.
Doppler data were analyzed using the Vingmed CFM 800 on-board data analysis
software package (EchoPAC 5.4.4, GE Vingmed). The images allowed analyzing
the forward flow through the mitral valve. The maximum velocity contour was man-
ually traced (figure IV.3(b)), with the area under the curve yielding the velocity time
integral (VTI [cm]). The onset of the forward mitral inflow was taken as the point
where the extrapolated slope of the early filling phase crossed the time axis. The end
of filling was determined by the ECG signal, indicating the onset of ventricular con-
traction (and thus the end of diastole). The software further gives maximum (Vmax
[m/s]) and mean velocity (Vmean [m/s]) during forward flow. For each condition,
three cardiac cycles were analyzed. All values given in the text are averaged.
IV.2.3.3. Valve performance indices derived from haemodynamic and
echocardiographic data
The percentage of regurgitation (% reg) is calculated as
%reg =
Vreg
(Vreg + SVfwd)
(IV.1)
The effective orifice area (EOA [cm2]) is calculated - based on the continuity equa-
tion - as the ratio of forward stroke volume and VTI:
EOA =
SVfwd
V TI
(IV.2)
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The performance index (PI [-]) of the valve is calculated as the ratio of the effective
orifice area (EOA) and the geometric orifice area (OA):
PI =
EOA
OA
(IV.3)
The mean Doppler velocity and the simplified Bernoulli equation are used to calcu-
late an estimated value of the forward pressure difference (∆PDoppler):
∆PDoppler = 4 · V 2mean (IV.4)
Besides the continuity equation, the Gorlin equation provides an alternative way to
calculate the effective orifice area (EOAGorlin). The Gorlin equation is based on the
fundamental hydraulic law of flow through an orifice and couples the flow through
the valve orifice to the Doppler pressure gradient over the valve. With mean flow
through the valve Qfwd,mean expressed in [ml/s] and Doppler gradients ∆PDoppler
expressed in [mmHg], the general formulation is given as:
EOAGorlin =
Qfwd,mean
51.6 ·√∆PDoppler (IV.5)
EOAGorlin is a fraction θ of the available geometric orifice area OA, with θ known
as the orifice constant. The constant 51.6 is obtained from
√
2 · 981 · √1.36, with
981 being the gravity constant in cm/s2 and 1.36 resulting from converting cmH2O
into mmHg.
It is clear that the orifice constant θ is comparable to the performance index PI.
IV.3. Results
For all valves and heart rates, PLVsys was regulated to 3 different levels (100, 130,
and 160 mmHg). To process the data, we pooled the data obtained at the different
pressure levels, yielding an average PLVsys of 129 ± 22 mmHg. Cardiac output
throughout these experiments was in the range 3.0 - 4.1 l/min (average value 3.54
± 0.28 l/min). ∆Pfwd,mean was 1.4 ± 1.2 mmHg for Qfwd,mean of 88 ± 10 ml/s.
Transthoracic Doppler-data are summarized in figure IV.4, showing Vmax (figure
IV.4(a)), Vmean (figure IV.4(b)) and VTI (figure IV.4(c)). Vmean is about constant
for the different pressure and heart rate settings (as expected seen the relatively
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Figure IV.4.: Velocity data for three samples (A, B, C) of the On-X valve in mitral position,
for three heart rates (60, 100, and 140 beats/min), and averaged for the different pressure
levels.
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Figure IV.5.: Mean value and standard deviation of the performance index (PI) for On-X valve
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and averaged for the different pressure levels.
constant cardiac output), but Vmax tends to be lower for the higher heart rates.
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Figure IV.7.: Simulated fibrillation conditions for valve sample A.
VTI decreases with increasing heart rate, as anticipated. All three samples yield
comparable results. ∆PDoppler, calculated with the simplified Bernoulli equation, is
0.92 ± 0.17 mmHg (range 0.59 - 1.39 mmHg). The effective orifice area calculated
with the continuity and the Gorlin equation is given in Table IV.2. The values for
both equations are in the same range (EOA = 2.1 ± 0.1 cm2; EOAGorlin = 1.8
± 0.2 cm2), but EOAGorlin is systematically lower. The overall average θ is 0.48
± 0.05 and PI is 0.56 ± 0.04. Valve-specific data for PI are shown in figure IV.5.
Regurgitation data (Vreg and %reg) are presented in figure IV.6, with Vreg split into
Vclose and Vleak. Overall, Vreg remains lower than 6 ml (average 3.5 ± 1.2 ml),
with Vclose = 2.9 ± 0.7 ml and Vleak = 0.6 ± 0.7 ml.
As an example, figure IV.7 gives the hydrodynamic data (PLV and flow) as measured
in the fibrillation simulation sequences for valve sample A. Similar data have been
measured for the other two samples. Due to the low transvalvular pressure gradients
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Table IV.2.: The effective orifice area (mean value and standard deviation) calculated accord-
ing to continuity equation (EOA) and to the Gorlin equation (EOAGorlin).
Effective Orifice Area
Heart Rate Continuity Equation (EOA) Gorlin Equation (EOAGorlin)
[beats/min] [cm2] [cm2]
60 2.05 ± 0.12 1.99 ± 0.10
100 2.09 ± 0.18 1.77 ± 0.09
140 2.14 ± 0.12 1.61 ± 0.12
and the low pressure differences needed for opening and closing of the valve, the
valve seems to close several times (presence of backflow in the flow data) within
this fibrillation sequence, which is confirmed by echocardiographic images of the
valve movement.
IV.4. Discussion
Overall, our data confirm the excellent hydrodynamic performance of the On-X
valve as reported in earlier studies.69, 71, 169, 171, 172 In this study, considering differ-
ent valve types (the standard mitral 27/29 and Conform 25/33) but of the same size,
we cannot discriminate between the different valve samples from a fluid-dynamic
point of view.
This observation is no surprise, given the fact that the geometric orifice area is the
same for the three valves. Furthermore, the connection between the left atrium and
the left ventricle in the pulse duplicator system generates a “tunnel-like” effect. As
such, the valves were mounted in a short tube and it was not possible to observe
the potential hydraulic effect of the geometrical difference between standard 27/29
On-X valves and 25/33 conform-X valve.
During forward flow conditions, measured mean pressure gradients are lower than
3 mmHg for cardiac outputs between 3.3 and 3.8 l/min. The Doppler-derived mean
pressure gradients are lower than 1.4 mmHg for the same flow conditions. This
value is lower than the 4.5 mmHg reported by Chambers et al.,169 probably due to
the relatively low cardiac output in the pulse duplicator system (cardiac output used
by Chambers er al.169 was 5.9 ± 2.6 l/min). For all pulsatile flow conditions, for-
ward maximum velocities remained below 1 m/s, with mean velocities in the order
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of 0.5 m/s. As expected, the velocity time integral decreases with heart rate due to
the reduced time that is available for left ventricular filling.
The effective orifice area, calculated with the continuity equation, was between 2
and 2.3 cm2. This value is in agreement with in vivo patient data: 2.2 ± 0.5 cm2 for
the 27/29 On-X mitral valve.168, 169 As Chambers et al., we found that methods to
calculate effective orifice area are not interchangeable. Using the Gorlin equation,
EOA is estimated about 0.2 cm2 lower (table IV.2) than using the continuity equa-
tion (overall average 1.79 cm2). There was no correlation between both parameters,
but this may again be due to the fact that data are within a narrow range and form a
cluster of data points.
The performance index was calculated as the ratio of the effective orifice area (con-
tinuity equation) and the geometric orifice area as given in table IV.1. Values range
from 0.49 to 0.65. Again, there was no difference between the samples. The per-
formance index given by Chambers et al. was 0.38, but they calculated PI using the
available tissue annulus (5.72 cm2). Using the same definition and reference value,
we found an average performance index of 0.37.
The total regurgitant volume was lower than 6 ml, the closing volume being the
most important contributor (between 2 and 4 ml). For heart rates of 140 beats/min,
we found no significant leak volume. On average, the leak volume was 0.6 ± 0.7 ml.
The average percent regurgitation was 9 ± 2%.
We tested the On-X valves during a sequence of fibrillation, simulated by applying
an irregular and low left ventricular driving pressure (see figure IV.7). Quantitative
analysis of haemodynamic and Doppler echocardiographic data is difficult due to
the irregularity of the signals, and data are strictly qualitative.
IV.5. Conclusion
In conclusion, the On-X Mitral 27/29 and On-X Conform-X Mitral 25/33 show an
excellent hydrodynamic performance. Effective orifice area is 2.1 cm2 and the per-
formance index 0.56 for a cardiac output of 3.5 l/min. Regurgitation volumes are
below 6 ml. We did not observe any difference in hydrodynamic performance be-
tween the standard On-X valve and the On-X Conform valve. Data are in agreement
with reported in vitro and clinical data.
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Chapter V
Omnicarbon® 21 mm aortic valve
prosthesis in vitro hydrodynamic
and Doppler echocardiographic
study
The contents of this chapter is published in Int J Artif Organs 2002;25(8):783-790.
Omnicarbon® 21 mm Aortic Valve Prosthesis in vitro Hydrodynamic and Echo-Doppler Study
Dumont K, Segers P, Vandenberghe S, Van Nooten G, Verdonck P
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Abstract
The aim of this study was to perform combined hydrodynamic and Doppler echocar-
diographic tests of the Omnicarbon 21 mm cardiac valve in aortic position in our
Pulse Duplicator System for simultaneous assessment of valve performance and
valve leakage data. During forward flow conditions, measured mean pressure gra-
dients are between 4.5 and 20.2 mmHg (11.9 ± 4.4 mmHg) for cardiac outputs be-
tween 3.6 and 5.3 l/min (4.5 ± 0.4 l/min). Doppler-derived mean pressure gradients
are between 2.0 and 17.0 mmHg (9.3 ± 3.9 mmHg) for the same flow conditions.
Effective orifice area is 1.31 ± 0.08 cm2 and the performance index is 0.74 ± 0.04,
using the actual geometric orifice area, and 0.38 ± 0.02, using the tissue annulus
diameter, for a cardiac output of 4.5 ± 0.4 l/min. Regurgitation volumes are below
3 ml. There is a trend to an effect of valve orientation on haemodynamics.
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V.1. Background and aim of the study.173,174,175,176,177
The Omnicarbon cardiac valve is a monoleaflet prosthesis that basically consists of
a ring and a curved freely-rotatable disc, which is retained by two shields extend-
ing from the ring. The Omnicarbon valve is particularly appropriate for ultrasound
visualization because of its simple geometric shape and the absence of inner struc-
tures. Its hingeless design produces central flow of blood. The disc opens to a
maximum angle of 80° at maximum cardiac output rate. An adequate opening an-
gle of approximately 60°-70° is expected at normal cardiac output at rest. Leakage
flow is relatively low because of the presence of a disk seat on the housing ring
where the disc closes at 12° angle. The seat eliminates the open gap which exists
in other valve designs. Further motion of the disc beyond its 12° position is wasted
energy and does not benefit the flow process. The aim of this study was to perform
combined hydrodynamic and Doppler echocardiographic tests of the Omnicarbon
21 mm cardiac valve in aortic position in a Pulse Duplicator System (PDS).130, 133
The PDS was designed to study prosthetic heart valves in mitral and aortic posi-
tion using both standard hydrodynamic measurements (pressure and flow) as well
as Doppler echocardiography.
V.2. Materials and methods
Three samples of the Omnicarbon 21 mm cardiac valve were provided by the manu-
facturer (MedicalCV Inc.). Valve dimensions are summarized in Table V.1. The
valve model is designed to be implanted intra-annularly, hence its size represents
the outside diameter including the suture ring.
V.2.1. Pulse Duplicator System
The PDS (figure V.1) is a hydraulic model of the human left heart, connected to a
windkessel model of the human systemic circulation. The test fluid (40% glycer-
ine - 60% water mixture with a dynamic viscosity of 3 mPa·s at room temperature)
enters the model from a controllable preload reservoir (5) representing the lungs.
The fluid enters the left ventricle (LV) (6) through the mitral valve (8). The left
ventricle ejects through the aortic valve into the afterload system that consists of an
air chamber (“windkessel”) (3) and a hydraulic resistance (4). A venous reservoir
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Table V.1.: Omnicarbon cardiac valve.
Omnicarbon Cardiac Valve Specifications [mm]
Tissue
Annulus
Diameter
Internal
Annulus
Geometric Orifice
Diameter:
ODmean
disc height
at hinge:
hleaflet
disc
thickness:
∆leaflet
21 16 15 1.39 0.8
Omnicarbon Cardiac Valve Areas [cm2]
Geometric Orifice Area (OA) Orifice Area Without Disc
1.77 1.88
guarantees a constant venous pressure of 5 mmHg. Both the preload lung and the
venous reservoir have an overflow system, with the overflows ending in a central
buffer reservoir out of which the test fluid is pumped continuously into the lung
reservoir. The left ventricle is a silicone sac, mounted in a Perspex housing. It is
surrounded by water and connected to an external circuit (2), consisting of Perspex
cylindrical reservoirs. Pressurized air is delivered computer-controlled to this ex-
ternal circuit and regulates the contraction and relaxation of the cardiac chambers.
The Omnicarbon valves were tested in aortic position (7). Measurements were done
with the valves in “vertical” position and “horizontal” position (figure V.2).
V.2.2. Data handling
Data were averaged per pressure level or, when appropriate, per heart rate. Multi-
variate analysis indicated no significant differences between results with the valve
in horizontal or vertical position. Therefore, these data were pooled for the analysis
of most results, except for the analysis of forward pressure gradient-flow relations.
V.2.3. Pressure and flow data
Left ventricular and aortic pressure and flow were measured using Labview Soft-
ware and a multifunction National Instruments data acquisition card (PCI 6024E,
National Instruments, Texas, USA). For all heart rates, 1024 samples were taken at
200 Hz. These data are further analyzed and parameters derived using customized
software, written in Matlab (Matlab 5.3, The Mathworks, Inc., Natick, MA, USA).
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Figure V.1.: Pulse Duplicator System and simultaneous measurement of data.
(a) Omnicarbon monoleaflet valve.
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(b) Orientation of the Omnicarbon monoleaflet valve.
Figure V.2.: Schematic drawing of the open Omnicarbon valve in the “vertical” and “horizon-
tal” position with indication of the vertical (V) and horizontal (H) echo-Doppler scan planes.
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After calibration of pressure and flow, one averaged cycle was calculated. Signals
were aligned in time to account for time delays in the fluid-filled 6 Fr pigtail catheter,
and these data were further used for subsequent analysis. Figure V.3 shows an exam-
ple of averaged LV and aortic pressure and according flow cycles. From these data
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(a) Averaged pressure and flow cycle.
(b) Continuous wave Doppler measurement.
Figure V.3.: Example of an averaged pressure and flow cycle for an Omnicarbon valve (valve
A) measured in vertical position at 60 beats/min and aortic systolic pressure of 150 mmHg.
the following numbers were derived. Cardiac output (CO) was calculated as mean
flow and though expressed in l/min. Systolic and diastolic flow periods were deter-
mined from the flow curve as the periods of forward and backward (regurgitation)
flow, respectively. Mean forward flow (Qfwd,mean) was calculated as the ratio of the
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positive area under the flow curve (Forward Stroke Volume SVfwd), divided by the
duration of forward flow (Tfwd). The reguritation volume (Vreg), i.e. the “negative”
area under the flow curve, was further split into the closing volume (Vclose) and the
leak volume (Vleak). The pressure difference (∆P) was the instantaneous difference
of LV and aortic pressure. The mean (∆Pfwd,mean) during systole was derived.
V.2.4. Continuous wave Doppler data
Doppler data were analyzed using the Vingmed CFM 800 on-board data analysis
software package (EchoPAC 5.4.4, GE Vingmed, (1) in figure V.1). The images al-
lowed analyzing the forward flow through the aortic valve. The maximum velocity
contour was manually traced, with the area under the curve yielding the velocity
time integral (VTI). The software further yielded maximum (Vmax) and mean ve-
locity (Vmean), the latter being calculated as the ratio of VTI and Tfwd. For each
condition, three cardiac cycles were analyzed. All values given in the text are aver-
aged.
V.2.5. Derived parameters
The percentage of regurgitation (%reg) is calculated as
%reg =
Vreg
Vreg + SVfwd
(V.1)
The effective orifice area (EOA [cm2]) is calculated - based on the continuity equa-
tion - as the ratio of the forward stroke volume (SVfwd) and VTI:
EOA =
SVfwd
V TI
(V.2)
The mean Doppler velocity and the simplified Bernoulli equation can be used to
estimate the forward pressure difference (∆PDoppler):
∆PDoppler = 4 · V 2mean (V.3)
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Besides the continuity equation, the Gorlin equation provides an alternative way to
calculate the effective orifice area (EOAGorlin):
EOAGorlin =
Qfwd,mean
51.6 ·√∆PDoppler (V.4)
Finally, the performance index (PI [-]) of the valve is calculated as the ratio of the
effective orifice area (EOA) and the geometric orifice area (OA):
PI =
EOA
OA
(V.5)
Depending on how the geometric orifice area is defined, different values are ob-
tained (table V.2). We calculated the performance index using a measured value for
the geometric orifice (1.77 cm2), giving PIgeo, and a value calculated from the tissue
annulus diameter (21 mm, yielding an area of 3.46 cm2), giving PItissue.
V.3. Results
Overall, cardiac output is 4.5 ± 0.4 l/min (table V.2). The mean pressure gradient
Table V.2.: Summary of data for Omnicarbon cardiac valve, valve size 21 mm
Summary of the Experimental Data of the Omnicarbon Study
Pressure Level Cardiac Output Effective Orifice Effective Orifice Performance Index Performance Index
Area Area using Tissue using Geometric
Continuity Equation Gorlin Equation Annulus Diameter Orifice Area
[mmHg] [l/min] [cm2] [cm2] [-] [-]
100 4.00 ± 0.274 1.30 ± 0.083 1.26 ± 0.080 0.38 ± 0.024 0.74 ± 0.047
125 4.49 ± 0.215 1.32 ± 0.063 1.28 ± 0.061 0.38 ± 0.018 0.75 ± 0.036
150 4.89 ± 0.228 1.32 ± 0.089 1.27 ± 0.086 0.38 ± 0.026 0.74 ± 0.050
Overall Average 4.50 ± 0.436 1.31 ± 0.078 1.27 ± 0.076 0.38 ± 0.023 0.74 ± 0.044
over the valve is 11.9 ± 4.4 mmHg and is function of flow (values between 4.5 -
20.2 mmHg) (figure V.4). Figure V.4(b) shows in more detail the relation between
measured mean pressure drop over the valve, and the mean forward flow through
the valve. A 2nd order polynomial was fitted to the data points. The regression
line through the data measured with the valve in vertical position being above the
regression line through the “horizontal” data. For example, for a ∆Pfwd,mean of
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10 mmHg the difference in Qfwd,mean between vertical and horizontal position is
30 ml/s (193 vs. 163 ml). Multivariate analysis, however, indicated no significant
difference between results in horizontal and vertical position. The Doppler-gradient
calculated from Vmean and using the simplified Bernoulli equation, are systemati-
cally lower than the measured pressure gradient (figure V.4(a)) (mean difference 2.6
mmHg). Regurgitation volume and % regurgitation are given in figure V.5 for three
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position of the valve.
Figure V.4.: Comparison of ∆Pmean,Doppler and ∆Pmean,measured (a), relation between forward
pressure gradient ∆Pfwd,mean and flow Qfwd,mean (b).
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Figure V.5.: Valve leakage based on flow data per pressure level and per heart rate.
different heart rates and three different pressure levels. Closing volume is rather
constant and between 1 and 1.5 ml. Total regurgitating volume is lower than 3 ml.
The leakage volume increases with systolic pressure and decreases with the heart
rate. The percentage regurgitation is less than 6%. Doppler velocities and VTI are
shown in figure V.6. Maximal velocities are between 2 and 2.5 m/s; mean velocities
(averaged over the period of forward flow) around 1.5 m/s. The Velocity Time Inte-
gral (figure V.6) strongly depends on heart rate; for this reason, data were averaged
per heart rate and per aortic pressure level.
The effective orifice area of the valve was calculated using the continuity equa-
tion and the Gorlin equation, respectively (table V.2). For the standard “continuity-
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Figure V.6.: Velocity data calculated from the Continuous Wave Doppler measurements and
Velocity Time Integral averaged per heart rate and per pressure level, respectively.
equation” approach, EOA is 1.31 ± 0.08 cm2; the Gorlin equation yields a somewhat
lower value of 1.27 ± 0.08 cm2. The performance index is 0.74 ± 0.04 using the ac-
tual geometric orifice area, and 0.38 ± 0.02 using the tissue annulus diameter.
V.4. Discussion
This study is, to our knowledge, the first to combine directly measured pressure and
volume flow data, with Doppler echocardiographic data to assess the hydrodynamic
performance of the Omnicarbon valve. This allowed us to simultaneously assess hy-
drodynamic performance as well as valve leakage information. This was achieved
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in an in vitro set-up designed to test heart valves in aortic and mitral position.
Overall, our data demonstrate an excellent hydrodynamic performance for the Om-
nicarbon aortic cardiac valve and confirm findings reported in earlier in vitro and
clinical studies.173, 175, 176, 178, 179, 180 During forward flow conditions, measured mean
pressure gradients are between 4.5 and 20.2 mmHg (11.9 ± 4.4 mmHg) for cardiac
outputs between 3.6 and 5.3 l/min (4.5 ± 0.4 l/min) under various systolic pres-
sures and beats/min frequency conditions. Doppler-derived mean pressure gradients
are between 2.0 and 17.0 mmHg (9.3 ± 3.9 mmHg) for the same flow conditions.
Doppler gradients are lower than the value reported by Fehske et al.173 and Messner-
Pellenc et al..176 This discrepancy between our in vitro experiments and in vivo data
are, at least in part, due to the specific character of the Pulse Duplicator System. The
valves were mounted in a short tube and this influences the flow pattern through the
valves. The velocity in this tube stays high and impeded “pressure recovery” distal
to the valve. This is different than in the real aorta, where the pressure can and will
rise due to pressure recovery. The absence of pressure recovery is also a possible
explanation for the difference in the Doppler derived and measured pressure gradi-
ents that we observed in our data.181 In addition the accuracy of the LV pressure
measurements (6 French pigtail catheter connected to a piezoelectric pressure trans-
ducer: Ohmeda, Ghent, Belgium) is a limitation for the measured pressure data.
The maximum deviation of the pressure transducers, due to the total effects of non-
linearity, hysteresis and sensitivity variation is no more than 2% of the reading.
Tilting disc and bileaflet aortic valve substitutes have an optimal orientation yield-
ing favorable haemodynamics and smallest pressure gradients.182, 183 We compared
the ∆Pfwd,mean-Qfwd,mean curves for two orientations of the valves, i.e. the valve
mounted in a vertical or a horizontal orientation (figure V.2). There is a trend for a
higher pressure drop for the vertical position of the valve (figure V.4), but our data
do not allow to demonstrate its statistical significance. This is due to the rather lim-
ited number of valves tested and to the variability in the measurements induced by
manipulation of the Pulse Duplicator System (opening the system and changing the
valve or its orientation) and/or variation on certain control parameters of the model,
such as cardiac output, total arterial compliance and resistance and pressure level.
The effective orifice area (table V.2), calculated with the continuity equation was
1.31 ± 0.08 cm2. This value is in agreement with in vivo patient data: 1.36 ± 0.1 cm2
found by Messner-Pellenc et al.176 and between 1.2 and 1.7 cm2 found by Carrier et
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al..180 Although it has been reported that methods to calculate effective orifice area
are not interchangeable (Chambers et al.168) we found quite good agreement using
the Gorlin equation (1.27 ± 0.08 cm2).
The value of the performance index (PI) strongly depends on how the geometric
valve area is defined. Using the actual geometric orifice area, we found a PIgeo of
0.74 ± 0.04. Using the tissue annulus diameter, however, the PItissue is 0.38 ± 0.02.
This value is close to the performance index given by Peter et al.175 (0.35), know-
ing that the PI was calculated using the available tissue annulus. It should be noted
that this Omnicarbon model is intended for intra-annular implantation and hence, its
outside diameter (including the compressed suture ring) closely matches the stated
nominal size of the tissue annulus diameter (21 mm).184
The total regurgitating volume was lower than 3 ml, the closing volume being the
most important contributor. As expected leak volume decreased with increasing
heart rate (less time available to leak) and increasing with systolic pressure level
(higher pressure gradient over closed valve). The average percent regurgitation was
4.5 ± 1.8 %.
V.5. Study limitations
The reported data includes echocardiographic and complete haemodynamic data,
but only for 1 valve size.
V.6. Conclusions
In conclusion, the Omnicarbon aortic cardiac valve prosthesis shows an excellent
hydrodynamic performance. Effective orifice area is 1.31 ± 0.08 cm2 and the perfor-
mance index is 0.74 ± 0.04, using the actual geometric orifice area, and 0.38 ± 0.02,
using the tissue annulus diameter, for a cardiac output of about 4.5 ± 0.4 l/min. Re-
gurgitation volumes are below 3 ml. There is a trend to a slight effect of valve
orientation on haemodynamics. Data are in agreement with reported in vitro and
clinical data.
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Chapter VI
Design of a new pulsatile bioreactor
for tissue engineered aortic heart
valve formation
The contents of this chapter is published in Artif Organs 2002;26(8):710-714.
Design of a new pulsatile bioreactor for tissue engineered aortic heart valve formation
Dumont K, Yperman J, Verbeken E, Segers P, Meuris B, Vandenberghe S, Flameng W, Verdonck P
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Abstract
Evidence has been gathered that biomechanical factors have a significant impact on
cell differentiation and behavior in in vitro cell cultures. The aim of this bioreac-
tor is to create a physiological environment in which tissue engineered (TE) aortic
valves, seeded with human cells, can be cultivated and conditioned during a period
of several days. The bioreactor consists of two major parts: (i) the left ventricle (LV)
and (ii) the afterload consisting of a compliance, representing the elastic function of
the large arteries, and in series a resistance, mimicking the arterioles and capillaries.
Between the LV and the compliance the TE aortic valve is placed. A mechanical
valve in mitral position ensures the uni-directional flow in the closed circuit. With
controllable resistance, compliance, stroke volume, and frequency, hydrodynamic
conditions can be changed over a wide physiological range. This study resulted in
a biocompatible prototype of a compact pulsatile flow system.
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Valvular heart disease is an important cause of morbidity and mortality. Currently
available substitutes for failing heart valves have serious limitations. Mechanical
heart valves require lifelong anticoagulation and are unable to grow. Currently used
biological heart valves are known to have superior haemodynamics, but they have
limited durability. A new promising alternative to overcome these shortcomings is
tissue engineering of heart valves. Tissue engineering is a new domain in which
techniques are being developed to transplant autologous cells onto a cell matrix,
which can be a biodegradable scaffold, or an acellularized heterograft cell matrix.
Ultimately this promising technique could lead to the creation of new functional
autologous tissue.84, 92, 110, 185, 186, 187 An important obstacle to the creation of im-
plantable tissue engineered heart valves is the fact that tissue engineered valves
show inadequate mechanical properties to withstand haemodynamic stresses on the
valve in aortic position.188, 189 This is especially important for aortic valves where
transvalvular pressure differences of 80 mmHg may exist during diastole, with high
mechanical stresses on the leaflet. Evidence has been gathered that the application
of pulsatile fluid flow stimulates the tissue engineered heart valve to develop struc-
tural integrity prior to implantation.97, 110, 189, 190 For this purpose, a new bioreactor
is developed, in which the seeded cells can grow under physiological aortic pressure
and flow conditions. The aim of this bioreactor is to create a physiological environ-
ment in which tissue engineered aortic valves can be cultivated and conditioned
during a period of several days.
VI.2. Basic demands of a bioreactor
A bioreactor tries to mimic the complex in vivo environment,97, 191, 192 including
all natural stimuli that have impact on cell growth and differentiation. In a classic
general cell culture-bioreactor system, these stimuli can be divided into 4 basic cat-
egories:84, 95, 97 (i) growth matrix in or on which cells can grow; (ii) the chemical
and physiological composition of the medium; (iii) the composition of the gas phase
in the incubator; (iv) the incubation temperature (including heat transport). How-
ever a modern approach to certain cell cultures is to create an in vitro environment
that not only embodies the 4 above-mentioned aspects but also includes mechanical
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stimuli as pressure and shear stress.84, 97 The bioreactor has to meet several other re-
quirements: compact in size, sterility, low volume, easy refreshment of the medium,
access to the TE-valve and visualization of the TE-valve. The use of a pump (heat
production) may not disturb the climate in the incubator. The medium should be
exposed to the controlled atmosphere (diffusion of O2, CO2, N2) of the incubator.
This way, a micro-environment is created with sufficient nutrients and without ac-
cumulation of metabolites. The bioreactor should allow testing of entire valves as
well as parts of it. From haemodynamic point of view, the bioreactor should be able
to mimic different haemodynamic conditions, within certain physiological limits
(transvalvular pressure gradient, flow, frequency).
VI.3. Materials and methods
VI.3.1. Bioreactor design
The bioreactor design (Figure VI.1) is based on the experience obtained with a pul-
satile mock loop of the left heart130(14) and a two-element windkessel model132(15).
It consists of two major parts: the left ventricle and the afterload consisting of a com-
pliance chamber and a resistance. The first part is the left ventricle (LV) made of
silicone rubber (Wilsor, the Netherlands). For the prototype, we chose a maximum
stroke volume of 80 ml. From this value the diameter of a spherical ventricle was
calculated as
3
√
6/pi · 8 · 10−5m3 = 5.35cm. (VI.1)
This LV is compressed and decompressed by the movement of a piston by means of
an external circuit (E), which allows varying the stroke volume and the frequency.
It is thus possible to create different pulsatile flow conditions. An air filled chamber
is used as a compliance (C), representing the elastic function of the large arteries.
The air volume (and compliance) is easily varied by pumping air in and out of the
chamber. As a constant volume V of air is compressed and relaxed at low pressures
P, the compliance can be mathematically described by the gas law. This means
that the process can be assumed isothermal and described by Boyle’s law: P.V =
constant. This also allows approximating the size of the air chamber. For standard
diastolic and systolic pressures of 80 and 120 mmHg, atmospheric pressure 105 Pa,
conversion factor 133 Pa/mmHg (mmHg to Pa) and a stroke volume of 50 ml, the
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Figure VI.1.: Basic design of prototype of the pulsatile bioreactor.
air chamber volume VC can be calculated as:
VC
VC − 50 =
(120 · 133) + 105
(80 · 133) + 105 ⇒ VC = 1024ml
∼= 1l (VI.2)
The TE aortic valve (V) is placed between the LV (LV) and the compliance (C).
Distal to this compliance chamber is a non-linear resistance (R), mimicking the
arterioles and capillaries. As a resistance we used a variable clamp, which controls
the diameter of the tubing. Downstream aeration is regulated (A). The mechanical
valve (M) ensures the flow in one direction.
VI.3.2. Hydrodynamic study
With controllable resistance, compliance, stroke volume and frequency, it is possi-
ble to change the hydrodynamic conditions over a wide physiological range. The
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hydraulic properties of the bioreactor were tested by using a mechanical valve as
well as a cadaveric ovine aortic valve (OAV) in aortic position. Flow was measured
with a Transonic flow probe positioned between the LV and the aorta valve. Aortic
pressure in the compliance chamber was measured with an Ohmeda pressure trans-
ducer. During this hydraulic evaluation, heart rate (40-100 BPM), stroke volume
(35-76 ml), resistance (0.98-4.70 mmHg.s/ml) and compliance (0.4-1.2 ml/mmHg)
parameters were varied.
VI.3.3. Biocompatibility study
The ISO 10993-1 gives a guideline of the characteristics, which should be exam-
ined in order to prove biocompatibility of certain materials. Taking into account
that no blood will be used in the bioreactor during in vitro tests, only cyto-toxicity
was investigated. A cell line of endothelial cells (EA. hy 926) was used for these
experiments. The bioreactor contains 8 different materials: 1) silicone tubing, 2)
silicone ventricle (Wilsor, the Netherlands), 3) rubber sealing, 4) Teflon sealing, 5)
plexiglass, 6) glue (Acrifix 192 Rhm GmbH Germany, glued pieces of plexiglass
and/or PVC), 7) PVC tubes, 8) PVC angles. Of each material, one piece was steril-
ized by ethylene oxide (EtO) and one by glutaraldehyde (2%) (GA). The materials
were leaching in cell medium (Dulbeccos’s modified eagle medium DMEM supple-
mented with 10% fetal bovine serum, 100 units/ml penicillin, 100 µg/ml strepto-
mycin and 0.25 µg/ml amphotericin B) for two weeks. As a reference, two samples
of cell medium without any material were added to this series. These different me-
dia were used to start up the cell cultures. The cell cultures were evaluated after
one and three days of growth. The cells were evaluated quantitatively by cell counts
after staining with trypan blue; only living cells were counted. Cell numbers of
the cultures corresponding to each of the 8 test materials are reported as the ratio
living cell number divided by the cell number observed in the reference culture at
t=0. The results are thus expressed as a relative cell number. The cells were qual-
itatively evaluated with immunocytochemical stainings for endothelial cells: Von
Willebrand factor and CD 31. As an index for proliferation KI 67 was used. Degen-
erating or dead cells do not express the endothelial antibodies. We scored the cell
cultures based on the intensity of the staining. A score between 0 (no dye visible)
and 5 (very intense) was attributed. The lower the quality factor, the less healthy or
proliferating the cells are.
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VI.4.1. Hydraulic evaluation of the bioreactor
The four controllable parameters are easily managed and the system adapts to a
change within some seconds and then remains stable. Figure VI.2 shows the open
(a) Closed during diastole. (b) Open during systole.
Figure VI.2.: Ovine aorta valve in the bioreactor.
and closed aortic ovine valve during the cardiac cycle. Figure VI.3 shows as exam-
ple aortic pressure and flow for 2 different settings of the 4 controllable parameters.
Adapting the parameters it is possible to start with low flow conditions (e.g. car-
diac output of 1.68 l/min or even lower) and thus according physiological low shear
stress on the endothelial surface of the valve leaflets. Later on, the flow and pressure
conditions can be progressively increased (e.g. cardiac output of 3,44 l/min) until
normal physiological conditions are reached. The results show the ability of the
bioreactor to perform a wide range of physiological conditions.
VI.4.2. Biocompatibility results
There are no important differences in cell numbers between the two sterilization
methods (figure VI.4). For cultures on medium in which EtO sterilized materials
had leached, cell counts are slightly higher in 6, slightly lower in 7 and the same in 2
cases compared to cultures in which GA sterilized materials are leached. Regarding
the silicone ventricle, cell counts are seriously lower when EtO sterilization is used.
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Figure VI.3.: Aortic pressure and flow curves for two (low flow: 1.68 l/min, high flow: 3.44
l/min) different parameter settings: stroke volume (Vstroke), compliance (C), resistance (R)
and, heart rate (BPM).
Both GA and EtO sterilized rubber have very lethal effects within hours. The cells
degenerate and detach from the bottom of the flask, resulting in medium containing
dead cell remnants (figure VI.5-VI.6). In addition, cell counts indicate that the
silicone ventricle is also harmful to cells although not to the same extent as rubber
(figure VI.5). Quantitatively, only the EtO sterilized silicone ventricle results are
very low, but qualitatively the GA sterilized silicone ventricle has low CD 31-score
(table VI.1). The scores of all other materials are analogue to these of the reference
cultures as well for the KI, CD-31 as the Von Willebrand factor staining.
VI.5. Discussion and conclusion
This study resulted in a prototype of a compact, biocompatible pulsatile flow sys-
tem that fits in an incubator. Safe and easy handling of the bioreactor is ensured
by its simple design. Although the ideal hydrodynamic conditions for the in vitro
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(a) Control. (b) Exposure to rubber for 3 days.
Figure VI.6.: (a) healthy reference culture, (b) lethal effect of rubber.
Table VI.1.: Qualitative evaluation with cytochemical dyes: KI 67, CD 31, Von Willebrand
factor for the silicone ventricle and rubber sealing after sterilization with glutaraldehyde (2%)
GA and ethylene oxide (EtO).
Material
Sterilization
Technique
KI 67 CD 31
Von Willebrand
Factor
Day 1 Day 2 Day 1 Day 2 Day 1 Day 2
Reference 2 4 4 3 2 4
Silicone
Ventricle
GA
EtO
3 4 2 1 3 4
0 2 3 4 0 4
Rubber
Sealing
GA
EtO
0 0 0 0 0 0
0 0 0 0 0 0
formation of a haemodynamically and mechanically competent tissue are at yet un-
known,193 recent publications reveal the positive effects of flow and shear stress for
the generation of cardiovascular tissue engineered constructs.95, 97, 110, 190 Thus, the
cultivation of tissue engineered heart valves can potentially be achieved using our
biomimetic flow culture system. The result of the biocompatibility tests showed the
highly cytotoxic effects of the sealing material and to a minor extent the negative
influence of the silicone material used to construct the left ventricle. Data in table
VI.1 show that rubber should be removed from the bioreactor. The KI 67 and Von
Willebrand factor staining results yield a low quality number for the EtO sterilized
silicone ventricle and the CD-31 staining yield a low quality score for the GA ster-
ilized silicone ventricle. Considering both qualitative and quantitative studies, an
analogous but more biocompatible material should be used to construct the flexi-
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ble ventricle. Future research includes the numerical research of the pulsatile flow
conditions, shear stress distribution and pressure distribution in the vicinity of the
aortic valve. Numerical simulation in combination with experimental studies in the
bioreactor will allow to quantify the mechanical load and to study its impact on the
seeded cells.
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Part C.
Computational fluid dynamics
and fluid-structure interaction
of heart valves
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Chapter VII
Stabilization of a fluid-structure
coupling procedure for rigid body
motion
The contents of this chapter is published as proceeding AIAA-2003-3720 and submitted for
publication in the AIAA journal.
Stabilization of a Fluid-Structure Coupling Procedure for Rigid Body Motion
Vierendeels J, Dumont K, Dick E and Verdonck P
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Abstract
Fluid-structure interaction computations in geometries where different chambers are
almost completely separated from each other by a movable rigid body but connected
through very small gaps, can encounter stability problems when a standard explicit
coupling procedure is used for the coupling of the fluid flow and the movement
of the rigid body. An example of such kind of flows is the opening and closing
of valves, when the valve motion is driven by the flow. In this paper, a stability
analysis is performed for the coupling procedure of the movement of a cylinder in a
cylindrical tube, filled with fluid. Between the moving cylinder and the tube a small
gap is present, so that two chambers are formed. It is shown that a standard explicit
coupling procedure or an implicit coupling procedure with explicit coupling in the
subiterations steps can lead to unstable motion depending on the size of the gaps,
the density of the rigid body and the density of the fluid. It is proven that a reduction
of the time step size cannot stabilize the coupling procedure. An implicit coupling
procedure with implicit coupling in the subiterations has to be used. An illustration
is given on how such a coupling procedure can be implemented in a commercial
CFD software package. The CFD package Fluent (Fluent Inc.) is used. As an
application, the opening and the closing of a prosthetic aortic valve is computed.
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Fluid-structure interaction (FSI) problems with moving valves are popular in biomed-
ical applications where the simulation of the flow in the heart during the cardiac
cycle is one of the goals to be achieved. Different coupling methods for this FSI
problem have been used. Both in the immersed boundary method145, 194 and in
the fictitious domain method29, 30, 150 a fixed grid is used for the flow calculation.
The influence of the structure is introduced by momentum sources in the momen-
tum equations of the flow. However, if details of the flow around the valves are
of interest (e.g. shear stresses), it would be more appropriate to use an arbitrary
Lagrangean-Eulerean (ALE) method because the accuracy of the latter method is
better in the vicinity of the moving boundaries for a given mesh density. Makhi-
jani et al. presented a real 3D simulation of a pericardial bioprosthetic aortic valve
during the complete cardiac cycle.166 They used an implicit ’influence coefficient’
technique to couple the flow with the motion of the structure.
In this paper, different coupling procedures for the motion of a rigid body in a
moving fluid are analyzed analytically and numerically. Different time integration
schemes for the motion of the valve are compared. First, a stability analysis is per-
formed for the coupling procedure of the movement of a cylinder in a cylindrical
tube, filled with fluid. Between the moving cylinder and the tube a small gap is
present, so that two chambers are formed. It is shown that the coupling procedure
for this kind of problem is representative for the rigid valve motion during opening
and closing. The valve motion is coupled with the flow motion computed with the
commercial CFD software package Fluent (Fluent Inc.). The dynamic mesh model
of Fluent 6.1 has been used for the ALE computations.
VII.2. Stability analysis for a generic 1D test case
VII.2.1. Definition of the test case
As a generic 1D test case for the kind of FSI problem treated in this paper, a moving
cylinder is considered in a cylindrical tube (figure VII.1). Between the cylinder
and the tube there exists a small gap which connects the fluid in front at the front
and the back of the cylinder. There exists an analogy between the moving valve
problem and the 1D test case because during certain phases of the valve motion also
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a small gap is present that connects the fluid on both sides of the valve. Also, both
problems are described with one degree of freedom. For this generic test case, the
Figure VII.1.: Motion of a rigid body in a tube, generic 1D test case. u(t) is the velocity of the
oncoming fluid, v(t) is the velocity in the gaps, x˙ is the velocity of the rigid body, A and Ab
are the cross sectional area of the tube and the front area of the rigid body respectively, L is
the length of the gap .
conservation of mass is given by:
Au(t) = Abx˙(t) + (A−Ab)v(t) (VII.1)
or
v(t) =
1
a
(u(t)− (1− a)x˙(t)) , (VII.2)
with a = Ag/A, Ag = A−Ab.
The conservation of momentum in the gap is:
∂v
∂t
+
1
ρf
∂p
∂x
= 0 (VII.3)
for inviscid flow. ρf denotes the density of the fluid, p is the pressure. In the analysis
the influence of the viscous terms is neglected. The driving force for the rigid body
motion is given by the pressure difference between the left and right wall of the
cylinder. This pressure difference is:
pl − pr = ∂v
∂t
Lρf , (VII.4)
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with L the length of the gap. The force on the solid body is then given by
F = Ab(pl − pr) = (1− a)A(pl − pr). (VII.5)
The equation of motion for the solid body becomes:
mx¨ = F (VII.6)
or using equation (VII.2),(VII.4),(VII.5) and m = AbLρs
x¨ =
∂u
∂t
ρf
ρs
1
a
− x¨1− a
a
ρf
ρs
, (VII.7)
with ρs the density of the solid.
VII.2.2. Discretization
Since a commercial package is used for the fluid calculation, the interface charac-
teristics of this software have to be taken into account. The fluid solver uses an ALE
algorithm. Thus starting from a known state at time level n, the new position of the
boundary at time level n+1 has to be provided. With the other boundary conditions
given as a function of the time (e.g. at inlet and outlet), the software computes a
new state on timelevel n + 1. The only time discretization scheme that can be se-
lected for the ALE calculations in Fluent is the backward Euler scheme. Therefore
the fluid discretization part of the generic 1D test case problem is also done with
a backward Euler approach. It is important to notice that the only variable that is
passed through the interface between the solid and the fluid problem is the position
x, which is common for both problems. It means that both problems have their
own variables for the other state variables (e.g. velocity). With a backward Euler
discretization, the force Fn+1 is given by
Fn+1/m =
ρf
ρs
vn+1 − vn
∆t
=
ρf
ρs
(
1
a
un+1 − un
∆t
− 1− a
a
x˙n+1NS − x˙nNS
∆t
)
. (VII.8)
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Remark that the velocity used in the Navier-Stokes solver is denoted as x˙NS . This
velocity can be related to the position vector x as
x˙n+1NS =
xn+1 − xn
∆t
, (VII.9)
again using the backward Euler discretization of the Navier-Stokes solver. The force
is then passed to the solid problem and used in the equation of motion:
mx¨n+1 = Fn+1. (VII.10)
Here x¨ denotes the acceleration variable in the solid problem. The equation of
motion can be integrated to obtain the velocity x˙n+1 of the solid problem and the
position xn+1. We consider a class of integration schemes given by
x˙n+1 = x˙n + (1− β) x¨n∆t+ βx¨n+1∆t
xn+1 = xn + x˙n∆t+ γx¨n∆t2 + αx¨n+1∆t2. (VII.11)
For γ=1/2-α this corresponds to the class of Newmark schemes. For γ=0 and α =
β = 1 this corresponds to the backward Euler scheme. Indeed, with the latter
choice, the scheme can be rewritten as
x˙n+1 = x˙n + x¨n+1∆t
xn+1 = xn + x˙n+1∆t. (VII.12)
From eqs. (VII.8), (VII.9), (VII.10) and (VII.11), Fn+1 and the variable xn and
xn+1 can be eliminated easily. The resulting equations can be written in matrix
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form: 
0 1 −α
1 0 −β
0 K 1


x˙∆t
x˙NS∆t
x¨∆t2

n+1
= (VII.13)

1 0 γ
1 0 1− β
0 K 0


x˙∆t
x˙NS∆t
x¨∆t2

n
+

0
0
K
1− a
(
un+1 − un)∆t

where K is given by
K =
ρf
ρs
1− a
a
. (VII.14)
Eq. (VII.13) can be rewritten is condense form as
Aφn+1 = Bφn +D. (VII.15)
VII.2.3. Stability of the time integration scheme
The time integration scheme (VII.15) is stable if the amplitude of all eigenvalues of
the matrix C = A−1B is not larger than one. The characteristic equation for the
eigenvalues λi of C is given by
(λ− 1)
(
λ2 − (α− β − γ)K
1 + αK
λ+
(1− β − γ)K
1 + αK
)
= 0. (VII.16)
The eigenvalues λi are
λ1 = 1, (VII.17)
λ2,3 =
(α− β − γ)K ±√(α+ β + γ)2K2 − 4K(1 + αK − β − γ)
2(1 + αK)
.
The eigenvector corresponding to the eigenvalue 1 is [1 1 0]T . It is seen, if u is
constant in time (D = [0 0 0]T ), that the solution of the generic test case corresponds
with a motion at constant speed. This solution corresponds to the eigenmode with
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eigenvalue 1, i.e. 
x˙
x˙NS
x¨

n+1
=

x˙
x˙NS
x¨

n
(VII.18)
if x˙n = x˙nNS and x¨n = 0. The other modes are spurious and should be damped.
They are formed by a linear combination of e.g. a mode corresponding with a
different speed in the solid and the fluid problem and no acceleration ([1 − 1 0]T )
and a mode with velocity zero and an acceleration different from zero ([0 0 1]T ).
It should be noted that the two latter modes are not neccessarily eigenmodes, but
form a span for these eigenmodes. So, in order to damp the spurious modes, the
amplitude of the eigenvalues λ2 and λ3 must be strictly smaller than one and for
good damping close to zero.
With the transformation
λi =
1 + zi
1− zi , (VII.19)
the inner part of the unit circle in the λ-plane is transformed into the left half plane
of the z-plane. After elimination of the factor (λ − 1) in eq. (VII.16), the transfor-
mation gives
(1 +K(1 + 2α− 2β − 2γ))z2 + 2(1 +K(α+ β + γ − 1))z + 1 +K = 0.
(VII.20)
or
a2z
2 + a1z + a0 = 0 (VII.21)
The conditions for stability are now that <(zi) ≤ 0 (Routh-Hurwitz conditions).
For a quadratic polynomial, these are fulfilled if a0, a1 and a2 have the same sign.
The stability conditions are given by
1 +K(1 + 2α− 2β − 2γ) > 0
1 +K(α+ β + γ − 1) > 0 (VII.22)
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For large, but finite values of K, the conditions are
β + γ ≤ α+ 1/2
α+ β + γ ≥ 1. (VII.23)
Note that solutions can be found only if α ≥ 1/4.
VII.2.4. Choice of the time integration scheme
An explicit scheme for the motion of the solid is obtained for α = β = 0. Con-
ditions for γ can then only be fulfilled if K < 3. This means that for large K an
explicit scheme is unstable and cannot be used.
A Newmark scheme is obtained if γ = 1/2 − α. For large K, the stability condi-
tions are 2α ≥ β ≥ 1/2. A Newmark scheme is second order accurate in time195
if β = 1/2. The product of the eigenvalues λ2 and λ3 are given by the constant in
eq. (VII.16) after elimination of the factor (λ− 1). For the second order Newmark
scheme this constant is equal to αK/(1+αK), which is very close to one for large
values of K. So, the second order Newmark scheme has almost no damping for the
spurious modes arising in the generic test case problem. A typical choice for α for
a second order Newmark scheme is α = 1/4. The eigenvalues are then given by
λ2,3 =
−K ± 2i√K
K + 4
, (VII.24)
which are close to -1 for large K. So, for this choice of parameters (α=1/4, β=1/2,
γ=1/4), the scheme is second order accurate in time, but weakly damped pi-oscillations
of the spurious modes are present.
A typical choice for a first order Newmark method is the scheme with parameters
(α=1/2, β=1, γ=0). This scheme is the fully implicit Newmark scheme. The eigen-
values are then λ2 = 0 and λ3 = −K/(K + 2). Again, one of the spurious modes
has weakly damped pi-oscillations.
Let us consider now the schemes for which β + γ = 1. The eigenvalues for these
schemes are λ2 = 0 and λ3 = (α−1)K/(1+αK) which reduces to λ3 = (α−1)/α
for large values of K. One of the spurious modes is damped immediately. For
α < 1/2 the scheme is unstable. For 1/2 ≤ α < 1, the other spurious mode is
oscillatory damped. For α = 1, all spurious modes are immediately damped. For
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α > 1, the other spurious mode is supercritically damped (without oscillations).
Several schemes are tested out in the results section to show the validity of this
analysis. The scheme with α = β = 1 and γ = 0 will finally be used for the
computations. This scheme corresponds to the first order backward Euler scheme
and corresponds to the time integration scheme for the fluid problem. It should
be pointed out that for another choice of the time integration scheme for the fluid
problem, the analysis should be repeated and will have an impact on the choice of
the integration scheme for the solid problem. A second remark is that for small K,
close to zero, the spurious modes are damped very well, independent of the choice
of α, β and γ. So, if only a weak coupling exists between the fluid and the solid
problems, the matching of the time integration scheme for both problems is of less
importance.
VII.2.5. Stability of the subiteration process
In more general applications, the system given by eq. (VII.13) is solved in an itera-
tive way because no closed expression for the force in function of the solid variables
is available. The force is obtained from a CFD computation, as is done for the valve
motion, shown later in this paper. A subiteration process can be set up as follows.
Starting from an approximation for the new acceleration x¨n+1,k a new value for
the velocity x˙n+1,k and the position xn+1,k are computed with the time integration
scheme for the solid. Here k denotes the subiteration index, starting at 0. The new
position is then passed to the fluid problem, where the force Fn+1,k is computed.
From the equation of motion (VII.6) a newer value for the acceleration x¨n+1,k+1 is
then computed and the cycle is repeated until convergence is achieved.
Let us first consider only schemes for which, when entering the fluid problem, the
velocity computed in the fluid problem x˙NS is equal to the velocity in the solid
problem x˙. From eqs. (VII.11) and (VII.9) can be deduced that the conditions for
the parameters are β + γ = 1 and α = β. The backward Euler scheme belongs to
this family of schemes, but none of the schemes of the Newmark family does. For
these particular schemes we can write the equation of motion for the generic test
case (VII.10) as
x¨n+1 = K
(
1
1− a
un+1 − un
∆t
− (αx¨n+1 + γx¨n)
)
, (VII.25)
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so that the discrete solution of the acceleration on the new time level is given by
x¨n+1 =
K
1 + αK
1
1− a
un+1 − un
∆t
− γK
1 + αK
x¨n. (VII.26)
However, eq. (VII.25) can not be solved directly for x¨n+1 in a more general appli-
cation as explained above, but has to be solved iteratively.
VII.2.5.1. Explicit coupling in the subiterations
If explicit coupling in the subiteration process is used, x¨n+1,k+1 is computed as
x¨n+1,k+1 = (1− ω)x¨n+1,k + ωK
(
1
1− a
un+1 − un
∆t
− (αx¨n+1,k + γx¨n)
)
.
(VII.27)
with ω the underrelaxation factor. With x¨n+1,k = x¨n+1 + ε¨n+1,k, where εn+1,k
represents the error in the subiteration process with respect to the discrete solution
x¨n+1, eq. (VII.27) can be written as
ε¨n+1,k+1 = −(1− ω − ωαK)ε¨n+1,k. (VII.28)
The amplification of the error is determined by∣∣∣∣εn+1,k+1εn+1,k
∣∣∣∣ = |1− ω − ωαK| . (VII.29)
The amplification factor is less than one if
ω <
2
1 + αK
. (VII.30)
For small gaps, an unusual small ω is required, close to zero. The amplification
factor is zero for ω given by
ω =
1
1 + αK
. (VII.31)
The error is then equal to zero after one subiteration. However, this approach is not
suitable for flows where the dimension of the gap changes with time as for opening
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and closing valves. Then it would be more appropriate to use an implicit coupling
method in the subiterations.
VII.2.5.2. Implicit coupling in the subiterations
A way to have implicit coupling in the subiterations, is to compute x¨n+1,k+1 from
mx¨n+1,k+1 = Fn+1,k+1 (VII.32)
≈ Fn+1,k + ∂F
∂x¨
(
x¨n+1,k+1 − x¨n+1,k
)
.
For the generic test case, the derivative ∂F
∂x¨
is given by ∂F
∂x¨
= −mK. The error
ε¨n+1,k+1 is defined by
ε¨n+1,k+1 = −Kε¨n+1,k −K
(
ε¨n+1,k+1 − ε¨n+1,k
)
(VII.33)
which result in ε¨n+1,k+1 = 0. So, the amplification factor is equal to zero, indepen-
dent of the gap size and the fluid and solid densities.
The derivative has to be evaluated numerically in more general applications. This
can be done as follows:
∂F
∂x¨
=
FNS(x¨n+1,0 +∆x¨)− FNS(x¨n+1,0)
∆x¨
. (VII.34)
Two extra Navier-Stokes (NS) evaluations per time step are needed with this ap-
proach to evaluate the derivative. It should be noted that the acceleration variables
in this equation are those of the solid problem, because the acceleration variables
are first used to compute new positions x with the time integration scheme and the
forces FNS are evaluated with these positions. So, the latter approach can be used to
converge the subiterations for any value of the parameters α, β and γ. This approach
is used with success for the moving valve problem, as is shown later.
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VII.3. FSI of an aortic valve
VII.3.1. Problem definition
In order to verify the numerical behavior of the coupling procedure a two-dimensional
representation of the aortic valve configuration is considered (figure VII.2). The
model contains an inflow tract (inlet = left ventricle), a sinus of Valsalva (aortic
valve), an outflow tract (outlet = aorta) and a rigid leaflet. The dimensions of the
model are l1 = 4 cm, l2 = 4 cm, r1 = 2 cm, r2 = 0.7 cm, h = 2 cm, θinitial = 0.384 rad =
22 degrees. The flow during the ejection phase (systole) is computed. As boundary
conditions (figure VII.3) a pulsatile aortic flow in x-direction is given as a function
of time at the inlet:
uinlet = umean + 0.5uampsin
(
2pi ((t− to)/Tp + 0.26)
1.26
)
for (VII.35)
0 < t < to and to + 0.37 Tp < t < Tp,
uinlet = umean + uampsin
(
2pi(t− to)/Tp
0.74
)
for (VII.36)
to < t < to + 0.37 Tp.
The parameters in this formula are Tp = 2.45 s, to = 0.4 s, umean = 0.04 m/s, uamp
= 0.11 m/s. The tangential velocity at the inlet is set equal to 0 m/s. At the outlet a
constant gauge pressure of 0 Pa is assumed. On all the other walls no slip conditions
are defined. The unknown variables of the problem are the velocity components
x
y
inlet outlet
aortic sinus
fluid domain valve leaflet
θ
l1 l2r1
r2
h
Figure VII.2.: Geometry of 2D aortic valve model.
in x- and y-direction and the pressure p, together with the coordinates (x, y) of the
valve nodes determined by the angle θ.
The 2D Navier-Stokes equations for unsteady flow written in a conservative ALE
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Figure VII.3.: Velocity boundary condition at the inlet as a function of time t.
formulation for incompressible laminar fluid flow are solved together with the con-
tinuity equation for each moving grid cell in the flow domain. Water (ρf=1000
kg/m3, dynamic viscosity µ=1 mPa s) and blood (ρf=1000 kg/m3, dynamic vis-
cosity µ=4 mPa s) are used in the calculations. Both are treated as a Newtonian
fluid. The computation is performed with the dynamic mesh model in the CFD
software package Fluent (Fluent Inc.). As input the new position of the boundary
nodes of the moving valve have to be prescribed at the beginning of a time step.
The dynamic mesh model assumes that grid nodes are connected with springs and
an equilibrium equation for the spring forces determines the position of the nodes at
the new time level. Between time steps a local remeshing technique is used in order
to keep a sufficient grid density during the movement of the valve. The positions
of the boundary nodes at the new time level are prescribed through a user defined
function (UDF) that can be coupled with the code. Since these positions depend on
the FSI solution, a straightforward calculation is not possible. Therefore a journal
file with commands to be executed, is used to drive the computation.
It is necessary to include read and write commands for the geometry and data files
in this journal file, since it should be possible to start over each time step several
times during the coupling procedure.
The equation of motion for the stiff valve leaflet is written as
M = Iθ¨ (VII.37)
with M the moment resulting from the forces acting on the surface of the leaflet,
I the moment of inertia and θ the angle that determines the position of the leaflet
as indicated in figure VII.2. For the valve leaflet, the moment of inertia I with the
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rotational axis at the end of the leaflet is given by:
I = (1/3)ml2 (VII.38)
with m = ρlt the mass of the leaflet per unit length, ρ the density of the leaflet
(1100 kg/m3), t the thickness of the leaflet (1 mm and 0.5 mm) and l the length
of the leaflet (22 mm). A reference length of 1 m is used in the third dimension,
corresponding to the reference length used in the CFD package to calculate the
moments. Both values for the moment of inertia I = 3.909 kg mm2 and I = 1.9545
kg mm2 are used.
VII.3.2. Implementation of the FSI
Figure VIII.3 presents a flow diagram of the coupling of the flow computations
and the movement of the leaflet. The flow diagram corresponds to the method with
implicit coupling in the subiterations. In the following paragraphs the different steps
of the implementation are explained. First all UDF variables t, ∆t, n, k, I , θ, θ˙, θ¨
are initialized. The subsequent position of the valve leaflet on the new time level is
calculated by coupling the time integration scheme for the solid with the CFD code.
The time integration scheme for the solid is given by
θ˙n+1 = θ˙n + (1− β)∆tθ¨n + β∆tθ¨n+1,
θn+1 = θn +∆tθ˙n + γ∆t2θ¨n + α∆t2θ¨n+1. (VII.39)
The indices n+ 1 and n correspond with time levels t+∆t and t respectively.
In order to obtain the position θn+1 at t+∆t an iterative approach is used. For each
timestep there are k subiterations performed in order to reach sufficient convergence
of eq. (VIII.6).
At the beginning of each time step, the derivative dM/dθ¨ has to be estimated. A
first estimation (k = 0) of the new position θn+1,k=0 is computed with the old value
of the angular acceleration θ¨n. This value of the acceleration is used to calculate the
position using the equation eq. (VII.39). With this initial guess of the new position
at t + ∆t, Fluent is called to adapt the mesh with the dynamic mesh model and to
solve the Navier-Stokes equations. After convergence of the Navier-Stokes equa-
tions, Mn+1,k=0 is calculated. A second estimation (k = 1) of the new position
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Begin
Initialize variables at t = 0s
n = 0, k = 0, θn = θ0, θ˙n = 0, θ¨n = 0
t = (n + 1) ·∆t and θ¨n+1,k = θ¨n Step 1
k = k + 1 calculate θn+1,k n = n+ 1, k = 0
read CAS and DAT file of timestep n
θ¨n+1,k+1 = θ¨n+1,k + δ DYNAMIC MESH
calculate θ¨n+1,k+1 Navier-Stokes Equations θ¨n+1 = θ¨n+1,k
calculate Mn+1,k in FLUENT
k = 0?
calculate
dM
dθ¨
k = 1?
Step 2 Mn+1,k ≈ I · θ¨n+1,k?
write CAS and DAT file of timestep n+ 1 t = Tp?
End
No
No
Yes
Yes
No
No
Yes
Yes
n = time step, k = iteration step for ∆θ, δ = 0.1
FLUENT Inc. software executed using generated journal file
UDF’s executed using generated journal file
Figure VII.4.: Flow diagram of the coupling of fluid and structure in FLUENT.
θn+1,k=1 is computed with the old value of the angular acceleration increased with
a constant δ=0.1 rad/s2. This value is about 1/100 of the maximum angular acceler-
ation, which can be estimated from the inlet profile. It is shown that the choice of
this value is not very sensitive. After convergence of the fluid problem, Mn+1,k=1
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and the derivative dM/dθ¨ is calculated as follows:
θ¨n+1,k=0 = θ¨n
θ¨n+1,k=1 = θ¨n + δ (VII.40)
dM
dθ¨
=
Mn+1,k=1 −Mn+1,k=0
θ¨n+1,k=1 − θ¨n+1,k=0 =
Mn+1,k=1 −Mn+1,k=0
δ
.
The derivative dM/dθ¨ can now be used to calculate a better approximation of the
position of the valve leaflet:
Mn+1,k+1 = Iθ¨n+1,k+1
⇓
Mn+1,k +
dM
dθ¨
(
θ¨n+1,k+1 − θ¨n+1,k
)
= Iθ¨n+1,k+1 (VII.41)
⇓
θ¨n+1,k+1 =
(
Mn+1,k − dM
dθ¨
θ¨n+1,k
)
(
I − dM
dθ¨
)
With this better approximation of the angular acceleration the new position is cal-
culated, the mesh is adapted and the Navier-Stokes equations are solved. After
convergence of the Navier-Stokes equations, Mn+1,k is calculated and convergence
of the inner loop is checked:
Mn+1,k ≈ Iθ¨n+1,k
The inner loop is repeated until convergence is achieved. A convergence criterium
of a residual drop of 3 orders of magnitude is used. Then the next time step is
computed. If only one cycle is computed, the simulation ends at t=Tp.
VII.4. Results and discussion
VII.4.1. Solution of the problem
Figure VII.5 shows the meshed geometry. It is shown in this figure that the ALE
remeshing requires at least one cell in the gap between the valve leaflet and the
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wall. Thus, the valve will never close completely. However, the gap can be made
as small as required by local refinement of the mesh. The backward Euler time
integration scheme for the solid has been used, unless stated otherwise. First a grid
Figure VII.5.: ALE grid of the 2D aortic valve model.
convergence study is performed. This study is done with water as fluid, with a
time step of 1 ms and with a moment of inertia I=3.909 kg mm2. Three grids are
considered. The angle of the valve is plotted as a function of time for the first cycle
in figure VII.6. The finest grid is further used for all computations. The influence
of the magnitude of the time step is shown in figure VII.7. Both computations are
done for blood as fluid and for a moment of inertia I = 1.9545 kg mm2. A time
step equal to 1/1000 of the interval of the cycle (∆t = 2.45 ms) is compared with
a time step of 1 ms for the coarse mesh. Both computations give the same result
for the movement of the valve. A time step of ∆t = 2.45 ms is further used for
all computations, unless specified otherwise. A convergence study for the cycle
is shown in figure VII.8. The positions of the valve at the beginning and the end
of the third cycle correspond to each other, and the positions of the valve during
the second half of the second cycle correspond with those of the third cycle. The
pressure differences between inlet and outlet are also shown as a function of time in
this figure. No differences can be seen between the different cycles. This pressure
difference is however less sensitive, because it is mainly determined by the velocity
profile applied at the inlet and this is the same for all cycles. The pressure difference
plot shows two discontinuities at t = to and at t = to + 0.37Tp. This is due to the
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Figure VII.6.: Comparison of the evolution of the angle of the valve for different grids densi-
ties. The fluid is water, the moment of inertia of the valve I=3.909 kg mm2 and the time step
is 1 ms.
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Figure VII.7.: Comparison of the evolution of the angle of the valve for two different time
steps. The fluid is blood, the moment of inertia of the valve I=1.9545 kg mm2.
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fact that the inlet velocity has also this discontinuity in its derivative (figure VII.3).
We conclude that from the third cycle on, the differences between the cycles can
be assumed to be negligible. This discontinuity wouldn’t have been present for a
smoother inlet profile. However, if a strong acceleration would be present in the
inlet profile during a short time interval and if a time step is used that does not
resolve this time interval the same problem would arise. At this point spurious
modes can enter the solution. These should be damped immediately. The inlet
profile that is used introduces a spurious mode independent of the size of the time
step. So, with this inlet profile the damping behavior for spurious modes of the
different numerical schemes can be tested. Figure VII.9 demonstrates the velocity
vectors at five different moments in time during the flow cycle. The arrows show
how the vortices are changing during the cardiac cycle. These figures show that the
opening and closing of the valve can be computed with the presented method. It is
clear that the backflow plays an important role in the closing of the aortic valve: in
the converged cycle the valve reaches the closed state because of the presence of a
period during which backflow is present at the inlet boundary. We will further focus
on the numerical behavior of the FSI problem, the application itself is not further
discussed.
VII.4.2. Stability of the time integration scheme
The conclusions of the stability analysis on the generic 1D test case are numerically
verified with the moving valve problem. The analogy between the two problems is
already mentioned. The main difference of the 1D test case and this 2D problem is
the difference in the length of the gap. In the 1D test case is assumed that only the
acceleration of the fluid in the gap is responsible for the pressure difference across
the solid. The influence of the 2D effects at both ends of the gap is neglected. In the
2D problem of the valve, the length of the gap is negligible. The pressure difference
between both sides of the valve is now not only due to the acceleration of a small
amount of fluid in the gap, but also the acceleration of fluid in front of and behind
the gap, must be taken into account. This influence can not be quantified easily, but
it is not necessary. It is clear that the mass of the fluid that must be accelerated is
much more than only the mass of the fluid in the gap. This means that the factor
K is not equal anymore to the expression given in eq. (VII.14), but much larger.
It must also be remarked that when the valve reaches the open state, a gap exists
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Figure VII.8.: Evolution of the angle of the valve and the pressure difference between the
inlet and outlet for the first three cycles. The fluid is blood, the moment of inertia of the valve
I=1.9545 kg mm2.
between the main flow and the fluid in the sinus of Valsalva. Therefore, the 1D test
case problem is representative for most of the cycle during opening and closing of
the valve, and especially in the completely closed and open positions.
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Figure VII.9.: Velocity vectors for t = 0.00s, t = 0.37s, t = 0.88s, t = 1.32s, t = 2.11s.
Tables VII.1 and VII.2 show the evolution of the angle, the angular velocity and the
angular acceleration during the first four time steps of the first cycle for an explicit
time integration scheme (α = β = γ = 0) for the motion of the solid. Two time
136
VII.4. Results and discussion
steps are compared: ∆t=1 ms and ∆t=0.01 ms. Blood is used as fluid and the
moment of inertia I=3.909 kg mm2.
Time θ [rad] θ˙ [rad/s] θ¨ [rad/s2]
0.000 0.3840 0.00 0.00
0.001 0.3840 0.00 284.91
0.002 0.3841 0.28 -4971.54
0.003 0.3819 -4.69 96525.94
0.004 0.4255 91.84 -5054412.89
Table VII.1.: Explicit stepping α = β = γ = 0, ∆t = 0.001 s.
Time θ [rad] θ˙ [rad/s] θ¨ [rad/s2]
0.00000 0.383972000 0.000000 0.00
0.00001 0.383972000 0.000000 269.71
0.00002 0.383972013 0.002697 -4319.77
0.00003 0.383971824 -0.040501 71972.37
0.00004 0.383975018 0.679223 -1193827.07
Table VII.2.: Explicit stepping α = β = γ = 0, ∆t = 0.00001 s.
The explicit scheme is unstable. The spurious modes are more or less amplified in
the same way in both calculations independent of the time step. This behavior is
predicted by the stability analysis.
For the calculations in the rest of this paragraph, blood is used as fluid, a time step
∆t=2.45 ms and a moment of inertia I=1.9545 kg mm2 are used.
In table VII.3, some Newmark schemes, the backward Euler scheme and some of
the other (β=1, γ=0) schemes are tried out. The angular acceleration of the first
three time steps of the first cycle are given. The backward Euler scheme gives a
critically damped behavior and can be treated as a reference for the other schemes.
In figures VII.10-VII.12, the angle, the angular velocity and the angular acceleration
computed with the backward Euler scheme, the second order Newmark scheme
(α = 1/4, β = 1/2), the fully implicit Newmark scheme (α = 1/2, β = 1) and a
damping Newmark scheme (α = 0.4, β = 0.6) are shown as a function of time for
137
VII. Stabilization of a FSI coupling procedure
the complete first cycle. With this table and these figures, part of the conclusions
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Figure VII.10.: Comparison of the evolution of the angle of the valve for the first cycle com-
puted with the backward Euler scheme, the second order Newmark scheme, the fully implicit
Newmark scheme and a damping Newmark scheme (α = 0.4, β = 0.6). The fluid is blood,
the time step ∆t is 2.45 ms and the moment of inertia of the valve I=1.9545 kg mm2.
Class Scheme θ¨ [rad/s2] θ¨ [rad/s2] θ¨ [rad/s2]
t=0.00245 s t=0.00490 s t=0.00735 s
Newmark α=1/4, β=1/2 29.201 -26.191 51.106
γ = 1/2− α α=1/2, β=1 14.963 0.413 14.577
α=0.4, β=0.6 18.604 5.101 1.415
α=0.4 18.604 -8.418 30.842
α=0.5 14.963 0.413 14.577
β=1, γ = 0 α=0.6 12.533 4.354 9.706
α=0.8 9.449 7.121 7.709
Backward Euler 7.576 7.587 7.592
α=1
α=1.5 5.077 6.751 7.312
Table VII.3.: Damping of the spurious modes for different schemes. θ¨ is converged in the
subiterations.
of the stability analysis for the generic 1D test case is verified. The second order
Newmark and the fully implicit Newmark scheme show almost no damping. The
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Figure VII.11.: Comparison of the evolution of angular velocity of the valve for the first cycle
computed with the backward Euler scheme, the second order Newmark scheme, the fully
implicit Newmark scheme and a damping Newmark scheme (α = 0.4, β = 0.6). The fluid is
blood, the time step ∆t is 2.45 ms and the moment of inertia of the valve I=1.9545 kg mm2.
damping of the (β=1, γ=0) schemes behaves also as was predicted. For α=0.4 the
scheme is unstable, for α=1/2, the scheme is weakly damped, for α=0.6 and α=0.8
the scheme gives subcritical damping for the spurious modes with an oscillatory
behavior. For α=1, the backward Euler scheme, is obtained which gives critical
damping for the spurious modes. They are damped immediately. For α=1.5, a
supercritical damping behavior is seen. Agreement with the stability analysis is
obtained for all these tests.
In table VII.4 the convergence of the subiteration process is analyzed for one time
step of the backward Euler scheme. The analysis is done at time level t = 2.695
s. This time level is chosen because at this point the convergence behavior of the
subiteration process is the worst compared with the rest of the cycle. At this time
level the angle of the valve is 0.6612 rad or 37.89 degrees. The difference be-
tween the moment computed with the CFD software and Iθ¨ is given for the first 4
subiterations. When the implicit approach is used in the subiterations, the first two
subiterations are used to calculate the derivative.
With explicit coupling in the subiterations, no convergence could be obtained.
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Figure VII.12.: Comparison of the evolution of the angular acceleration of the valve for the
first cycle computed with the backward Euler scheme, the second order Newmark scheme,
the fully implicit Newmark scheme and a damping Newmark scheme (α = 0.4, β = 0.6). The
fluid is blood, the time step ∆t is 2.45 ms and the moment of inertia of the valve I=1.9545
kg mm2.
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MCFD − Iq¨ MCFD − Iq¨ MCFD − Iq¨ MCFD − Iq¨
Method [Nm] [Nm] [Nm] [Nm] Remark
Subiter 1 subiter 2 subiter 3 subiter 4
Explicit 4.918E-04 1.177E-02 3.378E-01 Crash Diverging
ω = 0.05 1.119E-05 1.583E-05 2.313E-05 3.360E-05 Diverging
ω = 0.025 1.121E-05 2.431E-06 5.2670E-07 1.148E-07
ω = 0.005 1.123E-05 8.493E-06 6.428E-06 4.865E-06 Very slow
δ = 10−7 rad/s2 Calculation of ∂F/∂θ¨ 1.2944E-05 6.2502E-04 Diverging
δ = 0.001 rad/s2 Calculation of ∂F/∂θ¨ 1.3294E-05 3.0894E-08
δ = 0.1 rad/s2 Calculation of ∂F/∂θ¨ 1.122E-05 3.740E-07
δ = 1 rad/s2 Calculation of ∂F/∂θ¨ 1.122E-05 7.142E-07
δ = 100 rad/s2 Calculation of ∂F/∂θ¨ 1.3294E-05 3.0894E-08
δ = 100000 rad/s2 Calculation of ∂F/∂θ¨ crashes Crash
Table VII.4.: Behavior of the error of the subiterations for the backward Euler scheme (α =
β = 1, γ = 0) at time level t=2.695 s. Different subiteration strategies are compared.
For an underrelaxation factor ω=0.025, a good damping is obtained, a value ω=0.05
leads to divergence and for a value ω=0.005 almost no damping of the subiteration
process is obtained. This shows the sensitivity to the underrelaxation factor. As the
factor K changes during the opening and the closing process, a good value for the
whole cycle could not be obtained.
The implicit method uses the derivative of the force with respect to the angular
acceleration and shows good damping for a broad range of values of δ, defined in
eq. VIII.9. This value determines the displacement of the valve in the second step
of the subiteration cycle. This displacement should be less than the size of the grid
cells in the vicinity of the valve. We used a value of δ=0.1 rad/ss, because it is
almost 1/100 of the maximum acceleration present in the problem. This maximum
acceleration can be estimated from the inlet boundary condition in our application.
Another way to choose δ is to use a fraction of the current angular acceleration.
The value must then be prohibited to become too small if the angular acceleration
becomes close to zero. For too small values of δ, the difference between the two
moments from which the derivative is computed becomes too small and is of the
same size or even smaller than the error on the computed moments. The magnitude
of this error depends on the accuracy of the solution of the Navier-Stokes problem.
We used a residual drop of three orders of magnitude as a convergence criterium for
the fluid solver. In the table it is shown that a too small value of δ leads to a crash of
the calculation, because of this reason. If δ is taken too large, the displacement that
141
VII. Stabilization of a FSI coupling procedure
corresponds with it is also too large and the moving mesh solver diverges, which
explains the crash in this situation. The choice of δ is application dependent but not
very sensitive, which makes the method robust.
The behavior of the subiteration process also matches the behavior predicted in the
generic 1D test problem.
VII.5. Conclusions
This study shows a stability analysis for FSI problems where different fluid zones
are almost separated by a moving rigid body, but connected through gaps in the
vicinity of the moving rigid body. A FSI calculation procedure is constructed that
couples the movement of a rigid body with the flow calculations performed in a
commercial CFD package. The procedure is succesfully applied to the opening and
closing of a two dimensional model for the aortic valve.
From the stability analysis and the numerical experiments, it can be concluded that
the matching of the time integration scheme for the fluid and the solid problem is
very important for these kind of FSI problems. It has been shown that for a back-
ward Euler scheme used in the fluid problem, a backward Euler scheme for the solid
problem damps all the spurious modes of the coupling procedure immediately. The
second order Newmark scheme and the fully implicit Newmark scheme show a
weakly damped behavior. Other schemes with good damping behavior can be con-
structed. The stability analysis showed also that for loosely coupled FSI problems,
the matching of the numerical scheme for the fluid and the solid problem is much
less important to damp the spurious modes.
A second conclusion is that also the convergence of the subiteration process de-
serves a lot of attention for these kind of FSI problems. A standard underrelaxation
technique does not work well because the choice of the underrelaxation factor is
very sensitive to the amount of stiffness of the coupling. Since this stiffness is not
necessarily constant during a calculation, such a method is not robust. The use of
an implicit coupling procedure in the subiterations, with the use of a numerically
computed derivative, which acts as a sensitivity parameter, leads to a robust method
to tackle these stiff FSI problems.
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Chapter VIII
Validation of a fluid-structure
interaction model of a heart valve
using the dynamic mesh method in
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Validation of a fluid-structure interaction model of a heart valve using the dynamic mesh
method in Fluent
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VIII. Validation of the FSI model for heart valve modeling
Abstract
Simulations of coupled problems such as fluid-structure interaction (FSI) are be-
coming more and more important for engineering purposes. This is particularly
true when modeling the aortic valve, where the fluid-structure interaction between
the blood and the valve determines the valve movement and the valvular haemody-
namics. Nevertheless only a few studies are focusing on the opening and closing
behavior during the ejection phase (systole). In this paper we present the validation
of a FSI model using the dynamic mesh method of Fluent for the two-dimensional
(2D) simulation of mechanical heart valves during the ejection phase of the cardiac
cycle. The FSI model is successfully validated by comparing simulation results to
experimental data obtained from in vitro studies using a CCD camera.
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VIII.1. Introduction
The interaction between blood and structure plays an important role in many biofluid
dynamic flow problems such as blood flow in the heart, vessels, heart valves, car-
diac assist devices and in artificial organ design.134, 156 The opening and closing of
a heart valve during systole involves a strong interaction between blood and the sur-
rounding tissue. Only a few numerical models29, 30, 81, 141, 159, 166, 196, 197 have been
made to analyze the valve kinematics during systole using numerical fluid-structure
interaction models.
Different numerical techniques have been used to tackle this fluid-structure inter-
action (FSI) problem. Immersed boundary techniques were already used from the
late seventies by Peskin and McQueen145 and Yellin et al.198 Widespread is the Ar-
bitrary Lagrangian-Eulerian ALE method,199 commonly used for modeling blood
flow in arteries.200 The ALE method requires continuously updating the fluid mesh
to accommodate for the motion of the structural domain. In contrast, the fictitious
domain formulation150 circumvents the fluid mesh updating: the fluid is described
using a fixed mesh in an Eulerian setting, the coupling of fluid and structure is taken
care of by so called Lagrange multipliers.
These numerical techniques can be used to calculate details or features of the flow
field that are important to know, but impossible to measure. One such feature is
wall shear stress. Shear stress is an important biomechanical modulator of endothe-
lial function and vascular tissue remodeling,201 and thus a critical parameter that
requires precise control in various tissue engineering applications, among which the
cultivation of (aortic) valve prosthesis in bioreactor systems.
Recently, Fluent Inc. (New Hampshire, US) released the dynamic mesh model for
the simulation of flows where the shape of the domain is changing with time due to
the motion of the domain boundaries. The dynamic mesh model makes use of an
ALE and local remeshing approach to adapt the mesh in FSI problems. The motion
of a boundary is then described using user-defined functions (UDFs).
In this work, we describe a numerical model to simulate aortic valve haemodynam-
ics making use of Fluent software, but implementing a user-defined iterative proce-
dure to simulate valve motion. For the validation of our code, we run simulations
using the 2D geometry and boundary conditions as used in in vitro experiments by
the group of F.N. van de Vosse of the Eindhoven University of Technology.196, 197
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As such, we can directly compare the FSI model to experimental data obtained via
a CCD Camera in a pulse duplicator.
VIII.2. Methods
VIII.2.1. Experimental method
In order to validate the results obtained by the computational model, experiments
were performed in an in vitro setup. The experimental setup, shown in figure
VIII.1(a), is a two-dimensional representation of a cross section of the aortic valve.
The valve section of the setup (figure VIII.1(b)) consists of a plexiglass channel,
(a) Schematic drawing of the pulse duplicator setup. (p) piston, (d) dif-
fuser, (vs) the valve section, (r) reservoir, (sp) stationary pump and
(fm) flow meter.
(b) Schematic representation of the valve compartiment of the
experimental setup.
Figure VIII.1.: Experimental setup of TUEindhoven.
with a heigth of 20 mm and length of 120 mm. In order to obtain a two-dimensional
flow field in the center of the channel, the width of the channel is taken 120 mm.
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Located in the middle of the length of the channel, is a cilindrical cavity with a ra-
dius of 20 mm, representing the aortic sinus. At the downstream side of the cavity,
the transition of the cavity to the outflow channel is rounded, with a radius of 7.5
mm. At the upstream transition of the channel to the cavity a stiff strip of lexane,
representing the leaflet, is attached to the top of the channel using three strips of
water resistant adhesive tape, one in the center of the cavity and two near the side
walls. In order to keep the bending stiffness of the tape low, the width of the strips
of adhesive tape was 5 mm. The valve section was mounted in a pulse duplicator
setup, as shown in figure VIII.1(a). The pulse duplicator setup consists of a steady
pump (sp), a computer controlled piston (p), a diffusor (d), the valve section (vs)
and reservoir (r). The flow downstream the piston was measured using an elec-
tromagnetic flow meter (fm). In order to obtain physiologically relevant fluid flow
parameters, the fluid used was a mixture of 36% by volume of glycerol in water,
having a dynamic viscosity µ of 4 mPa · s.
The generated flow pulse resembles the aortic flow in the sense that there is a large
flow peak lasting approximately 37 % of the cardiac cycle which is due to the blood
being ejected from the heart, while during the rest of the cardiac cycle the flow
rate is low. The flow pulse was obtained by a stationary flow rate, delivered by the
stationary pump, to which a pulsating flow is added by the computer controlled mo-
tion of the piston. With an average peak inflow velocity (V ) of 0.15 m/s, a density
(ρ) of 1090 kg/m3, a channel heigth (h) of 20 mm, a viscosity (µ) of 4 mPa·s =
4·10-3kg/(m · s) and a period time Tp of 2.45 s, the flow pulse is characterized by the
Reynolds number of 750 and the Strouhal number of 0.055, where Reynolds and
Strouhal are defined as:
Re =
ρ V h
µ
Sr =
h
TpV
(VIII.1)
The position of the valve leaflet was recorded by a CCD camera (Kodak ES-1.0) at
50 instants in the flow cycle. The opening angle of the valve is derived from the
position of the valve in the camera images.
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VIII.2.2. Geometry and mesh of the numerical aortic valve
model
The two-dimensional geometry (figure VIII.2) consists of an inflow tract (inlet =
left ventricle), a sinus of Valsalve (aortic valve) and an outflow tract (outlet = aorta).
The dimensions of the geometry are l1 = 4 cm, l2 = 4 cm, r1 = 2 cm, r2 = 0.75 cm,
h = 2 cm, θinitial = 0.384 rad = 22 degrees.
An example of the computational mesh is shown in figure VIII.2(b). First a grid
convergence study is performed. Three different grid densities, e.g. ±1000, ±3000
and ±5000 nodes, were studied. The finest mesh showed to give grid independent
results. Because of the limitations in the dynamic mesh model, there is at least one
cell required to cover the gap between the valve leaflet and the wall. This one cell
needs to ensure that the fluid domain is preserved as one entity. Furthermore, to in-
crease the accuracy of the flow calculations, the mesh at the gap is made even more
dense, as can be seen in figure VIII.2(b). As such, it is not possible to simulate
perfectly closing devices using the remeshing technique, which could be seen as a
limitation of the technique. As we are interested in studying aortic valve hydrody-
namics during systole (ejection phase), we assume that this does not influence our
study. Furthermore the diastolic phase is not taken into account.
VIII.2.3. Governing equations of the numerical model
The unknown variables are the velocity component u in x-direction, the velocity
component v in y-direction, the pressure p and the coordinates (x, y) of the valve
nodes determined by the angle θ.
The continuity equation in integral form Eq(VIII.2) is given by
∂
∂t
∫
V
ρdV +
∫
S
ρ( v−→− vb−→) · n−→dS = 0 (VIII.2)
where
∫
V ...dV is the integral over a control “volume”,
∫
S ...dS is the integral over a
control “surface”, n−→ is the outwardly directed vector normal to dS, ρ is the density
of the fluid, v−→ = (u,v) is the velocity vector of the fluid, vb−→ = (ub,vb) is the velocity
vector of the moving boundary. For each face j of the control volume vb,j−→· n−→dSj is
computed from δVj∆t where δVj is the volume swept out by the control volume face
j over the time step ∆t. With this definition of vb,j−→ the so called space conservation
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(a) Geometry of 2D aortic valve model.
(b) ALE Grid of the 2D aortic valve model.
Figure VIII.2.: Geometry and mesh of the 2D valve model.
law Eq(VIII.3) is fulfilled for each control volume.
∂
∂t
∫
V
dV =
∫
S
vb
−→ · n−→dS (VIII.3)
The momentum equation in integral form is given by Eq(VIII.4)
∂
∂t
∫
V
ρ v−→dV +
∫
S
ρ v−→( v−→− vb−→) · n−→dS = −
∫
S
pn−→dS +
∫
S
τ · n−→dS (VIII.4)
where τ is the stress tensor. Body forces were neglected. The density of the rigid
leaflet (1100 kg/m3) is almost equal to the fluid density (1090 kg/m3), therefore the
buoyancy force can be neglected. The stress tensor τ is given by Eq(VIII.5)
τ = 2µγ = 2µ

∂u
∂x
1
2
(
∂u
∂y
+
∂v
∂x
)
1
2
(
∂u
∂y
+
∂v
∂x
)
∂v
∂y
 (VIII.5)
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where γ is the strain rate tensor. Flow is assumed laminar and a constant dy-
namic viscosity µ of 4 mPa·s for the fluid is used. Finally, the equation of motion
Eq(VIII.6) for the leaflet can be written as
M = I · θ¨ (VIII.6)
with M the torque per unit length on a stiff valve leaflet, I the moment of inertia
per unit length and θ the opening angle of the leaflet as indicated in figure VIII.2(a).
For the valve leaflet the moment of inertia I with the rotational axis along the edge
of the leaflet can be calculated as Eq(VIII.7):
I = (1/3) ·m · l2 (VIII.7)
with m = ρleaflet · l · t the mass of the leaflet per unit length, ρleaflet the density of
the leaflet (1100 kg/m3), t the thickness of the leaflet (1 mm) and l the length of the
leaflet (22 mm). This results in I = 3.9·10−6 kg·m2/m.
The continuity Eq(VIII.2), space conservation Eq(VIII.3) and momentum Eq(VIII.4)
equations for incompressible laminar flow are solved for each moving grid cell in
the fluid domain. The CFD software package Fluent (Fluent Inc.) is used to solve
the governing equations. Fluent is based on the finite volume method, where the
domain is discretized into a finite set of control volumes or cells. A backward Eu-
ler 1st order implicit scheme is used for the time integration of the fluid flow. The
implementation of these equation in the Fluent package is out of the scope of this
paper.
Our FSI model uses the dynamic mesh method of the CFD software package. This
method uses a user defined function (UDF) that can be coupled with the code. As
input of the UDF the position of the boundary nodes of the moving valve have to
be prescribed at the beginning of a new time step. Since these positions depend on
the FSI solution, a straightforward calculation is not possible and an iteration strat-
egy is necessary. Therefore journal files are generated and then used to drive the
computation.
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VIII.2.4. Implementation of the interaction between fluid and
structure
Figure VIII.3 presents a flow diagram of the solution strategy. In the following
paragraphs the different steps of the scheme are explained.
First all UDF variables t, ∆t, n, k, I , θ, θ˙, θ¨ are initialized. The subsequent position
in function of time of the valve leaflet is calculated with a backward Euler scheme
(figure VIII.3). This in accordance with the scheme used in Fluent.
θ˙n+1 = θ˙n +∆t · θ¨n+1
(VIII.8)
θn+1 = θn +∆t · θ˙n+1
In this way a full implicit scheme is obtained. The indices n + 1 and n correspond
with time levels t + ∆t and t respectively. In order to obtain the position θn+1
at t + ∆t an iterative approach is used. For each timestep there are k iterations
performed in order to reach sufficient convergence of Eq(VIII.6).
VIII.2.4.1. Step 1
Two initial steps are done in order to estimate the derivative dM/dθ¨ (Eq(VIII.9)). A
first estimation (k = 0) of the new position θn+1,k=0 is computed with the old value
of the angular acceleration θ¨n. This value of the acceleration is used to calculate
the position using equation Eq(VIII.8). With this initial guess of the new position
at t + ∆t the mesh is adapted with the dynamic mesh model. After adaptation of
the mesh, Fluent is used to solve the continuity and momentum equations. After
convergence of the Navier-Stokes equations, Mn+1,k=0 is calculated. A second
estimation (k = 1) of the new position θn+1,k=1 is computed with the old value of
the angular acceleration increased with a constant δ=0.1rad/s2. This iteration step
results in the value of Mn+1,k=1 and the derivative dM/dθ¨ can be calculated.
θ¨n+1,k=0 = θ¨n
θ¨n+1,k=1 = θ¨n + δ (VIII.9)
dM
dθ¨
=
Mn+1,k=1 −Mn+1,k=0
θ¨n+1,k=1 − θ¨n+1,k=0 =
Mn+1,k=1 −Mn+1,k=0
δ
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Begin
Initialize variables at t = 0s
n = 0, k = 0, θn = θ0, θ˙n = 0, θ¨n = 0
t = (n + 1) ·∆t and θ¨n+1,k = θ¨n Step 1
k = k + 1 calculate θn+1,k n = n+ 1, k = 0
read CAS and DAT file of timestep n
θ¨n+1,k+1 = θ¨n+1,k + δ DYNAMIC MESH
calculate θ¨n+1,k+1 Navier-Stokes Equations θ¨n+1 = θ¨n+1,k
calculate Mn+1,k in FLUENT
k = 0?
calculate
dM
dθ¨
k = 1?
Step 2 Mn+1,k ≈ I · θ¨n+1,k?
write CAS and DAT file of timestep n+ 1 t = Tp?
End
No
No
Yes
Yes
No
No
Yes
Yes
n = time step, k = iteration step for ∆θ, δ = 0.1
FLUENT Inc. software executed using generated journal file
UDF’s executed using generated journal file
Figure VIII.3.: Flow diagram of the coupling of fluid and structure in FLUENT.
The derivative is only computed once for each timestep and held constant during
the iteration cycle. The value of this derivative only affects the convergence of the
iteration proces.140
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VIII.2.4.2. Step 2
The derivative dM/dθ¨ can now be used the calculate more correct position of the
valve leaflet (Eq(IX.7)).
Mn+1,k+1 = I · θ¨n+1,k+1
⇓
Mn+1,k +
dM
dθ¨
·
(
θ¨n+1,k+1 − θ¨n+1,k
)
= I · θ¨n+1,k+1 (VIII.10)
⇓
θ¨n+1,k+1 =
(
Mn+1,k − dM
dθ¨
· θ¨n+1,k
)
(
I − dM
dθ¨
)
With this better approximation of the angular acceleration the new position is cal-
culated, the mesh is adapted and the Navier-Stokes equations are solved. After
convergence of the Navier-Stokes equations, Mn+1,k is calculated and convergence
of the Eq(VIII.11) is checked.
Mn+1,k ≈ I · θ¨n+1,k
⇓ (VIII.11)
|Mn+1,k − I · θ¨n+1,k|<
Step 2 will be repeated until convergence of Eq(VIII.11) is achieved. The simulation
ends at t = Tp with Tp the time period.
VIII.2.5. Boundary conditions
As boundary conditions for the computer model (figure VIII.4) pulsatile aortic flow
is used. The velocity component u in x-direction (m/s) is given in function of the
time t at the inlet. This flow pulse was derived from the experimental flow data as
shown in figure VIII.4.
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Figure VIII.4.: Boundary conditions for the computational model and the experimental model.
uinlet = umean + uampl · sin
(
2 · pi · tTp
0.74
)
for 0s < t < 0.37 · Tp,
(VIII.12)
uinlet = umean + 0.5 · uampl · sin
2 · pi ·
(
t
Tp
+ 0.26
)
1.26

for 0.37 · Tp < t < Tp
The flow pulse consists of two sinus functions (Eq(VIII.12)). The parameters in this
formula are Tp = 2.45 s = the time period, umean = 0.04 m/s = mean velocity during
Tp, uampl = 0.11 m/s = the velocity amplitude. Velocity component v in y-direction
at the inlet is set to 0 m/s. At the outlet a constant gauge pressure of 0 Pa is assumed.
On all the other walls no slip conditions are defined. In order to apply the no slip
condition on the moving leaflet, the boundary fluxes are computed with the leaflet
face velocities which are computed from the space conservation law Eq(VIII.3). The
calculation in Fluent is started at to = 2.05 s corresponding with zero flow or uinlet
= 0 m/s. Three subsequent cycles are calculated in order to obtain a solution which
is independent of the initial position of the valve leaflet. The solution is calculated
with ∆t = 0.00245 s. It was verified that further reduction of the timestep did not
alter the solution.
VIII.3. Results
Figure VIII.5 demonstrates the flow at five different instants of time in the flow
cycle. Also the pressure difference between inlet and outlet of the geometry is
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shown in this figure. In these figures the boundary flow pulse is shifted in time, so
that the curves starts with v=0m/s at t=0s (figure VIII.5(a)) corresponding with the
beginning of the acceleration. The figures are the result from the third of the three
subsequent cycles that were simulated. The first cycle is initialized with zero flow in
the whole fluid domain. Three subsequent cycles are thus necessary in order to ob-
tain results independent of the previous cycle. During the acceleration of the aortic
flow (figure VIII.5(a) t=0s and figure VIII.5(b) t=0.37s), the valve leaflet is pushed
towards the aortic sinus. Two vortices are observed. A large vortex is present in the
sinus cavity and a smaller secondary vortex is shown at the bottom wall downstream
of the leaflet. The angle of the valve leaflet reaches his maximum value at t=0.88
s (figure VIII.5(c) and VIII.6). The large vortex is reduced to a small vortex in the
sinus cavity. At t=1.32s (figure VIII.5(d)) the vortex is almost filling the complete
sinus cavity. Thus, during the closure of the valve the vortex in the sinus is growing.
During the further closure of the valve, a second small vortex rotating clockwise has
developed downstream the large vortex (figure VIII.5(e)). During the acceleration
the vortices get smaller and the secondary vortex is even disappearing. The pres-
sure difference ∆p over the valve model shows two discontinuities corresponding
with the discontinuities in ∂v∂t . Furthermore the pressure difference is zero at t=0.88s
(figure VIII.5(c)) and t=2.11s (figure VIII.5(e)). These moments in time correspond
with the maximum and minimum flow rate respectively.
Figure VIII.6 shows the comparison for the valve leaflet excursion between the sim-
ulations and experiments. The data is plotted for the same shifted boundary flow
pulse as used in figure VIII.5. There is a good qualitative and quantitative agree-
ment, although figure VIII.6 demonstrates that the numerical leaflet angles are sys-
tematically higher than the experimental values. The simulations showed a maxi-
mum opening angle of θsimulation,max=93.2 degrees at t=0.88s. The experimental
maximum opening angle θexperiments,max is lower, e.g. 85.5 degrees, and later in
the cycle at t=0.95s.
VIII.4. Discussion
A two-dimensional fluid-structure interaction (FSI) model of the aortic valve is de-
veloped, which is based on the dynamic mesh method of the Fluent software. To
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Figure VIII.5.: Velocity vectors and pressure difference ∆p of the last of the three calculated
subsequent cycles.
the best of our knowledge, this numerical model is the first using the Fluent soft-
ware for the simulation of the FSI of heart valve dynamics. The results presented in
figure VIII.5 indicate that the opening and closing of the valve during the ejection
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Figure VIII.6.: Comparison of experimental data with simulation data.
phase of the cardiac cycle is modeled quite well using the presented method. The
observed vortices are essential for the efficient closure of the aortic valve and were
also observed in experiments done by De Hart et al29 and Van Steenhoven et al.202
Furthermore the results demonstrate the effect of the regurgitation (negative inlet
velocity) on the closing of the aortic valve. It must be stated that the regurgitant
flow is a prescribed quantity in our numerical model. Without this regurgitation the
valve would unable to close fully, as the closing of the valve has not yet finished at
t = 2.11 s (figure VIII.5).
The computational model has been validated with experiments using a CCD camera
(Kodak ES-1.0) to record the valve positions at 50 instants in the flow cycle. The
opening angles are used for comparison, since this quantity is a direct result of the
fluid-structure interaction. Although a good qualitative and quantitative agreement
is shown in figure VIII.6, the numerical leaflet positions are systematically larger
than the experimental positions. A few reasons for this difference between the CFD
simulations and experimental setup (figure VIII.6) can be found. The CFD simu-
lations are done in two dimensions, although the experimental setup is of course
three-dimensional. Due to these three dimensions, there are instationary boundary
layer flows near the side walls interacting with the leaflet. These instationary bound-
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ary layers are of course not modeled in the numerical two-dimensional model, but
they certainly influence the movement of the leaflet in the in vitro experiments. Fur-
thermore, since the valve is fixed to the top of the inflow channel using three strips
of adhesive tape, a small amount of fluid can leak over the top of the valve between
the strips of tape. When the valve is closed and the fluid starts to move forward,
the fluid passing underneath the valve will push the valve open. Since some of the
fluid will leak over the valve, the valve will possibly not open as far as without the
leakage. Another factor is the gap in the computer model between the leaflet and the
boundary of the domain. Because this gap isn’t present in the experimental setup, it
can also induce some errors on the computational results of the leaflet movement.
Our final aim is to calculate wall shear stress on the valve leaflets during a com-
plete cardiac cycle, fully accounting for the delicate interaction between blood flow
and stiffness properties of the valve leaflets, and to asses in this way the impact of
leaflet properties on the shear stress distribution and the potential impact in tissue-
engineered heart valve applications. The ALE method in combination with remesh-
ing allows the accurate calculation of these wall shear stresses.
VIII.5. Conclusions
We have presented a 2D numerical model of the aortic valve haemodynamics in Flu-
ent, making use of ALE and remeshing techniques. Typical aortic flow phenomena
were observed in our simulations. Furthermore, our CFD results are in good agree-
ment with experimental observations (CCD Camera), where the same geometry and
boundary conditions were applied. From the results it is concluded that our new de-
veloped fluid-structure interaction method can be used to describe the fluid-leaflet
interaction of the aortic valve.
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Abstract
Background: In vitro studies on the ATS heart valve have shown that the valve opens
to the maximum opening angle when it is placed in a straight conduit, but that valve
opening is less than maximum when placed in an expanding conduit. This unex-
pected behaviour can only be due to fluid-structure interaction (FSI) of the valve
leaflets in a diverging flow, and is an interesting test case for our newly developed
numerical FSI code.
Method of approach: The computational FSI model makes use of Fluent software
for solving the flow problem, extended with a dedicated user-defined function to
account for the FSI. A 3D model of the ATS valve was created and studied in 2 ge-
ometries, simulating the valve in a straight conduit and an expanding conduit. For
both geometries, the same velocity inflow profile, with a peak velocity of 1 m/s was
applied.
Results: In the straight conduit, the ATS valve opens to the maximum opening angle
and remains in that position until closing. Peak transvalvular pressure difference is
3.5 mmHg (465.5 Pa). In the expanding conduit, the valve opens to the maximum
opening angle but remains in this position only for 0.092 seconds, after which it
moves toward less than maximum opening. Peak pressure difference is 2.8 mmHg
(371.4 Pa). We further calculated shear stress distribution on the valve leaflets.
Conclusions: Our numerical study thus confirms that valve opening and haemo-
dynamics depend on the geometrical conditions of the valve. The presence of a
diverging flow opens the valve to less than maximum opening and reduces the shear
stresses on the leaflets.
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IX.1. Introduction
Actual prosthetic bileaflet heart valves are generally considered to be safe and ef-
ficient as replacements for malfunctioning natural valves, although complications
such as thrombosis and thromboembolism are still unsolved problems. These prob-
lems are directly related to valve design characteristics and haemodynamics. The
ATS valve (ATS Medical, Minneapolis, MN, USA) is a pyrolytic carbon, open pivot,
low-profile cardiac prosthesis. The theoretical opening angle of the ATS valve is
85° (Fig. IX.1(a)) with 60° angle of travel. Compared with conventional mechani-
cal bileaflet valves, its open pivot structure is expected to induce less thrombolytic
events. However, it was noticed that normally functioning ATS valves in both the
Symmetry Plane
Opening
Angle
CS S
(a) Opening angle and symmetry plane.
Side (S) and central (C) flow orifice.
(b) The ATS AP valve as implemented in the
numerical model.
(c) The ATS open pivot hinge in close-up as im-
plemented in the numerical model.
Valve
Leaflet
cgap
Valve
Housing
(d) Gap at leaflet tip cgap.
Figure IX.1.: ATS valve.
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aortic and the mitral position open to less than maximum angle in clinical situa-
tions.203 In order to clarify ATS valve opening more in detail, in vitro tests have
been conducted.73, 204 It was found that in a straight outlet, the ATS valve opened
to maximum opening angle. However, the opening angle was less than maximum
in the expanding conduit.73, 204 These studies confirmed to some degree the clinical
finding that the ATS valve did not open to maximum opening angle except when the
outflow was straight, and when the leaflet did not extend into an expanding down-
stream chamber. Design characteristics of the ATS valve, such as its axis being
located close to the leaflet straight edge and its leaflets extending further down-
stream from the ring orifice, may cause this valve behavior.
The literature on computational three dimensional studies of heart valve dynamics
is still limited, possibly due to the difficulties associated with the modeling of the
complex mechanical heart valve geometry, flow unsteadiness, and the interaction
between the blood flow and the leaflet motion. Several studies have been reported on
the computation of the flow in the pivot region127, 156 and shear stresses in the clear-
ance region157 with the leaflets of the mechanical valve in a fixed position. These
studies neglected the interplay between the blood flow field and the leaflet motion.
In other studies, however, the fluid flow was coupled with the leaflet motion using
prescribed valve motion in a simplified flow domain.155 This prescription of the
leaflet motion avoids the complex problem of the blood-leaflet interaction during
the valve closure. Only recently, more realistic simulations have become possible,
modeling the leaflet motion including the blood-leaflet interaction.140, 141
We previously developed a robust computational fluid-structure interaction model,140
capable of calculating the leaflet motion together with the flow field. The algorithm
was tested and validated on a two dimensional (2D) model.142 Since the peculiar
behavior of the ATS valve leaflets can only result from the interaction between the
flow field and the leaflet, we thought this valve to be an excellent 3D test case for
our numerical model. The aim of this study was therefore to simulate the 3D leaflet
motion of the ATS valve during the complete cardiac cycle and to gain insight into
the complex interplay between valve leaflet motion and the geometrical conditions
of the heart valve in situ.
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IX.2.1. Valve and conduit geometries
The model is based on the 22mm AP ATS Open Pivot™ heart valve shown in figure
IX.1(b). The inside diameter of the valve orifice is 20.8 mm with a geometric orifice
area of 3.17 cm2. Specific to this valve is its open pivot design (figure IX.1(c),
in which the convex pivot and stops are located on the inner circumference and
extended in the flow field. Figure IX.1 defines the opening angle of leaflets (Fig.
IX.1(a)), the side and central flow orifice of the valve (Fig. IX.1(a)) and the gap cgap
between the leaflet tips and the housing of the closed valve (Fig. IX.1(d)).
The first geometry in which the valve haemodynamics is computed is a straight
conduit (Fig. IX.2(a)) with a diameter of 21.9 mm. The second geometry (Fig.
(a) the straight conduit: ATS valve positioned in a straight conduit.
(b) the expanding conduit: ATS valve positioned in an expanding conduit.
Figure IX.2.: The straight and expanding geometries as used in the computational study.
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IX.2(b)) has an enlargement downstream of the valve and thus the leaflets extend
into an expanding downstream chamber during the opening of the valve, further
referred as expanding conduit. The diameter is 21.9 mm for the inflow conduit and
40.0 mm for the outflow conduit. The length of the in- and outflow conduits is 50.0
mm for both geometries.
IX.2.2. CFD package and remeshing
Meshing the geometries was achieved with Gambit 2.1 (Fluent Inc.). The valve
motion is coupled with the blood flow. The latter is computed with the commercial
CFD software package Fluent (Fluent Inc.). The dynamic mesh model of Fluent 6.1
has been used for the arbitrary Lagrangian-Eulerian (ALE) computations.
Because of computational time efficiency reasons, there are some limitations on the
mesh density when the valve is near and in its closed position. Given that cgap is
of the order of 5·10-5m,155 the volume of the cells of the mesh at the gap are of the
order c3gap = 1.25·10-13m3. Meshing of the inflow and outflow conduit with larger
cells and the valve section with these small cells would lead to hundreds of millions
of cells. A coarser mesh with refinements of the mesh at the gap of the leaflet tip,
still resulted in Gambit in more than 5 million cells. Also this number is quite high,
taking into account the fact that unsteady calculations will be performed with an
ALE remeshing at every subiteration.
A second limitation concerns the remeshing capability of Fluent. The displacement
of the leaflet tip in one calculation timestep should not exceed the length of the
smallest boundary of neighboring cells, because otherwise this would result in neg-
ative cell volumes. This can be avoided with a decrease of the used timestep. The
length of the smallest boundary is proportional to cgap. Knowing that the leaflet tip
velocity vtip is in the order of magnitude of 2.1m/s155 during opening and closing,
the required timestep is cgap/vtip = 2.5·10-5s. With the total time for opening and
closing of 0.066s,155 more than 2600 timesteps need to be calculated for one car-
diac cycle. In this, it is assumed that the valve is in the maximum open or closed
position during the remaining time of the cycle, a condition which is not necessarily
fulfilled, as will be shown further in this work. Converging of 1 timestep (with 4
subiterations for the fluid-structure interaction problem) for 500.000 elements takes
about 2 hours on an Intel Xeon Pentium PC (1.7 GHz with 2GB RAM). This would
result in a total calculation time of more than half a year!
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To avoid such excessive computing times, we had to make simplifications to the
meshed geometry. Firstly we take advantage of the symmetry of the bileaflet geom-
etry and simulate only one half of the valve. We further reduced the leaflet dimen-
sions to 95% of their original size. This results in a gap of 25·10-5m = 5cgap. Fur-
thermore the maximum opening angle of the leaflets is restricted to 80°. This should
avoid contact of the leaflet with the pivot stops, which would result in squeezed cells
and bad convergence of the Fluent solver. These adaptations result still in a total
number of grid cells used in the computation of about 500.000 for both geometries.
IX.2.3. Governing Equations
The unknown variables are the velocity component u in the x-direction, the velocity
component v in the y-direction, the velocity component w in z-direction, the pres-
sure p and the coordinates (x, y, z) of the valve nodes determined by the angle θ.
The continuity equation in integral form Eq(IX.1) is given by
∂
∂t
∫
V
ρdV +
∫
S
ρ( v−→− vb−→) · n−→dS = 0 (IX.1)
where
∫
V ...dV is the integral over a control “volume”,
∫
S ...dS is the integral over a
control “surface”, n−→ is the outwardly directed vector normal to dS, ρ is the density
of the fluid, v−→ = (u,v,w) is the velocity vector of the fluid, vb−→ = (ub,vb,wb) is the
velocity vector of the moving boundary. For each face j of the control volume
vb,j
−→· n−→dSj is computed from δVj∆t where δVj is the volume swept out by the control
volume face j over the time step ∆t. With this definition of vb,j−→ the so called space
conservation law Eq(IX.2) is fulfilled for each control volume.
∂
∂t
∫
V
dV =
∫
S
vb
−→ · n−→dS (IX.2)
The momentum equation in integral form is given by Eq(IX.3)
∂
∂t
∫
V
ρ v−→dV +
∫
S
ρ v−→( v−→− vb−→) · n−→dS = −
∫
S
pn−→dS +
∫
S
τ · n−→dS (IX.3)
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where τ is the stress tensor. Body and buoyancy forces were neglected. Finally, the
equation of motion Eq(IX.4) for the leaflet can be written as
M = I · θ¨ (IX.4)
with M the torque on a stiff valve leaflet, I the moment of inertia = 4.0· 10-9kg·m2
and θ the opening angle of the leaflet as indicated in figure IX.1(a).
The continuity Eq(IX.1), space conservation Eq(IX.2) and momentum Eq(IX.3)
equations for incompressible laminar flow are solved in the fluid domain. Since
the calculations are unsteady and performed in 3D, the large scale turbulence, with
scale larger than the mesh size, is completely captured by the flow solver and thus
needs no modeling. The fluid is assumed to be Newtonian with the density of 1050
kg/m3 and viscosity of 0.004 kg/m·s, which is representative of human blood prop-
erties at 37°C. The CFD software package Fluent (Fluent Inc.) is used to solve the
governing equations. Fluent is based on the finite volume method, where the do-
main is discretised into a finite set of control volumes or cells. A backward Euler
1st order implicit scheme is used for the time integration of the fluid flow. The
implementation of these equation in the Fluent package is out of the scope of this
paper.
Our FSI model uses the dynamic mesh method of the CFD software package. This
method uses a user defined function (UDF) that can be coupled with the code. As
input of the UDF the position of the boundary nodes of the moving valve have to
be prescribed at the beginning of a new time step. Since these positions depend on
the FSI solution, a straightforward calculation is not possible and an iterative ap-
proach is necessary. Therefore command files are generated and then used to drive
the computation.
IX.2.4. Blood-Leaflet interaction model
Figure IX.3 shows a flow diagram of the coupling of the flow computations and
the movement of the leaflet. A partitioned approach is used but strong coupling
is achieved through implicit coupling in the subiterations. Implicit coupling is ob-
tained through the derivative of the moment M to the angular acceleration θ¨ which
is derived numerically. In the following paragraphs the different steps of the imple-
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Begin
Initialize variables at t = 0s
n = 0, k = 0, θn = θ0, θ˙n = 0, θ¨n = 0
t = (n + 1) ·∆t and θ¨n+1,k = θ¨n Step 1
k = k + 1 calculate θn+1,k n = n+ 1, k = 0
read CAS and DAT file of timestep n
θ¨n+1,k+1 = θ¨n+1,k + δ DYNAMIC MESH
calculate θ¨n+1,k+1 Navier-Stokes Equations θ¨n+1 = θ¨n+1,k
calculate Mn+1,k in FLUENT
k = 0?
calculate
dM
dθ¨
k = 1?
Step 2 Mn+1,k ≈ I · θ¨n+1,k?
write CAS and DAT file of timestep n+ 1 t = Tp?
End
No
No
Yes
Yes
No
No
Yes
Yes
n = time step, k = iteration step for ∆θ, δ = 0.1
FLUENT Inc. software executed using generated journal file
UDF’s executed using generated journal file
Figure IX.3.: Flow diagram of the coupling of fluid and structure in FLUENT.
mentation are explained. First all UDF variables t, ∆t, n, k, I , θ, θ˙, θ¨ are initialized.
The subsequent position of the valve leaflet on the new time level is calculated by
coupling the backward Euler time integration scheme for the solid with the CFD
code. The backward Euler scheme for the solid is given by
θ˙n+1 = θ˙n +∆tθ¨n+1,
θn+1 = θn +∆tθ˙n+1. (IX.5)
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The indices n+ 1 and n correspond with time levels t+∆t and t respectively.
In order to obtain the position θn+1 at t+∆t an iterative approach is used. For each
timestep there are k subiterations performed in order to reach sufficient convergence
of eq. (IX.4).
At the beginning of each time step, the derivative dM/dθ¨ is computed numerically.
A first estimation (k = 0) of the new position θn+1,k=0 is computed with the old
value of the angular acceleration θ¨n. This value of the acceleration is used to cal-
culate the position using the equation eq. (IX.5). With this initial guess of the new
position at t+∆t, Fluent is called to adapt the mesh with the dynamic mesh model
and to solve the Navier-Stokes equations. After convergence of the Navier-Stokes
equations, Mn+1,k=0 is calculated from the flow field. A second estimation (k = 1)
of the new position θn+1,k=1 is computed with the old value of the angular accel-
eration increased with a constant δ=0.1 rad/s2. This value is about 1/100 of the
maximum angular acceleration, which can be estimated from the inlet profile. Tests
have demonstrated that the convergence of the algorithm is not very sensitive to the
choice of this value. After convergence of the fluid problem, Mn+1,k=1 and the
derivative dM/dθ¨ is calculated as follows:
θ¨n+1,k=0 = θ¨n
θ¨n+1,k=1 = θ¨n + δ (IX.6)
dM
dθ¨
=
Mn+1,k=1 −Mn+1,k=0
δ
.
The derivative dM/dθ¨ can now be used to calculate an approximation of the angular
acceleration of the valve leaflet in an implicit way:
Mn+1,k+1 = Iθ¨n+1,k+1
⇓
Mn+1,k +
dM
dθ¨
(
θ¨n+1,k+1 − θ¨n+1,k
)
= Iθ¨n+1,k+1 (IX.7)
⇓
θ¨n+1,k+1 =
(
Mn+1,k − dM
dθ¨
θ¨n+1,k
)
(
I − dM
dθ¨
)
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With this approximation of the angular acceleration the new position is calculated,
the mesh is adapted and the Navier-Stokes equations are solved. After convergence
of the Navier-Stokes equations, Mn+1,k+1 is calculated and convergence of the
inner loop is checked:
Mn+1,k+1 ≈ Iθ¨n+1,k+1
The inner loop is repeated until convergence is achieved. A convergence criterium
of a residual drop of 3 orders of magnitude is used. Then the next time step is
computed. The simulation ends at t=Tp. The developed FSI code belongs to the
class of partitioned but strongly coupled methods, also known as iterative methods
for fluid-structure interaction,148, 147 i.e. separate solvers are used for the fluid and
the structure, but strongly coupling is achieved.149, 205, 206
IX.2.5. Boundary conditions
The inlet velocity profile is given in Fig. IX.4(a). The spatial velocity distribution is
shown in Fig. IX.4(b)127 with r the radial position and R the conduit radius. At the
outlet of the conduit in both geometries a constant pressure is assumed. The absolute
value of the outlet pressure is of no importance because only the transvalvular pres-
sure difference between inlet and outlet, computed with the incompressible solver,
is important for the simulation of the leaflet motion. The remaining boundaries are
solid walls, and the standard no-slip velocity condition is used. Simulations are per-
formed during the whole cycle starting from the closed valve assuming zero velocity
over the whole fluid domain. One and a half cycle are simulated. In this way the
opening of the valve is independent of the initial zero flow conditions. The com-
putations advances in time with a time step ranging between 0.001s and 0.00025s,
dependent on the angular velocity of the valve.
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Figure IX.4.: Velocity boundary condition used at the inlet of both geometries.
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IX.2.6. Derived parameters
The following parameters are calculated from the simulation results:
∆topening = the time period during which the valve
is moving towards the open position
∆tmaximum opening = the time period during which the valve
is at maximum opening angle, θ=80°
∆tclosing = the time period during which the valve
is moving towards the closed position
∆tcycle = ∆topening +∆tmaximum opening +∆tclosing
θmean,fwd flow = mean leaflet angle during forward flow
θ
mean,∆tthe straight conduit
maximum opening
= mean leaflet angle during
∆tmaximum opening of the straight conduit (Fig. IX.5(a))
∆pmax = the maximum transvalvular pressure
difference between inlet and outlet
SSavg = the spatial average of the shear stress
on the leaflet at a certain timestep
maxSSavg = the maximum value of the SSavg curve
SSmax = the local maximum shear stress
The parameters are summarized in table IX.1.
IX.3. Results
Opening angles, opening times, transvalvular pressure differences, flow pathlines
and shear stresses are compared for the two geometries and discussed below.
Figure IX.5(a) and table IX.1 compare the angle of the leaflets during the whole cy-
cle. At the beginning of inflow the time behavior of the opening angles are similar
for both geometries. The opening time ∆topening for the straight conduit is 0.147s
compared to 0.200s for the expanding conduit. In the straight conduit the valve
opens to the maximum opening angle (80°) during 0.702s. In contrast, the leaflet
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Table IX.1.: Summarized time, angle, pressure and shear stress data.
Results: time, angle, pressure and shear stress data
the straight conduit the expanding conduit
∆topening
[s]
0.147 0.200
∆tmaximum opening
[s]
0.702 0.092
∆tclosing
[s]
0.344 0.726
∆tcycle
[s]
1.193 1.018
θmean,fwd flow
[degrees]
74.0 69.7
θ
mean,∆tthe straight conduit
maximum opening
[degrees]
80.0 74.7
∆pmax
[mmHg]
3.5 2.8
SSmax
[Pa]
44.4 44.6
maxSSavg
[Pa]
26.6 17.8
in the expanding conduit opens to the maximum opening angle for a very short
period of 0.092s. From this timelevel on the leaflets are moving slowly towards the
closed leaflet position. In the expanding conduit the streamlines diverge from the
axis of the conduit, and the leaflets respond to this divergent flow. In the straight
conduit ∆tclosing takes 0.344s while 0.726s in the expanding conduit. This results
in ∆tcycle of 1.193s for the straight conduit and 1.018s for the expanding conduit.
The mean angle during forward flow in the straight conduit is 74.0° and 68.7° in the
expanding conduit. The mean angle θmean during ∆tthe straight conduitmaximum opening (Fig. IX.5(a)) is
80.0° in the straight conduit and 74.7° in the expanding conduit.
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Figure IX.5.: Comparison of opening angle and transvalvular pressure difference in both geometries.
The simulations can also be used to calculate transvalvular pressure differences be-
tween inlet and outlet (Fig. IX.5(b)). The maximum pressure difference is 3.5mmHg
in the straight conduit and 2.8mmHg in the expanding conduit (table IX.1).
Figure IX.6 shows flow pathlines for both geometries at three different timesteps
of the cycle. Figures IX.6(a) and IX.6(b) show the flow pathlines during the open-
ing of the valve. The flow pathlines in figures IX.6(a) are streamlined, while they
are more diverging downstream the valve in the expanding conduit (Fig. IX.6(c)).
This indicates the presence of the diverging flow which is guiding the valve leaflet
motion. At a later stage in the flow cycle the flow pathlines in the straight conduit
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(a) t=0.100s (b) t=0.100s
(c) t=0.600s (d) t=0.600s
(e) t=1.025s (f) t=1.025s
(g) Pressure Values [mmHg].
Figure IX.6.: Flow pathlines colored with respect to pressure values in both geometries.
are still streamlined (Fig. IX.6(c)), while large circular flow pathlines are present in
the expanding conduit (Fig. IX.6(d)). These circular flow pathlines remain present
during complete closing phase of the valve (Fig. IX.6(f)). In the straight conduit
also less streamlined flow pathlines are present during valve closure (Fig. IX.6(e)).
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Average shear stress on the leaflet is lower in the expanding conduit with a maxi-
mum value equal to 17.8 Pa, compared to a maximum value of 26.6 Pa in the straight
conduit (Fig. IX.7(a)).
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(a) Average shear stress on the leaflet.
(b) Shear stress distribution on the leaflet at t=0.500s.
Figure IX.7.: Shear stress on the valve leaflets.
Figure IX.7(b) compares the shear stress distribution on the leaflet for the two ge-
ometries and for the side and central orifice (Fig. IX.1(a)). The figure shows the
shear stress at t=0.5s for a peak inlet velocity of 1.0m/s. Although the maximal
shear stress was in both cases around 44.5Pa, the location of the high shear stresses
on the leaflets differs in both geometries: proximal of the leaflet in the straight con-
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duit compared to distal of the leaflet in the expanding conduit, especially for the
shear stress at the side orifices.
IX.4. Discussion
We simulated the ATS valve opening and closing in two geometries, a straight con-
duit and a expanding conduit. In both cases we used the same boundary conditions.
Results confirm earlier in vitro observations of the ATS valve leaflet motion, i.e. the
leaflet motion is dependent on geometrical conditions.73, 203, 204 The opening angle
in the straight conduit is larger than in the expanding conduit.
The impact of geometrical conditions on the ATS valve leaflet motion was studied
in vitro by Feng et al.,73, 204 confirming earlier published in vivo results reported by
Aoyagi et al.203 They73, 204 reported less than maximum opening of the valve in
an expanding conduit under mitral flow conditions. Their results are in qualitative
agreement with our numerical simulations.
In our simulations, using the inlet profile as shown in Fig. IX.4(a), the valve actu-
ally reached the maximal possible opening angle, which was restricted to 80°. Due
to open pivots, even if the leaflets do not go to maximum opening angle, it does not
compromise the function of the valve: the trend towards less than maximum open-
ing reduces shear stresses on the leaflets. Also the pressure difference was lower
in the calculation with the expanding conduit, but here the pressure recovery due to
the expansion can be the cause of this. Therefore we compared pressure differences
in the expanding conduit for a leaflet angle of 75°and 80°using steady flow calcula-
tions. These calculations showed that there is almost no difference in pressure drop
due to the less than maximum opening of the ATS valve.
Obviously, the leaflet motion is also highly dependent on the applied boundary con-
dition which was, in this case, an inflow profile adopted from a previous study
in which we validated the algorithm in a 2D setting.142 This 2D validation study
showed the robustness and accuracy of the FSI algorithm and thus it could be used
in 3D. It is, however, at the same time acknowledged that further experimental mea-
surements are needed to validate the agreement between the measured and calcu-
lated complex 3D flow phenomena around the moving valve leaflet.
At this point, we can only state that the application of a flow profile to an ATS-
like valve in 2 different geometrical constraints yields a different behaviour of the
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leaflets. In order to match our findings to clinical data (i.e., a valve in aortic and
mitral position), more physiological flow profiles are to be prescribed. Although we
could not demonstrate an incomplete opening of the valve in the expanding conduit,
we could prove a strong difference in the leaflet behavior in both geometries. In
the straight conduit the valve is open at the maximum opening angle for a long pe-
riod of time (0.702s). The leaflet in the expanding conduit is open at the maximum
opening angle for only 0.092s of the total flow cycle. From this timelevel on the
leaflets are moving towards a less open position. The leaflet responds to the diver-
gent flow in the expanding conduit. The mean opening angle during forward flow
is 74.0° in the straight conduit, but only 68.65° in the expanding conduit. Even dur-
ing ∆tthe straight conduitmaximum opening the mean angle in the expanding conduit is only 74.7°. This
value is close to the reported 75.5°.73, 155, 204 Another interesting observation is the
fact that ∆tthe straight conduitcycle =1.193s is larger than ∆t
the expanding conduit
cycle =1.018s. Thus,
although the boundary conditions and the amount of regurgitation are the same in
both geometries, the valve in the expanding conduit is closing earlier. The valve
leaflet responds to the divergent flow in the expanding conduit, resulting in an ear-
lier closing of the valve.
With our CFD model, we not only obtain information on the motion of the valve
leaflets, but also detailed haemodynamic data such as, for instance, the transvalvular
pressure difference between inlet and outlet. The transvalvular pressure differences
∆pthe straight conduitmax = 3.5mmHg and ∆pthe expanding conduitmax = 2.8mmHg are of the same
order of magnitude as found in the Feng studies.73, 204 Due to the leaflet reduction
the negative transvalvular pressure difference over the closed valve could not be
shown. Either flow or pressure has to be imposed as boundary conditions. Since
the gap size is larger, a small pressure difference is needed to obtain the imposed
regurgitation flow. This follows from the computations. If pressure differences were
imposed as boundary conditions, the regurgitation flow that would come out of the
simulations, would have been very high due to the enlarged gap size. We therefore
do not report the regurgitation data, as this issue requires further exploration in fu-
ture studies. Also, reducing the leaflet size will have an impact on flow phenomena
during closing of the valve, i.e. cavitation and rebound of the leaflet.141, 51
Another important haemodynamic variable, impossible to measure directly in vivo
and in vitro, is the shear stress on the valve leaflet. The maximum shear stress is
in both cases around 44.5Pa for a peak blood flow of 1m/s and are far lower than
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hemolytic threshold (<200Pa).124, 126, 207 These values are comparable to what is
found in the literature.44, 125, 51 The average shear stress on the leaflet is 17.8Pa in
the expanding conduit compared to a larger value of 26.6Pa in the straight con-
duit (Fig. IX.7(a)). The location of the higher shear stress on the leaflet at the side
orifice in the straight conduit is located at the upstream edge of the leaflet. In the
expanding conduit the diverging flow interacts with the leaflet, causing a different
location of the high shear stress on the leaflet as can be seen in Fig. IX.7(b). At
the center orifice, there is only a minor difference between the 2 geometries. The
location of the high shear stress is almost the same at the center orifice. Our nu-
merical study unravels that the presence of a diverging flow reduces the shear stress
distribution on the leaflets.
This new FSI model will be a major tool to study the haemodynamics associ-
ated with thrombolytic and hemolytic events of existing and new mechanical heart
valves. Although our CFD model has revealed its potential as a tool to study valve
dynamics in a much more detailed way than possible with any in vitro technique,
there are still some limitations. The shear stress during the leakage flow125, 141 could
not be accounted for because of the enlarged gap. In the simulations, valve excur-
sions reached 80°. It is not clear whether the valve would have reached the max-
imum open position (85°) of the ATS valve if it would have been included in the
model.
Although it is reported by Liang et al.158 that grid density should be 5·10 6 grid
points in order to simulate the symmetry-breaking instabilities and flow fields in
heart valve modeling, we could not achieve this goal because of limited available
PC power. It is also stated in the same study that the high Reynolds numbers of the
flow could result in symmetry-breaking instability. In spite of this remark, we still
assume symmetrical flow through the leaflet in order to save computer CPU time.
Perhaps the most challenging obstacle is the development of turbulence models ca-
pable of simulating pulsatile flows periodically undergoing transition to turbulence
and laminarization.158 Since our laminar calculations are unsteady and performed
in 3D, the large scale turbulence, with scale larger than the mesh size, is completely
captured by the flow solver and thus the large scale turbulence needs no modeling.
Successful application of laminar or more advanced turbulence models to mechan-
ical heart valve flows, however, will require detailed experimental measurements,
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i.e. PIV measurements, and validation.158
IX.5. Conclusion
We have studied the dynamic behavior of a mechanical ATS bileaflet heart valve in
2 different geometries. In agreement with in vitro studies, our simulations demon-
strate a trend to less than maximum opening of the valve leaflets in an expanding
geometry. This new FSI algorithm will be a major engineering tool available to
unravel the haemodynamics associated with thrombolytic and hemolytic events of
existing and new mechanical heart valves. Although improvements could be made
concerning the mesh of the closed valve and more physiological boundary condi-
tions, the computer model has shown its ability of modeling the dynamic behavior
of mechanical heart valves.
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Abstract
In vitro studies on the ATS heart valve have observed that valve opening is less in
an expanding conduit compared to opening in a straight conduit.
We have studied bileaflet valve behavior using a new computational fluid-structure
interaction model. A 3D model of the ATS valve was studied in two geometries,
simulating the valve in a geometry with a sudden expansion downstream of the
valve and in a straight conduit. Mitral and aortic flow patterns are simulated. The
computer model was used to study standard clinical performance parameters.
The ATS valve in the expanding geometry showed opening to a maximum angle of
77.5°. This finding was confirmed by earlier clinical and in vitro studies. The mean
and maximum transvalvular pressure gradients are 2.1 mmHg and 4.6 mmHg. The
effective orifice area is 2.5 cm2. The maximum shear stress calculated on the leaflet
is 25 Pascal.
Maximum opening of the valve is achieved in the straight conduit. The mean and
maximum pressure gradients are 1.1 mmHg and 4.3 mmHg. The effective orifice
area is 2.3 cm2. The maximum shear stress calculated on the leaflet is 35 Pascal.
Our numerical study confirms that valve haemodynamics and leaflet motion are de-
pendent on the geometrical conditions of the valve: the presence of a diverging
flow influences the maximum opening angle of the valve leaflets. The model can be
used to predict pressure gradients, effective orifice area, and shear stress loading of
mechanical heart valves. This model will be a major research tool in the future to
unravel the haemodynamics of existing and new mechanical heart valves.
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X.1. Introduction
Important design criteria of heart valves are related to the behavior of the valve in
the flow field. In particular, pressure gradients should be as low as possible. Stag-
nation, recirculation zones127, 156 and shear stresses in the clearance region157 are to
be minimized in order to prevent initiation of coagulation.
Traditionally, the behavior of the valve (leaflets) is tested in in vitro mock circula-
tions,73, 130, 133, 204 which implies that prototypes of the valves are already available
at the time of testing. In the course of the design process, however, valves are com-
puter designed, and virtual valve prototypes are available in an early stage of the
design process. The challenge remains, however, to test the haemodynamic perfor-
mance of these virtual prototypes. To do so, advanced computational algorithms,
which take into account the continuous and full interaction between the flow and
the valve leaflets are required.140, 141, 155
Several attempts have been made to assess heart valve kinematics using numerical
fluid-structure interaction (FSI) models. Peskin and McQueen et al.145 developed
a three-dimensional model including the heart and vessel walls based on the im-
mersed boundary method. Mechanical heart valve dynamics were studied only in
two dimensions using the fictitious domain method by van de Vosse et al.197 Al-
though these methods have the advantage that they avoid the mesh movement, they
are less accurate at the interface between the blood and the leaflet. As such, shear
stress values on heart valve leaflets can not be estimated with these methods.
Using the arbitrary Lagrangian-Eulerian ALE-remeshing approach,153 shear stress
values on heart valve leaflets can be estimated more accurate. There are different
ways to tackle the coupled interaction problem. One possibility is to develop new
software and solution methods for each of these coupled applications. This is re-
ferred to as the monolithical approach or the direct method.146 On the other hand,
one can make use of existing methods and software packages which have been de-
veloped for either fluid or structural applications and consider iterative methods147
- also known as partitioned methods148 for fluid-structure interaction. As such, sep-
arate solvers are used for the fluid and the structure problem. The coupling between
both, with an exchange of updated meshes and boundary conditions, is done in an
iterative way.
We have recently developed a new numerical code that fulfils these requirements,
and validation studies have demonstrated the accuracy of the numerical simula-
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tions.140, 142 Our FSI code belongs to the class of partitioned but strongly coupled
methods.140, 142, 205 In this study, we apply this numerical code on a computer model
of the ATS bileaflet valve. The motivation for choosing this particular valve is based
on the observation that in some conditions, the valve opening angle does not reach
the maximum opening position.203 In vitro experiments73, 204 seem to suggest that
this behavior is related to the geometrical conditions in which the valve functions:
the maximum opening angle is achieved in a straight conduit, but not when the valve
is placed in a expanding conduit.
In the following, we will simulate the flow pattern through the ATS valve and the
motion of the valve leaflets in two conditions: (i) in a straight geometry subjected to
a nominal aortic flow profile; (ii) in an expanding geometry, subjected to a nominal
mitral flow profile. To further illustrate the possibilities of numerical simulations as
’virtual haemodynamic bench tests’, we will use the simulated data (pressure, ve-
locity fields) to calculate well known indices, traditionally calculated in in vitro and
clinical studies,73, 203, 204, 208, 209 and characterizing valve performance. In addition
this allows us to calculate the shear stress distribution on the valve leaflets.
X.2. Materials and methods
X.2.1. Valve specifications
The model is based on the 22mm AP ATS Open Pivot™ heart valve. The inside
diameter of the valve orifice is 20.8 mm with a geometric orifice area of 3.17 cm2.
Specific to this valve is its open pivot design, in which the convex pivot point and
stops are located on the inner circumference and extended in the flow field. The
opening angle of the leaflets and the side and central orifice of the valve are defined
in Figure X.1.
X.2.2. Geometrical and boundary conditions
Two different configurations are studied and referred to as the ‘straight’ and ‘ex-
panding’ geometry. Only one half of the valve is studied assuming symmetry of
the flow. The straight geometry (Figure X.2(b)) is a conduit of 100 mm length and
a diameter of 21.9 mm. The outflow conduit of the expanding geometry (Figure
X.2(a)) is increased to 40 mm.
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Figure X.1.: Opening angle, symmetry plane, side (S) and central (C) orifice of the ATS valve.
Inflow conditions are set 5 cm proximal to the valve. The applied flow profiles are
nominal mitral and aortic flow profiles (Figure X.2(c) and X.2(d)), with the duration
(a) ‘Expanding’ geometry. (b) ‘Straight’ geometry.
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(d) ‘Aortic’ inlet velocity profile.
Figure X.2.: Studied geometries and velocity profiles.
of one cardiac cycle being 1 second (60 beats/minute). The cardiac output for both
flow profiles is 4 l/min.
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X.2.3. Clinical relevant parameters derived from the model
Numerical simulations produce pressure and velocity in each node of the numer-
ical grid, and the position of the valve leaflet at any moment during the cardiac
cycle. We calculated the velocity in the central VCO and side orifice VSO , and
the pressure 1.5 cm and 5 cm proximal and distal to the valve. From these pres-
sure data, we derived two transvalvular pressure gradients. The pressure gradient
∆P∆x=10cm is defined as the pressure difference between points 5cm proximal and
distal to the valve. Likewise, the pressure gradient ∆P∆x=3cm is defined as the pres-
sure difference between points 1.5cm proximal and distal to the valve. Mean and
maximum transvalvular pressure gradients are calculated: ∆Pmean is the mean pres-
sure gradient during forward flow, ∆Pmax is the maximum pressure gradient during
the cardiac cycle. Furthermore the pressure gradient ∆PFeng as defined by Feng et
al. is calculated.73, 204 The ∆PFeng is defined as the mean pressure difference during
acceleration phase.
Velocity profiles are simulated at the center orifice VCO and side orifice VSO of the
valve. The velocity profile at the center orifice represents the velocity that would be
measured by an ultrasound machine and is referred to here as the ‘Doppler’ velocity
profile. The simplified Bernoulli equation is used to estimate the maximum forward
pressure gradient ∆Pdoppler,max:
∆Pdoppler,max = 4 · V2max (X.1)
and the mean forward pressure gradient ∆Pdoppler,mean:
∆Pdoppler,mean = 4 · V2mean . (X.2)
The effective orifice area (EOAcontinuity [cm2]) is calculated as the ratio of the for-
ward stroke volume SV and velocity time integral VTI:
EOAcontinuity =
SV
VTI
. (X.3)
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Besides the continuity equation, the Gorlin equation provides an alternative formula
to calculate the effective orifice area (EOAGorlin):
EOAGorlin =
SV
tfwd
51.6 ·√∆Pdoppler,mean (X.4)
with tfwd the time period of forward flow.
From the simulated velocities we were able to calculate the shear stress distribution
on the leaflet assuming a constant blood viscosity. Shear stress is recognized as
the primary biomechanical trigger for thrombolytic and hemolytic events.124, 126, 207
From the shear stress distribution we calculated:
• For each timestep the spatial average shear stress on the leaflet: SSavg
• The time variation of SSavg during the cardiac cycle with a maximum value:
maxSSavg
• Maximum value of shear stress during the cardiac cycle on the leaflet: SSmax
X.3. Results
X.3.1. ‘Expanding’ geometry
The time course of leaflet opening is given in Figure X.3(a). The valve opening
angle initially reaches 76.2°, moves toward a more closed position during diastasis
(59.6°), and reopens during atrial contraction to an angle of 77.5°. The valve thus
never reaches the maximum opening position.
Figure X.3(c) shows the velocity profiles as observed at the center orifice VCO and
side orifice VSO of the valve compared to the inlet velocity profile. Then VCO and
VSO are used to calculate ∆Pdoppler,max, ∆Pdoppler,mean and the VTI as given in Table
X.1. The maximum Doppler gradient ∆Pdoppler,max is 4.27 mmHg and the mean
value ∆Pdoppler,mean is 1.11 mmHg. The mean pressure gradients derived from the
numerical simulations are ∆Pmean,∆x=10cm = 0.49 mmHg and ∆Pmean,∆x=3cm = 0.71
mmHg. The maximum pressure gradients derived from the numerical simulations
are ∆Pmax,∆x=10cm = 9.20 mmHg and ∆Pmax,∆x=3cm = 4.10 mmHg. The pressure
gradient as defined by Feng et al. ∆PFeng is 2.79 mmHg.
The effective orifice area (Table X.1), calculated with the continuity equation, is
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(a) ‘Expanding’ geometry: valve opening
angle.
0 0.5 1.0
0
30
60
90
time [s]
O
p
en
in
g
A
n
g
le
[d
eg
re
es
]
80
degrees
(b) ‘Straight’ geometry: valve opening an-
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(c) ‘Mitral’ velocity profiles.
-0.5
0.0
0.5
1.0
1.5
0 0.5 1.0
time [s]
V
el
o
ci
ty
[m
/
s]
Vinlet
VSO
VCO
(d) ‘Aortic’ velocity profiles.
Figure X.3.: Valve opening angle and velocity profiles.
2.36 cm2 and that with the Gorlin equation is 2.23 cm2.
The flow pathlines are given in Figure X.4. These figures demonstrate some of
the capabilities of the numerical model. The flow pathlines are diverging into the
enlargement downstream of the valve (Figure X.4(a) and X.4(b)) guiding the valve
leaflet motion. Circular pathlines are furthermore present during complete closing
phase of the valve (Figure X.4(c)).
X.3.2. ‘Straight’ geometry
The valve opening with time for the straight geometry is given in Figure X.3(b).
The valve opens fully and reaches the model maximum of 80°.
Figure X.3(d) shows the velocity profiles that are used to calculate ∆Pdoppler,max,
∆Pdoppler,mean and the VTI as given in Table X.1. The maximum Doppler gradient
∆Pdoppler,max is 4.58 mmHg and the mean value ∆Pdoppler,mean is 2.06 mmHg. The
mean pressure gradients derived from the numerical simulations are ∆Pmean,∆x=10cm
= 0.70 mmHg and ∆Pmean,∆x=3cm = 0.76 mmHg. The maximum pressure gradi-
ents derived from the numerical simulations are ∆Pmax,∆x=10cm = 9.79 mmHg and
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Table X.1.: Summarized haemodynamic data.
Haemodynamic Flow and Pressure Data
‘Expanding’ Geometry ‘Straight’ Geometry
∆Pmean,Feng [mmHg] 2.79 3.29
∆Pmean,∆x=10cm [mmHg] 0.49 0.70
∆Pmax,∆x=10cm [mmHg] 9.20 9.79
∆Pmean,∆x=3cm [mmHg] 0.71 0.76
∆Pmax,∆x=3cm [mmHg] 4.10 3.74
∆Pdoppler,mean [mmHg] 1.11 2.06
∆Pdoppler,max [mmHg] 4.27 4.58
VTI [cm] 28.19 26.5
EOAcontinuity [cm2] 2.36 2.52
EOAGorlin [cm2] 2.23 2.50
∆Pmax,∆x=3cm = 3.74 mmHg. The pressure gradient ∆PFeng is 3.29 mmHg.
The effective orifice area (Table X.1), calculated with the continuity equation, is
2.52 cm2 and that with the Gorlin equation is 2.50 cm2.
The flow pathlines are given in Figure X.5. The flow pathlines in Figures X.5(a) and
X.5(b) are more streamlined compared to the pathlines during the closure of the of
the valve (Figure X.5(c)).
X.3.3. Shear stress distribution
We calculated shear stress distribution on the valve leaflet in the two geometries.
The time variation of average shear stress SSavg is shown (Figure X.6(a)). Average
shear stress SSavg is higher in the straight geometry than in the expanding geometry
(Figure X.6(a)). The maxSSavg is calculated 10.4 Pa for the expanding geometry
and 19.3 Pa for the straight geometry. Figure X.6(b) compares the shear stress
distribution on the leaflet for the two geometries and for the side and central orifice
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(b) t=0.25s, θ =63°, Vinlet=0.05m/s
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(d) Pressure values colorbar.
Figure X.4.: ‘Expanding’ geometry: pathlines colored with reference to pressure.
(Figure X.1). The figure shows the shear stress distribution corresponding with the
time of maxSSavg in figure X.6(a). The SSmax is 25 Pa for of the expanding geometry
and 35 Pa for the straight geometry.
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Figure X.5.: ‘Straight’ position: pathlines colored with reference to pressure.
X.4. Discussion
We simulated the opening and closing of the ATS Open Pivot™ heart valve in two
geometries, a ‘expanding’ conduit and a ‘straight’ conduit. In both cases we used
the physiological inflow pattern corresponding to a cardiac output of 4 l/min. Clin-
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Figure X.6.: Shear stress [Pa] on the valve leaflets.
ical relevant parameters were investigated from the numerical simulations.
We have recently developed a numerical code that accounts for the complex blood-
leaflet interaction, and a 2D validation study has demonstrated the accuracy of the
numerical simulations.140, 142 Based on these observations we applied the algorithm
in a 3D setting. It is however acknowledged that further experimental measurements
are needed to validate the agreement between the measured and calculated complex
3D flow phenomena around the moving valve leaflet. During forward flow condi-
tions, mean pressure gradients remain below 3.3 mmHg for a cardiac output of 4.0
l/min. The mean forward pressure gradients ∆Pdoppler,mean are 1.11 mmHg in case
of mitral flow conditions and 2.06 mmHg for aortic flow pattern. These values are
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in the same range as reported by Laske et al.210 The maximum forward pressure
gradients are in good agreement with the maximum pressure gradients ∆P∆x=3cm
for both geometries. The maximum pressure gradients ∆P∆x=10cm are higher than
∆P∆x=3cm. In order to compare the calculated pressure gradients with published ex-
perimental data, we calculated the mean pressure gradient as defined by Feng et al.73
Our calculated values are 2.79 mmHg for the expanding conduit and 3.29 mmHg
for the straight compared to 4.8 mmHg for the same cardiac output as reported by
Feng et al.73
The effective orifice area, calculated with the continuity equation, is 2.36 cm2 for
the expanding conduit and 2.52 cm2 for the straight conduit. The effective orifice
area, calculated with the Gorlin equation is 2.23 cm2 for the expanding conduit and
2.50 cm2 for the straight conduit. The ATS FDA submission72 reported an effective
orifice area of 2.1 cm2 for the same valve size.
The impact of geometrical conditions on the ATS valve leaflet motion was studied
in vitro by Feng et al.,73, 204 which confirms earlier published in vivo results reported
by Aoyagi et al.203 in mitral position. They73, 204 reported less than maximum open-
ing of the valve in an expanding conduit under mitral flow conditions. Their results
are in qualitative agreement with our numerical simulations. The ATS valve in the
expanding geometry showed opening to a maximum angle of 77.5°, which closely
resembles the 75.5 ± 1.7° reported by Feng at al.73, 204
Another important haemodynamic parameter, impossible to measure directly in vivo
and in vitro, is the shear stress distribution. The SSmax on the valve leaflet is 25 Pa
for the expanding geometry and 35 Pa for the straight geometry. These values are
comparable to what can be found in literature.44 The average SSavg on the leaflet
is 10.4 Pa in the expanding geometry compared to 19.3 Pa in the straight geometry
(Figure X.6(a)). In the expanding geometry the diverging flow interacts with the
valve opening, reducing shear stress on the leaflets as shown in Figures X.6(a) and
X.6(b). Thus, less than maximum opening of the valve and alignment of the leaflets
with the streamlines, improve the shear stress distribution and reduce potential for
damage to platelets and blood cells.
The aim of the study was to apply our computational fluid dynamics code on a
realistic 3D geometry of the ATS valve using relevant geometrical and physiolog-
ical conditions. Our results are in qualitative agreement with in vivo and in vitro
observations.44, 72, 73, 203, 204, 210
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X.5. Conclusion
Our numerical simulation confirms that valve haemodynamics and leaflet motion
depend on the geometrical conditions of the valve: the diverging flow caused by the
expanding conduit combined with the valve design characteristics lead to less than
maximum valve opening, but results in reduced shear stresses on the leaflets.
The computer model can be used to predict pressure gradients, shear stress distri-
bution and effective orifice area of mechanical heart valves. The calculated haemo-
dynamic performances of the ATS medical valve are in agreement with published
data. This new numerical model will be a major research tool to unravel the haemo-
dynamics associated with thrombolytic and hemolytic events of new and existing
mechanical heart valves.
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Chapter XI
Fluid-structure interaction modeling
of a tissue engineered heart valve
leaflet
The contents of this chapter is submitted for publication in Computers in Biology & Medicine.
Feasibility Study of Fluid-Structure Interaction of a Flexible Heart Valve Leaflet in Fluent
Dumont K, Vierendeels J, Segers P and Verdonck P
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Abstract
A new method for the computational analysis of fluid-structure interaction with
highly flexible bodies is presented. Methods and software systems which have been
developed for either fluid or structural applications are used separately. The goal of
this study was to show the feasibility of a new innovative algorithm for the strongly
coupling of a commercial available computational fluid dynamics code (Fluent) with
a in-house coded structural solver. Fluent (Fluent Inc, New Hampshire, US) uses a
dynamic mesh approach for the simulation of flows where the shape of the domain is
changing with time due to the motion of the domain boundaries. The dynamic mesh
model makes use of an arbitrary Lagrangian Eulerian (ALE) formulation of the
Navier-Stokes equations with local remeshing. A full implicit iteration scheme is
developed in order to obtain a stable algorithm. The strong response of the pressure
distribution to the displacement is represented by a Jacobian matrix and is added
to the structural solver in order to obtain a stable iteration scheme. The method is
demonstrated for the opening and closing of a 2D model of a flexible aortic valve
leaflet during the complete cardiac cycle. Futhermore the model is used to calculate
the shear stress on the leaflet applicable for the development of tissue engineered
constructs.
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XI.1. Introduction
Detailed knowledge of the flow field and forces acting upon the heart valve appara-
tus is critical for the design of prosthetic heart valves, and for a better understanding
of biomechanical actors in heart valve disease. This is particularly true for tissue en-
gineered aortic valves. It is still problematic to transplant an in vitro cultured valve
into the aorta, where it is subjected to high pressures and shear forces acting on the
newly seeded cells. Measuring these forces in a direct way is impossible, but nu-
merical techniques may be used to assess them. Ideally the numerical computation
fully accounts for the interaction between the fluid and the leaflet moving within the
fluid, without predefining the fluid field or the leaflet motion.
Several attempts have been made to assess heart valve kinematics using numerical
fluid-structure interaction (FSI) models. Horsten et al.167 modeled the interaction
of a flexible two-dimensional valve leaflet with a rigid channel flow. Peskin and
McQueen et al.145 developed a three-dimensional model including the heart and
vessel walls based on the immersed boundary method. A fluid-structure simulation
of a bioprosthetic aortic valve functioning was performed by Makhijani et al.,166
but the leaflet structure had a much higher resistance to bending compared to the
natural leaflets. A physiological more realistic fluid-structure interaction model of
the natural valve, has been developed by De Hart et al. using the fictitious domain
method.30, 81, 143
Another method often applied to fluid-structure interaction simulations is the ar-
bitrary Lagrangian-Eulerian (ALE) formulation.153, 154 This method combines the
Eulerian formulation, describing the fluid using a fixed mesh, and the Lagrangian
formulation, where the numerical grid follows the motion of the structure. Using the
ALE-remeshing approach, there are different ways to tackle a coupled interaction
problem. One possibility is to develop new software and solution methods for each
of these coupled applications. This is referred to as the monolithical approach or
the direct method.146, 147 On the other hand, one can make use of existing methods
and software packages which have been developed for either fluid or structural ap-
plications and consider iterative methods148 - also known as partitioned methods147
for fluid-structure interaction. As such, separate solvers are used for the fluid and
the structure problem.149 The coupling between both, with an exchange of updated
meshes and boundary conditions, is done in an iterative way.
Recently, Fluent Inc. (New Hampshire, US) released the dynamic mesh model for
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the simulation of flows where the shape of the domain is changing with time due to
the motion of the domain boundaries. The dynamic mesh model uses an ALE and
local remeshing approach to adapt the mesh to a described motion, which can be
described using user-defined functions (UDFs).211 Using Fluent, a structural solver
has to be coupled to the fluid solver in an iterative way.147
In this study, we apply a newly developed FSI algorithm to solve the problem of a
flexible valve leaflet in 2D flow. Furthermore, we believe that one of the potential
applications of the FSI model is the estimation on shear stress forces exerted by the
fluid flow on the endothelial cell surface of a tissue engineered heart valve. There-
fore, to demonstrate the feasibility of calculating detailed flow directed features in
the vicinity of the moving valve leaflets, we calculated shear stresses (SS) on the
leaflets over the complete cardiac cycle.
XI.2. Methods
XI.2.1. A 2D structural model of a flexible heart valve leaflet
Figure XI.1 illustrates how the 2D flexible heart valve leaflet with a length l is mod-
eled. The leaflet consists of N equidistant segments with length ∆l = lN connected
to each other with frictionless pivots and with torsional springs, characterized by
the constant ks = EI∆l . The material model is based on earlier studies done by David
et al.212 and Horsten et al.167 If the pressure distribution p on the leaflet is given by
the fluid solver Fluent, the unknown variables are the positions X of the segment
centers, the angles θ defining the position of the leaflet, and the reaction forces Rx
and Ry in the x-direction and the y-direction, respectively.
p =

p1
.
.
.
pi
.
.
.
pN

, X =

x1
y1
.
.
.
xi
yi
.
.
.
xN
yN

, θ =

θ1
.
.
.
θi
.
.
.
θN

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
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.
.
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.
.
.
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
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
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.
.
.
Ry,i
.
.
.
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(XI.1)
204
XI.2. Methods
θ0 = 0
y
ks,hinge
ks
x
 
θ1
−→
p1
θ2
−→
p2

c
∆l
θN−1
−→
pN−1

θN
−→
pN

(a) Scheme for flexible leaflet: segments are connected with
frictionless pivots and angular stiffness.
 
+
x
y
Rx,i+1
Rx,i
Ry,i
Ry,i+1
Mi+1
Mi
pi
−→
−→
xc,i= (xi, yi)
θi
(b) Forces acting on a single segment of the
flexible leaflet.
Figure XI.1.: Schematic overview of the implemented material model: total leaflet length (top
panel), single segment (bottom panel).
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The equation describing the material model is written as
G(p,X, θ,Rx, Ry) = 0 (XI.2)
Two equations (2 dimensional model) will express that the length of the leaflet seg-
ments is a constant value ∆l. Furthermore, Newton’s 2nd Law of Motion states
that the acceleration of a particle is equal to the vector sum of forces acting upon
that particle. This Conservation of Momentum results in an equilibrium equation
of the forces in the x-direction, and the y-direction and the rotational equilibrium
equation.

Gi,1 = 0 ,
Gi,2 = 0 ,
Gi,3 = 0 ,
Gi,4 = 0 ,
Gi,5 = 0
=

xi = xi−1 + ∆l2 · sin(θi−1) + ∆l2 · sin(θi) ,
yi = yi−1 − ∆l2 · cos(θi−1)− ∆l2 · cos(θi) ,
m · x¨i = −Rx,i +Rx,i+1 + pi · cos(θi) ,
m · y¨i = −Ry,i +Ry,i+1 + pi · sin(θi) ,
I · θ¨i = Mi −Mi+1 + ∆l2 · (Rx,i +Rx,i+1) · cos(θi)
+∆l2 · (Ry,i +Ry,i+1) · sin(θi)
(XI.3)
The equations are linearized with Newton linearization and solved iteratively upon
convergence. The index n indicates the timestep and s denotes the subiterations of
the structural model.
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xn+1,s+1i = x
n+1,s+1
i−1 (XI.4)
+ ∆l
2
·(sin(θn+1,si−1 )+sin(θn+1,si ))
+ ∆l
2
·cos(θn+1,si−1 )·(θn+1,s+1i−1 −θn+1,si−1 )
+ ∆l
2
·cos(θn+1,si )·(θn+1,s+1i −θn+1,si ) ,
yn+1,s+1i = y
n+1,s+1
i−1 (XI.5)
− ∆l
2
·(cos(θn+1,si−1 )+cos(θn+1,si ))
+ ∆l
2
·sin(θn+1,si−1 )·(θn+1,s+1i−1 −θn+1,si−1 )
+ ∆l
2
·sin(θn+1,si )·(θn+1,s+1i −θn+1,si ) ,
m
∆t2
·xn+1,s+1i = m∆t2 ·(x
n
i +x˙
n
i ·∆t) (XI.6)
− Rn+1,s+1x,i +Rn+1,s+1x,i+1 +pi·cos(θn+1,si ) ,
m
∆t2
·yn+1,s+1i = m∆t2 ·(y
n
i +y˙
n
i ·∆t) (XI.7)
− Rn+1,s+1y,i +Rn+1,s+1y,i+1 +pi·sin(θn+1,si ) ,
I
∆t2
·θn+1,s+1i = I∆t2 ·(θ
n
i +θ˙
n
i ·∆t) (XI.8)
+ EI
∆l
(θn+1,s+1i−1 −θn+1,s+1i −∆θi,no stress)
− EI
∆l
(θn+1,s+1i −θn+1,s+1i+1 −∆θi+1,no stress)
+ ∆l
2
·(Rn+1,s+1x,i +Rn+1,s+1x,i+1 )·cos(θn+1,si )
− ∆l
2
·(Rn+1,sx,i +Rn+1,sx,i+1 )·sin(θn+1,si )·(θn+1,s+1i −θn+1,si )
+ ∆l
2
·(Rn+1,s+1y,i +Rn+1,s+1y,i+1 )·sin(θn+1,si )
+ ∆l
2
·(Rn+1,sy,i +Rn+1,sy,i+1 )·cos(θn+1,si )·(θn+1,s+1i −θn+1,si )
The equations look slightly different for the outer segments i=1 and i=N of the
leaflet: M1 = ks,hinge · (θ1 − θ0) and x0 = y0 = 0 m, MN+1 = 0 Nm, Rx,N+1 =
Ry,N+1 = 0 N. The structural equations are solved for a certain imposed pressure
distribution p. This gives the displacements Xn+1 as a result. The angles and
reaction forces can be seen as internal variables for the structural solver. In the
sequel we can thus write the structural solver as
G(Xn+1, p) = 0 . (XI.9)
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As explained, the structural problem will be solved in an iterative manner, with s+1
the new subiteration and s the previous subiteration.
G(Xs+1, p) = 0 = G(Xs, p) +
∂G
∂X
∣∣∣∣
s
·∆X (XI.10)
If A = ∂G∂X
∣∣∣
s
, we can solve ∆X from the equation:
A · (−∆X) = G(Xs, p) (XI.11)
This scheme is solved iteratively until ∆X equals zero, so that the Conservation
of Momentum is fulfilled in all the nodes. The position of the nodes X is then in
equilibrium with the pressure distribution p. From now on we drop the index s as
notation.
XI.2.2. The implicit iteration scheme
To achieve implicit time integration with the partioned (fluid and structural) solvers,
an iterative coupling is needed per timestep. To obtain a coupled solution of both
fluid and structural solver, an explicit coupling procedure can be used, consisting of
subsequent calls of both solvers. An estimated pressure distribution pn+1,k is used
in the structural model G(Xn+1,k+1, pn+1,k) = 0 to estimate the new positions of
the valve leaflet Xn+1,k+1. Here k denotes the subiteration level of the coupling
of the fluid and the structural solver. A new pressure distribution pn+1,k+1 is then
estimated by solving the flow equation in Fluent F (Xn+1,k+1, pn+1,k+1) = 0 for
this new position of the valve leaflet Xn+1,k+1. This new pressure distribution will
then again be used to estimate the new positions of the flexible valve leaflet.
G(Xn+1,k+1, pn+1,k) = 0,
F (Xn+1,k+1, pn+1,k+1) = 0 .
(XI.12)
However, this explicit procedure is not stable, because the displacements ∆X of the
structural solver are highly sensitive to variations of the imposed pressure distribu-
tion ∆p from Fluent on the valve leaflet. The pressure distribution ∆p calculated in
Fluent, on the other hand, is reacting very sensitively on variations of the displace-
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ments ∆X from the structural solver. The problems with this explicit scheme, is
that the equations G are not solved with pn+1,k+1, but with pn+1,k. Thus, in the
iterative procedure the pressure distribution of the previous Fluent subiteration is
used. Because the valve leaflet is highly flexible and the structural problem is not
accounting for the influence ∂p∂X of the displacements X on the pressure distribution
p, it is overreacting to the pressure forces from Fluent. Earlier studies on mechanical
heart valves with stiff leaflets and thus only one degree of freedom, e.g. the angle of
the valve leaflet, showed the importance of this derivative for the stabilization of the
iteration scheme.140, 142, 213 The iterative scheme becomes stable and fully implicit
if we could predict in the structural solver how the pressure distribution would react
on changes in the positions of the leaflet nodes. The implicit formulation of the
equation for the flexible leaflet becomes
G(Xn+1,k+1, pn+1,k+1) = 0 . (XI.13)
An approximation of pn+1,k+1 (Equation XI.14) can be obtained from a Reduced
Order Model FROM which predicts the behavior of the fluid solver to the prescribed
displacements of the leaflet.
pn+1,k+1 = FROM (X
n+1,k+1) = pn+1,k+AROM (Xn+1,k+1−Xn+1,k) (XI.14)
Since the pressure distribution on the leaflet is not longer a constant value, but
changing with the leaflet position, the equation XI.10 needs to be rewritten:
0 = G(Xn+1,k+1, pn+1,k+1) ≈ G(Xn+1,k+1, pn+1,k) (XI.15)
+
∂G
∂p
∣∣∣∣n+1,k · (pn+1,k+1 − pn+1,k) .
With equation XI.14 this becomes
0 = G(Xn+1,k+1, pn+1,k+1) ≈ G(Xn+1,k+1, pn+1,k) (XI.16)
+
∂G
∂p
∣∣∣∣n+1,k ·AROM (Xn+1,k+1 −Xn+1,k)
where pn+1,k and Xn+1,k are solutions of F (Xn+1,k, pn+1,k) = 0 and AROM is
the Jacobian matrix of a reduced order model of the response of the fluid solver.
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START: Xn=start
Solve Fluent with
Xn+1,k=1 = Xn
⇓
pn+1,k=1 and k=k+1
Solve Fluent with
Xn+1,k=2 = Xn + v1
⇓
pn+1,k=2 and k=k+1
Solve Fluent with
Xn+1,k=3 = Xn+ v2
⇓
pn+1,k=3 and k=k+1
Xn+1,k+1=Xn+1,k
and
pn+1,k+1=pn+1,k
calculate ∂p
∂∆X
and Amod
solve G(Xn+1,k+1, pn+1,k+1) = 0
Xn+1,k+1,s+1
| |
Xn+1,k+1,s?
s=s+1
Solve Fluent with
Xn+1,k+1
⇓
pn+1,k+1
k=k+1 Xn+1,k+1=Xn+1,k? n=n+1
Xn+1=Xn+1,k+1 tend=(n+1)·∆t?
END
No
No
Yes
Yes No
Yes
timestep loop: index n FSI loop: index k material solver: index s
Figure XI.2.: Iterative scheme of the 2D flexible leaflet fluid-structure interaction model.
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With Amod = ∂G∂p
∣∣∣n+1,k ·AROM , this results in
0 = G(Xn+1,k+1, pn+1,k+1) ≈ G(Xn+1,k+1, pn+1,k) (XI.17)
+Amod · (Xn+1,k+1 −Xn+1,k) .
This equation is solved iteratively in the same way as equation XI.11. The index
mod of the matrix Amod is based on the use of “displacements modes”, which is
further explained in paragraph “Calculation of Amod”.
Finally, figure XI.2 shows how the three iterations loops fit into the flow diagram:
the smallest loop with index s is the iteration loop for the structural leaflet model,
the middle loop with index k is the iteration loop for the coupling of Fluent with the
structural solver and the outer loop with index n is the timestep loop.
XI.2.2.1. Calculation of Amod
To calculate the matrix Amod we remark that the force on one single segment is
only function of the pressure on that segment and is independent on the pressure
distribution on the other segments. With this simplification the calculation of ∂G∂p is
relatively simple.
∂G
∂p
=

0
0
∂G1,3/∂p1
∂G1,4/∂p1
0
.
.
.
0
0
∂Gi,3/∂pi
∂Gi,4/∂pi
0
.
.
.
0
0
∂GN,3/∂pN
∂GN,4/∂pN
0

(XI.18)
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The calculation of AROM is more complicated. AROM represents the relation be-
tween ∆p and ∆X within one timestep. The proposed method uses “displacement
modes” or possible displacements of the valve leaflet. As the leaflet has 2 · N de-
grees of freedom, there are maximum 2 · N linear independent modes. By using
these modes, we can calculate an approximation of ∂p∂X .
The process is started from the initial positions Xn+1,k and the pressure distribution
pn+1,k. Small perturbations with reference to Xn+1,k are introduced in the model
and the correspondent pressure distribution is calculated with the Fluent solver.
When using m displacement modes vj , Fluent gives us correspondingly m pres-
sure distributions p
j
. By doing so, we can construct the matrix with the pressure
responses to the applied displacements modes.[
∆p
1
· · · ∆p
j
· · · ∆pm
]
(XI.19)
with ∆p
j
= pn+1,j−pn+1,k−1 for k > 3, j = 1 . . . k−2 and with p
j
the pressure dis-
tribution resulting from the perturbation vj−1 (v0 = 0). An arbitrary displacement
∆X can now be written as the sum of 2.N perturbation modes:
∆X =

∆x1
∆y1
∆x2
∆y2
.
.
.
∆xN
∆yN

= α1.v1 + α2.v2 + α3.v3 + . . .+ α2.N .v2.N (XI.20)
where the scalars αj represent the weighting factor of the perturbation modes. As it
is not necessarily required to use all 2.N modes, we can rewrite the above equation
for m modes.
∆X ≈ α1.v1 + . . .+ αj .vj + . . .+ αm.vm (XI.21)
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Multiplying to the left with vT1 , gives:
vT1 ·∆X ≈ α1. 〈v1, v1〉+ . . .+ αj .
〈
v1, vj
〉
+ . . .+ αm. 〈v1, vm〉 (XI.22)
with
〈
vj , vj
〉
= vTj · vj . If this is done for every mode, this results in:

α1
.
.
.
αj
.
.
.
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
≈

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v1, vj
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≈ V ·
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The calculated α’s represent the ‘contribution’ of each mode to the total displace-
ment ∆X and thus we can write:
∂G
∂p
·∆p ≈ ∂G
∂p
·
[
∆p
1
· · · ∆p
j
· · · ∆p
m
]
·

α1
.
.
.
αj
.
.
.
αm

(XI.24)
The matrix Amod is thus defined and is given by:
Amod =
∂G
∂p
·
[
∆p
1
· · · ∆p
j
· · · ∆p
m
]
· V (XI.25)
With this knowledge, one can solve the equation XI.17. During the subiterations the
modes are subsequently calculated and added to the model. Only a few subiterations
are needed for convergence (3 to 4 orders of magnitude). In practice minimally one
mode needs to be prescribed to get started. The other modes are then the result
from the calculated displacements with the structural model. In other words, the
structural model generates the additional modes itself. These new modes fasten
the convergence of the algorithm. Experience learned that better convergence can
be obtained if two or more modes are prescribed. This is also reflected in figure
XI.2 where the FSI loop starts with the computation of the pressure responses on
prescribed modes v1 and v2. Figure XI.3 shows as an example the shape of the two
prescribed modes. These quadratic functions of the form A · (s/l)2+B · (s/l) = 0,
with 0 < s < l the distance along the leaflet, are based on the structural analysis
theory of an elastic beam. For v1 we used A = 2 and B = −2 and for v2 the
parameters are chosen A = −2.5 and B = 2. The final result is independent of the
prescribed modes, although the chosen shape can influence the convergence speed
of the procedure.
XI.2.3. Geometry, meshes and boundary conditions
The two-dimensional geometry used for the actual simulation (figure XI.4(a)) con-
sists of an inflow tract (inlet = left ventricular outflow tract), a sinus of Valsalve
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Figure XI.3.: Prescribed modes.
(aortic valve) and an outflow tract (outlet = aorta). The dimensions of the geometry
are l1 =4cm, l2=6cm, r1=2cm, r2=0.75cm and h=2cm.
A physiological aortic inflow pattern (Qao) (figure XI.4(b)) is imposed as bound-
ary condition. An example of the computational mesh is shown in figure XI.4(c).
Because of the limitations in the dynamic mesh model, there is at least one cell re-
quired to cover the gap between the valve leaflet and the wall. This one cell needs
to ensure that the fluid domain is preserved as one entity.
XI.2.3.1. Stability of the algorithm
Firstly a grid convergence study was performed. Two different grid densities, i.e.
±2100 cells with the leaflet divided in N=10 segments and ±4650 cells with the
leaflet divided in N=15 segments, were studied with ∆t=0.001s. Secondly it is
verified whether solutions were timestep independent with variations in the timestep
from ∆t=0.001s to ∆t=0.0005s for the coarse mesh. Two subsequent cycles were
calculated in order to have results independent of the initial zero flow in the entire
fluid domain fluid. The stiffness EInormal of the aortic valve leaflet used in this
model is 2.7 ·10−5 N ·m2. The modulus of Young E for normal aortic valve leaflets
found in literature is between 1 · 106 N/m2 and 2 · 106 N/s2.29, 30, 31, 32 We chose
E equal to 1.5 · 106 N/m2. The thickness of the leaflet varies between 0.2 and
1.4mm,29, 33 but as most researchers, we use about 0.6mm as the leaflet thickness
for aortic valve.31, 32, 34 With the moment of inertia I = b·h312 , h = thickness of the
leaflet and b = 1m the reference width of the 2D model, the above mentioned value
of 2.7 · 10−5 N · m2 is obtained. As proposed by David at al.212 the stiffness of
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Figure XI.4.: 2D flexible aortic valve model.
the hinge ks,hinge is somewhat lower than the leaflet stiffness. For both meshes the
same value for ks,hinge = 0.0075N ·m/rad is used.
XI.2.3.2. Application: shear stress on flexible valve leaflets
One of the potential applications of the FSI model is the estimation of shear stress
(SS) forces exerted by the the fluid flow on the endothelial cell surface of a tissue
engineered heart valve. We calculate the spatial average SS on the ventricular and
aortic side of the leaflet over time. First of all, the influence of a low flow rate with
Qlow=
Qao
10 on the SS was investigated for the same leaflet stiffness properties as
used in the stability analysis. Furthermore, the SS was estimated on a stiffer leaflet
with EIhigh four times higher, thus EIhigh = 1.08 · 10−4 N ·m2 and ks,hinge,high =
0.03N ·m/rad.
XI.3. Results
XI.3.1. Flow fields and leaflet motion
Figure XI.5 demonstrates the behavior of the flexible valve leaflet during the open-
ing phase of the aortic valve. The fluid flow is accelerating and initially pushes the
leaflet towards the outlet. Due to the flexible properties, the leaflet shows a bump
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Figure XI.5.: Aortic flow vector plots during the opening phase of the valve motion.
(figure XI.5(b) because of the forward flow at t=0.05s. At t=0.10s the leaflet is al-
most moving into the sinus cavity. In figure XI.5(d) at t=0.20s, the leaflet is guided
by the flow and the vortex in the sinus cavity is responsible for the curving of the
leaflet.
Figure XI.6 demonstrates the flexible behavior of the valve leaflet during the clos-
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Figure XI.6.: Aortic flow vector plots during the closing phase of the valve motion.
ing phase of the aortic valve, where the flow is decelerating. The vortex in the
aortic sinus is enlarging, forcing the leaflet to move downwards (figures XI.6(b) and
XI.6(c)). In figure XI.6(d) the large vortex in the sinus is guiding and curving the
flexible valve leaflet.
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XI.3.2. Grid dependence study
The FSI problem was solved on two different grids: a dense grid with approxi-
mately 4650 cells and N=15 segments for the valve leaflet and a coarse grid with
approximately 2100 cells and N=10 segments for the valve leaflet. Figures XI.7
show results which are virtually grid independent. The biggest difference exists at
t=0.09s (figure XI.7(a)). Figure XI.7(a) shows an “overshoot” of the valve leaflet
almost into the aortic sinus. Eventually the leaflet is moving downwards to a more
stable position. During closure of the valve small differences are shown in figure
XI.7(b). It is important to mention that the ks,hinge needs to be the same value for
both the values of N , with N representing the number of segments of the valve
leaflet. The stiffness EI∆l =
EI
l/N of the other springs is dependent on N .
XI.3.3. Timestep dependence study
Figure XI.8 shows the results obtained with the two timesteps used: ∆t=0.001s
(dashed lines) and ∆t=0.0005s (dotted line). They are qualitatively and quantita-
tively the same. The small difference in “overshoot” of the valve leaflet at t=0.09s
is not influencing the closure of the valve, as shown in figure XI.8(b).
XI.3.4. Application: shear stress on flexible valve leaflets
Figure XI.9 shows the average SS on the ventricular and aortic leaflet side during
the complete cardiac cycle. Figure XI.9(a) shows lower SS at the aortic side of the
valve leaflet compared to the ventricular side (figure XI.9(b)). The higher stiffness
(EIhigh=4 ·EInormal), results in higher SS values, especially at the ventricular side
of the valve leaflet. A lower flow rate (Qlow=Qao10 ) results in a similar decrease in
SS.
XI.4. Discussion and Conclusion
A novel fluid-structure interaction algorithm has been developed to study the in-
teraction between the flow and highly flexible structures such as heart valves. The
available Fluent software was extended with dedicated User Defined Functions (UDFs)
and coupled with a customized structural solver with an iterative algorithm. The
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Figure XI.7.: Grid dependence study.
structural solver is based on a model previously studied by Horsten et al.167 and
by David et al.212 Several studies demonstrated the behavior of a flexible heart
valve29, 167, 202, 212 in settings similar to the one we used. The leaflet moves towards
the aortic sinus, and tends to move into this sinus.29 After this “overshoot” of the
valve leaflet, the leaflet starts moving downwards. The vortex is present during the
complete cardiac cycle. This vortex helps and guides the closure and movement of
the aortic valve leaflet during the closure of the valve.202
A grid and timestep dependence study was performed, in order to demonstrate the
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Figure XI.8.: Timestep dependence study.
robustness of the newly developed FSI code. Figure XI.7 shows that grid indepen-
dence is achieved. The same study was performed to assess timestep independence.
In both cases small differences are shown in figures XI.8 and XI.7 concerning the
valve leaflet “overshoot”, but this difference does not influence the valve closure
of the flexible leaflet as shown in figure XI.8(b). Thus figures XI.7 and XI.8 give
qualitative and quantitative good results, and it proves the robustness of the new FSI
algorithm.
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Figure XI.9.: Shear stress SS in Pa on the 2D valve leaflet.
The final goal of the flexible leaflet study is to use the model in the development of
guidelines for bioreactor and tissue engineering studies of aortic heart valve leaflets.
An important haemodynamic parameter influencing the endothelial cell layer is the
shear stress (SS). Cells seeded on TE constructs are matured and conditioned in a
bioreactor. Although flow and pressure can be regulated in a bioreactor, the mag-
nitude of SS on the cells is unknown. Maturing them in a bioreactor requires a
gradual increase of shear stress.96, 97, 110 Little is known about how a protocol for
these TE constructs needs to look like, and there is a need for standardization.96, 110
This FSI-CFD algorithm should allow to assess SS exerted on the valve inside the
bioreactor and could thus help to develop a protocol with gradually increasing shear
stress. In this way, the endothelial cells would be able to adapt to the flow and grad-
ually orientate in the direction of the flow.118
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A stable FSI code was obtained, through our experience with the 2D and 3D mod-
eling of mechanical heart valves.140, 142, 213 Although the modeling of mechanical
heart valves requires the FSI algorithm to solve only for one variable θ, the angle
of the stiff leaflet, a similar iterative approach was necessary. This approach was
extended for the simulation of flexible heart valve leaflets. Because there are more
degrees of freedom the problem is more difficult to solve in a stable way. Therefore
a matrix Amod is included in the structural model. Our newly developed FSI code
has the advantage that current available and widely used CFD codes could be cou-
pled to arbitrary structural code.147, 149
Our goal was to study the feasibility of the iterative coupling of Fluent with a struc-
tural solver. The used method implies that commercial structural solver need to be
highly open source when used for iterative coupling with CFD packages. This open
source allows the user to add the variations of the pressure forces in function of the
found displacements. In this way a fully implicit iteration scheme can be obtained.
The method is demonstrated on the opening and closing of the aortic valve during
the complete cardiac cycle in 2D and has potential for shear stress estimation on
tissue engineered leaflet constructs.
XI.5. Model limitations and future developments
This study has some inherent limitations. Firstly, the study is restricted to two di-
mensions and a simple structural model for the leaflets is used. This will have to be
extended to three dimensions with incorporation of the layered structure of native
heart valves. Secondly, although a stability study was performed, the code should
be validated further, comparing calculated flow fields and valve movement with
measured data in an in vitro setup.
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Conclusion
Surgical replacement of diseased human heart valves by mechanical and tissue valve
substitutes is now commonplace. Still, new valves are designed to improve the bio-
compatibility and haemodynamics, optimizing the transvalvular flow with special
attention to prevent stagnation and excess (shear) forces on the valve. Different
techniques can be used to assess the haemodynamic performance of these heart
valves. In this dissertation both in vitro testing and numerical simulation have been
described.
Two different types of mechanical heart valves (On-X bileaflet valve and Omni-
carbon monoleaflet valve) were tested in a Pulse Duplicator Mock loop. More
important than the assessment of the performance of these specific valves, these
experiments allowed us to get insight in the requirements associated with haemo-
dynamic valve testing, and to get an overview of parameters which are currently
in use to quantify valve functioning. In addition, the knowhow gathered with the
mock loop enabled us to design mechanical parts of the bioreactor and to create a
system allowing the generation of versatile and diverse haemodynamic conditions,
necessary for the conditioning of tissue engineered heart valves.
From CFD perspective, the challenging task was not only to calculate the flow
through the valve, but especially to model the dynamic interaction of the aortic
valve with the surrounding blood, and finally to calculate the local deformations
and stresses in the structure. In this thesis, we have presented a model based on
the available commercial fluid solver Fluent (Fluent Inc.), which makes use of an
ALE (arbitrary Lagrange-Euler) approach. The software allows for the simulation
of flows where the shape of the structure is changing with time. Although, this soft-
ware is capable of solving a wide range of engineering and biomedical problems, it
is not accounting for the interaction between the fluid and the structure. For that rea-
son, we developed an iterative methodology based on the available Fluent software.
To reduce complexity of the iterative model in the initial phase, the flexible proper-
ties of the leaflet were neglected and an aortic valve with stiff leaflet was studied.
The stability and accuracy of the new model was investigated with a 2D model of
the aortic valve.
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The potential of this model as a research and development tool for mechanical heart
valves has been demonstrated in this dissertation. For instance, the above men-
tioned in vitro techniques imply that prototypes of the valves are already available
at the time of testing. In the course of the development process, however, valves
are computer designed, and virtual valve prototypes are available in an early stage
of the design process. We have shown that our numerical model is capable of test-
ing the haemodynamic performance of these virtual prototypes, as we simulated a
commercially available 3D bileaflet mechanical heart valve (ATS valve). Although
the size of the leaflet and the maximum opening angle had to be reduced due to the
mentioned remeshing and/or CPU-time limitations, the model was able to reproduce
reported in vitro and clinical results. It is clear that the model can be used to pre-
dict shortcomings of available and new mechanical heart valves. Future work may
include the numerical comparison of currently available mechanical heart valves in
different geometries and for different inflow conditions and, obviously, virtual pro-
totype testing in the early stage of new mechanical heart valve design.
Current available heart valves are non-viable valves and all have disadvantages in
one way or another. Most of the shortcomings of current valves could be solved by
tissue engineering, where it is theoretically possible to grow a valve with patient-
specific biological material, consisting of viable tissue. Until now, most research
efforts failed in the final stage of implantation of the valve in aortic position, which
seems to indicate that preconditioning of the valve should be optimized to train the
valve in withstanding the high forces in vivo. The developed bioreactor is capable
of providing a physiological environment for growing and testing these tissue engi-
neered heart valve constructs with a high degree of flexibility in creating pulsatile
flow conditions, though further attention should be paid improving the biocompati-
bility of the design.
There is overwhelming evidence that the function and integrity of cells exposed
to flow is highly dependent on the nature of the flow regime, which determines the
magnitude and direction of the shear forces exerted on the cells. Therefore, in order
to set up a protocol for cultivating, maturing and growing a tissue engineered car-
diovascular device, it is important to assess and to control the shear forces exerted
on the fragile freshly seeded cells. These shear stresses can be easily calculated in
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simple flow geometries, as in cell culture devices, but not in the more complex in
vivo environment or inside a bioreactor. This is where numerical (CFD) techniques
can help.
To tackle this type of problem, the stiff leaflet model needed to be extended to a
flexible leaflet model, as one of the goals was to predict the shear stresses on a tis-
sue engineered valve construct, cultivated in a bioreactor. Adding the flexibility of
the valve leaflet resulted in an innovative complex iteration procedure, embedded,
however, within available software code, demonstrating that fluid-structure interac-
tion of the flexible heart valve is feasible in this setting. The robustness (grid and
time step independence) of the model has been demonstrated, but further validation
with comparison to in vitro experiments is mandatory. The model will allow to es-
timate shear stress not only for different flow rates, but also for different stiffness
properties of the flexible leaflet model. At this stage, a relatively simple material
model is used, which does not account for the layered structure of the natural heart
valves. A first extension could be the implementation of a layered material model
and a detailed parameter study of the internal stresses and the shear stresses. Fur-
thermore, only a 2D model is developed in this dissertation, but the extension to 3D
is, though more complex (due to more complex 3D deformation modes), straight-
forward.
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